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SUMMARY
Progressive familial heart block type I (PFHBI) is a cardiac ventricular conduction disorder of
unknown cause associated with risk of sudden death, which has been described in several
South African families. Clinically, PFHBI is characterised by right bundle branch block on
ECG, which may progress to complete heart block, necessitating pacemaker implantation.
The disease shows an autosomal dominant pattern of inheritance with evidence of genetic
anticipation. Using genetic linkage analysis, the PFHBI-causative gene was mapped to a 10
eentimorgan (cM) gene-rich area of chromosome (C) 19q13.3, which has, subsequently, been
reduced to 7cM by fine mapping with polymorphic dinucleotide (CA)n short tandem repeat
(STR) markers. Several attractive candidate genes, including muscle glycogen synthase
(GSY 1) and histidine-rich calcium binding protein (HRC), lie within this region.
The aim of the present study was two-fold: 1) to identify and characterise tetranucleotide
(AAAT)n STRs within the PFHBI critical region that could be developed as polymorphic
markers for use in genetic fine mapping and 2) to screen selected regions of GSY1and HRC,
positional candidate genes, for the presence ofPFHBI-causing mutation(s).
Cosmids harbouring CI9q13.3 insert DNA were screened for the presence of (AAAT)n STRs
by dot blot and Southern blot hybridisation using a radiolabelled (AAAT)lO oligonucleotide
probe. To characterise the harboured (AAAT)n STRs, the positively hybridising fragments
identified by Southern blot were sub-cloned, sequenced and primers designed from the unique
repeat-flanking sequences. These primers were used to genotype the (AAAT)n repeat locus to
assess its polymorphic nature in a panel of unrelated individuals. Alternatively, vectorette
PCR, a rapid method of identifying repeat sequences and obtaining the flanking sequences in
large inserts, was employed to develop polymorphic markers from the positively hybridising
clones. Selected exons of GSY1 and HRC were screened for the presence of potentially
disease-causing mutations by PCR-SSCP analysis and direct sequencing, respectively, in
PFHBI-affected and unaffected family members.
Of the available cosmid clones that gave strong signals on dot blot and Southern blot
hybridisation, three, 29395, 24493 and 20381, were located within the critical PFHBI area
and were used for marker development. An interrupted (AAAT)n repeat motif (n less than 5)
was identified in cosmid 29395, however, the repeat locus was not polymorphic in the tested
population. No (AAAT)n motif, single or repeated was observed in the partial sequence of the
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sub-cloned fragment of cosmid 24493. Using vectorette peR, no repeated (AAAT)n motif
was identified on sequencing the generated products in either cosmid 24493 or 2038l.
However, diffuse single AAAT motifs were detected in both cosmids. Exons 4, 5, 11, 12 and
16 of GSY 1, containing domains that are conserved across species, and the conserved e-
terminus-encoding exons 2-6 of HRC were selected for screening for potential PFHBI-causing
mutation(s). However, no sequence variations were detected.
The interrupted (AAAT)n repeat identified in cosmid 29395 was not polymorphic, which
confirmed reports that complex repeats, especially those containing AAAT motifs of less than
6 repeats, are not polymorphic. One possible explanation for the absence of a repeated AAAT
motif in cosmids 24493 and 20381, which both gave positive hybridisation signals, is that the
low annealing temperature of the AfT -rich repeat-anchored primers used in vectorette peR
may have resulted in transient annealing to the diffuse single AAAT motifs detected on
sequencing. The screened regions of candidate genes GSYI and HRC were excluded from
carrying the disease-causing mutation(s).
The availability of new sequence data generated by the Human Genome Project will influence
future strategies to identify the PFHBI gene. Electronic searches will allow identification of
STR sequences for development of polymorphic markers and gene annotation will allow
selection of new candidate genes for mutation screening.
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OPSOMMING
Progressiewe familiële hartblok tipe I (PFHBI) is 'n outosomaal dominante siekte van die
kardiale geleidingsisteem. PFHBI, waarvan die oorsaak onbekend is, kom voor in verskeie
Suid-Afrikaanse families en kan lei tot voortydige dood. PFHBI word op elektrokardiogram
(EKG) gedefiniëer deur regter bondeltak blok. Hierdie toestand kan lei tot volledige hartblok
en die gevolglike implantering van 'n pasaangeër. PFHBI word outosomaal dominant
oorgeërf en daar is bewyse van genetiese afwagting. Genetiese koppelingsanalises het die
PFHBI geen gelokaliseer tot 'n 10 eentimorgan (eM) area op chromosoom 19q13.3. Hierdie
area is verkort tot 7 eM deur kaartering met polimorfiese dinukleotied (CA)n herhalings
(STR) merkers. Verskeie kandidaat gene, onder andere spier glikogeen sintase (GSD) en
histidien-ryke Kalsium bindingsproteïen (HRC) word binne die 7 eM area gevind.
Die doel van hierdie studie was twee-voudig: 1) die identifisering van tetranukleotied
(AAAT)n STRs in die PFHBI kritiese area wat ontwikkel kan word as polimorfiese merkers
vir gebruik in genetiese kaartering en 2) die identifisering van mutasies wat lei tot PFHBI in
die GSD en HRC areas.
Die teenwoordigheid van (AAAT)n STRs in kosmied klone bevattende die c19q13.3 area, is
aangedui deur Southern klad en Dot klad hibridisasie. 'n Radio-aktief gemerkte (AAAT)lO
oligonukleotied pylfragment is in die studies gebruik. Die positief gehibridiseerde fragmente
is gesubkloneer, DNA volgorde bepaling is gedoen en primers is ontwerp vanaf die unieke
herhalings volgordes. Hierdie primers is gebruik om die (AAAT)n herhalings lokus te
genotipeer en te gebruik om die polimorfismes in onverwante individue te bepaal. Vectorette
PCR is ook gebruik om polimorfiese merkers vanaf die positief gehibridiseerde klone te
ontwerp. PCR-SSCP analises en DNA volgorde bepaling is gebruik om potensïele PFHBI
veroorsakende mutasies te identifiseer in eksons van GSl1 en HRC in PFHBI-geaffekteerde
en nie-geaffekteerde familie lede.
Die kosmied klone, 29395, 24493 en 20381, wat sterk seine in die DNA klad tegnieke getoon
het, is gelokaliseer binne die kritiese PFHBI area en is gebruik vir die ontwikkeling van
genetiese merkers. 'n (AAAT)n herhalingsmotief (n is kleiner as 5) is geïdentifiseer in
kosmied 29395 maar hierdie lokus was nie polimorfies in die populasie wat ondersoek is nie.
Geen (AAA T), motief, enkel of herhalend, is geïdentifiseer in kosmied 24493 nie. Vectorette
peR het geen herhalende (AAAT)n motief geïdentifiseer in kosmiede 24493 of 220381 nie.
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yEnkel AAAT motiewe is egter geïdentifiseer in beide kosmiede. Eksons 4, 5, 11, 12 en 16
van GSTI bevattende spesie gekonserveerde domeine, en die gekonserveerde C-terminus-
enkoderende eksons 2-6 van HRC is geïdentifiseer as mutasies wat kan lei to PFHBI. Geen
DNA volgorde variasies is waargeneem nie.
Die onderbroke (AAAT)n herhaling wat geïdentifiseer is in kosmied 29395 was me
polimorfies nie. Hierdie bevinding bevestig studies wat aandui dat komplekse herhalings,
veral die bevattende minder as ses AAAT herhalings motiewe, nie polimorfies is nie. 'n
Verduideliking vir die afwesigheid van 'n herhalende AAAT motief in kosmiede 24493 en
20381, wat albei positiewe hibridisasie seine getoon het, is dat die lae aanhegtings
temperatuur van die AlT ryke primers wat gebruik is in vectorette PCR kon gelei het tot
aanhegting van die primers aan die enkel AAAT motiewe wat geïdentifiseer is deur DNA
volgorde bepaling. Die areas van die kandidaat gene GSYI en HRC is uitgesluit vir die
moontlike voorkoms van PFHBI veroorsakende mutasies.
DNA volgorde data vanaf die Menslike Genoom Projek sal toekomstige studies om die
PFHBI geen te identifiseer positief beïnvloed. Identifisering van STR volgordes vir die
ontwikkeling van polimorfiese merkers en geen annotering vir die seleksie van nuwe
kandidaat gene word vergemaklik deur die gebruik van elektroniese hulpmiddels.
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GENERAL ABBREVIATIONS
a alpha
A lambda
°c degrees Celsius
flCi microCurie
flg microgram
fll micro litre
flM micromolar
AgN03 silver nitrate
Amp ampicillin
Aps ammoniun persulphate
ASD atrial septal defect
ATP adenosine triphosphate
A-V atrioventricular
BAC bacterial artificial chromosome
BB bundle branch
BBB bundle branch block
bp base pair
2+
Ca calcium
CaCl2 calcium chloride
CHB complete heart block
CHD congenital heart disease
cM centiMorgan
dATP deoxy -adenosine triphosphate
dCTP deoxy-cytosine triphosphate
ddATP dideoxy-adenosine triphosphate
ddCTP dideoxy-cytosine triphosphate
ddGTP dideoxy-guanosine triphosphate
ddH20 double distilled water
ddTTP dideoxy-thymidine triphosphate
dGTP deoxy -guanosine triphosphate
DMSO dimethyl sulphoxide
DNA deoxyribonucleic acid
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TBE tris, boric acid and EDTA buffer
TeA trichloroacetic acid
TE tris, EDT A buffer
Tc tetracycline
U unit
UTR untranslated region
UV ultra violet
VNTR variable number of tandem repeats
www world wide website
YAe yeast artificial chromosome
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21.1 THE HEART
The true function of the heart was unknown before the 1ill century. When Harvey (1578-
1657) wrote "the blood is driven round a circuit with an increasing sort of movement; this is
an activity or function of the heart, which it carries by virtue of its own pulsation", he not only
was describing the circulation, but also drew attention to the heart's ability to provide the
mechanical force necessary to sustain the circulatory flow (Opie, 1991). The late 1800s
marked the beginning of the evolution of knowledge of the anatomy of the heart. It was
during this period that Purkinje described two morphologically distinct cell populations
within the heart, the contractile and the conducting cells (Davies, 1971). In spite of the
controversies surrounding cardiology at that stage, further work done earlier in the twentieth
century laid the basis for current knowledge of the anatomy and physiology of the heart (as
reviewed by Davies, 1971 and Opie, 1991). The human heart, in its function as a mechanical
blood pump, is driven by two major distinguishable components, namely, the cardiac
conduction system and the working myocardium. The cardiac conduction system is primarily
responsible for the generation of the depolarising electrical impulse and its propagation in a
sequential manner to the rest of the heart, which is necessary for the synchronised contraction
of the working myocardium, forming the walls of the heart's chambers (Hurst, 1978).
The maxim "you don't know what you've got until it's gone" is very much applicable in
human medicine, when a disease manifests. Thus, with better understanding of the basic
anatomy and physiology of the heart, in subsequent years, the focus logically shifted to heart
defects. Although many human cardiac malformations are well characterised anatomically,
there is still little understanding of their genetic basis (Olson and Srivastava, 1996), and this is
especially true of the cardiac conduction system, where evolution of knowledge of cell
biology has lagged behind compared with that of the working myocardium. This is mostly
attributed to the difficulty in accessing the conduction tissue, either by biopsy or autopsy
(Gorza et al., 1994). In addition, the human cardiac conduction system is less discernible than
that of some of its mammalian counterparts (for example, the pig, cow and dog) (Davies,
1971). However, the challenge still remains to understand the cell biology that drives this
complex system, and, subsequently, to understand cardiac conduction system defects, some of
which if left untreated by implantation of a pacemaker, contribute to the already high cardiac
disease-related mortality rate. In the following sections a review of cardiac conduction system
and the hereditary defects thereof will be presented, focussing on the progressive familial
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3heart block type I (PFHBI) a ventricular conduction system disorder, the subject of the present
study.
1.2 THE CARDIAC CONDUCTION SYSTEM
1.2.1 Anatomy of the Cardiac Conduction System
The most widely accepted concept to date is that the cardiac conduction system is specialised
cardiac muscle organised into nodes, that generate and conduct electrical impulses relatively
slowly and the rapidly conducting ventricular conduction fibres (Figure 1.1) (Davies et al.,
1971). The electrical impulse is generated at the sinoatrial (S-A) node with the normal heart
rate of 70 beat/min, which may be modified to beat faster or slower by the sympathetic or
parasympathetic nervous system, respectively (Opie, 1991). The S-A node is therefore,
referred to as the pacemaker determining the heart rate. The generated impulse is depolarising
to the electrically excitable cardiomyocytes, thus it generates myocyte action potential, which
effects changes that result in the contraction of the working myocardium (see section
electrophysiology). Propagation of the depolarising impulse from the S-A node to the
atrioventricular (A-V) node is via the normal atrial myocardium (Davies, 1971, Opie, 1991).
Despite a number of debates about the nature of the atrial conduction pathways, no
"specialised" conduction tracts have been shown (Davies, 1971; Anderson et al., 1981; Opie,
1991). At the A-V node, the impulse is temporarily delayed, thus allowing sufficient time for
the atria to contract and empty the blood contained within them and for the ventricles to fill
before the impulse is transmitted to the ventricular conduction system.
The fast-conducting ventricular conduction system comprises the His (A-V) bundle, which
bifurcates into the right bundle branch (RBB) and left bundle branch (LBB), terminating as a
network of Purkinje fibres at the apex, penetrating the ventricles (Figure 1.1) (Davies, 1971).
Following the delay at the A-V node, the depolarising impulse is rapidly relayed to the His-
bundle and is distributed to the ventricles by the right and left bundle branches. Consequently,
the ventricles contract forcing the blood out either to the lungs (deoxygenated) or through the
aorta to the rest of the body (oxygenated blood). This rapid transmission of the depolarising
impulse from the A-V region to the ventricles ensures the synchronous contraction of the
heart chambers, thus preventing retrograde flow of blood.
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Figure 1.1: The cardiac conduction system (The Sourcebook of Medical Illustration, 1989).
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51.2.2 Morphology of Cardiac Conduction Cells
The cardiac conduction system is referred to as specialised cardiac muscle because it consists
of a group of cells that are histologically distinct from working myocardium (Opie, 1991;
Zipes, 1997). The contractile cells (cardiomyocytes) in the heart are morphologically similar,
comprising myofibrils (the contractile units), nuclei, mitochondria, sarcoplasmic reticulum
and the sarcolemma (cell membrane), except for slight variation in size between the atrial
(20llm in length) and ventricular (50-100llm in length) myocytes (Opie, 1991). The cardiac
conduction system myocytes, in contrast, consists mainly of a heterogeneous group of cells,
namely, P (pacernakerj-cells, transitional cells and Purkinje cells, in addition to scantily
distributed contractile cells (James, 1970; Davies, 1971; Opie, 1991). These cells are
morphologically distinct both from each other and from those of the working myocardium
and are distributed within the conduction system components according to their specialisation.
Cell-to-cell communication is a characteristic feature often found in multicellular organisms,
which is essential for synchronised communication and behaviour of cells (Paul, 1995).
Within the context of the heat tissue, particularly the conduction system, this synchronised
behaviour of cells is critical for the orderly and co-ordinated propagation of the depolarising
impulse orchestrating heart contraction (Rossant, 1996). Thus, in addition to the
morphologically distinct group of cells, the conduction system myocytes are resistively
coupled by means of gap junctions (Sommer and Johnson, 1970, Spray et al., 1994),
membrane proteins that form boundaries between adjacent cell, thus ensuring efficient cell-
cell communication and optimum conduction of the depolarising impulse. In the following
sections the morphology of the cells within each of the major components of the conduction
system will be discussed in relation to their role in impulse conduction.
The nodal cells
The pacemaker or P-cells and transitional cells are the two groups of cells found in the S-A
and A-V nodes. The P-cells, thought to be the source of impulse formation, are small
(smaller than atrial cells) ovoid cells arranged in grape-like clusters, located centrally within
the nodes. Unlike the normal cardiomyocytes, P-cells contain very few myofibrils,
mitochondria or sarcoplasmic reticulum and interconnection between adjacent cells is by
simple apposition of plasma membranes (James, 1970; Opie, 1991; Zipes1997). The P-cells
can generate electrical impulses without any outside stimulation (James, 1970).
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6Transitional cells, on the other hand, are thin elongated cells (intermediate between sinus
nodal and atrial cells) that are longitudinally oriented at the periphery of the nodes and
provide the only functional pathway for transmission of the impulse to the atrial myocardium.
The connection between the P- and transitional cells is by simple apposition. In contrast,
intra-communication in adjacent transitional cells and inter-communication with atrial
myocardium is by intercalated discs. Although intercalated discs do not facilitate exchange of
molecules from the cytoplasms of adjacent cells they, nevertheless, form good conduits
(Campbell, 1990). Consequently, transitional cells have better cell-to-cell communication
than the P-cells.
Although both the S-A and A-V nodes have pacemaking abilities, the S-A node dominates
due to a fast pacemaking rate, postulated to be enhanced by the:
• Sinus nodal artery, which synchronises the otherwise relatively random pacemaking
cellular activity and
• The collagen framework around the node, although the mechanism IS not well
understood.
• Sinus node autonomic innervation, which is the link between the normal pacemaking of
the heart and extracardiac regulatory centres such as the brain. (James, 1970).
Transitional and P-cells form the major group of cells found in the nodes. The small size of
these cells and the weak intercellular connections correlate to their relatively slow impulse
conduction rates (5cm/sec) (Opie, 1991).
The ventricular conduction fibres
Purkinje cells are large pale elongated cells (l50-200J-lm in length) found mostly in the
ventricular conduction system (Davies, 1971; Opie, 1991; Zipes, 1997). Although these cells
have been compared to the slow conducting embryonic heart cells because of their
appearance, they have a conduction velocity of 200cmlsec (Opie, 1991). The characteristic
feature of Purkinje cells responsible for the increased velocity of conduction is that, in
addition to their size, they are arranged end-to-end longitudinally and are also interconnected
by the well developed gap junctions, which are membrane channel proteins facilitating the
exchange of cytoplasmic material between adjacent cells (James, 1970, Opie, 1991 and Spray
et al., 1994). In contrast, although myocardial cells are arranged longitudinally, the gap
junctions connecting adjacent cells are located all around the cells, thus the depolarising
impulse is not unidirectional but distributed in all directions to neighbouring cells (Opie,
1991). The distribution and organisation of all three types of cells within the conduction
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slow-conducting nodes and the fast-conducting His-Purkinje system ensure orderly and
synchronous activation of the heart.
1.2.3 Electrophysiology
Depolarisation
In the resting state, myocardial cells are polarised. The electrical impulse transmitted by the
conduction system depolarises the cell membrane, activating the membrane bound voltage-
dependent ion channels that facilitate sodium (Na) and calcium (Ca) ion transition into the
cell (Davies et al., 1971). The inward flux of the Na+ and cl+ into the cytosol of cell
generates action potential, which results in the contraction of the myocyte (Figure 1.2). The
activation of the Na+ channels is much faster than that of the cl+ channels (Katz, 1993).
Consequently, the conduction of the electrical impulse in the rapidly conducting ventricular
conduction system is dependent on the Na+ channel-generated action potential, with the cl+
channel generating secondary inward currents (Opie, 1991; Katz, 1993). In contrast, the slow
conducting nodes depend mostly on the slow calcium ion channel-generated action potential.
In the A-V node the conduction delay is largely due to the slow conduction rate mediated by
the Ca2+ channels. The same depolarising stimulus responsible for the activation of the ion
channels effects their inactivation, thus closing the Na+ and Ca2+ channels.
Repolarisation
The return of the cells to their resting state is effected by outward potassium (K) ion fluxes,
through K ion channels. The two K+ potassium ion currents involved for this process are;- the
transient outward current (Ito), which is responsible for the early repolarisation and the
delayed rectifier (IK), which is responsible for the delayed repolarisation and also for
maintaining the repolarisation (Katz, 1993; Wetzel and Klitzner, 1996).
The electrocardiogram
The electrocardiogram (ECG) is a non-invasive technique that records the heart's cumulative
electrical activity, thereby providing valuable information about the heart's normal or
abnormal function (Dubin, 1989). The ECG records the effect of the depo1arising stimulus on
the myocardium (i.e., sequential contraction of the atria and then the ventricles) as deflections,
Stellenbosch University http://scholar.sun.ac.za
V1
8
V6
Figure 1.2: Patterns of impulse conduction from the sinoatrial node to the ventricular
conduction system (Opie, 1991).
Schematic representation of the components of the cardiac conduction system indicating the
dominant depolarising ionic currents in the slow conducting nodes and in the fast-conducting
ventricular conduction system (left). Action potential generated by the different ionic fluxes in
the conduction system and the ventricles (right).
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9namely, the P wave and QRS complexes. The return to the resting state, repolarisation, is
represented by the ST-segment and the T wave (Figure 1.2).
In a normal heart, the P wave represents the contraction of both atria in response to the
depolarising stimulus initiated at the S-A node. The P wave is followed by a flat baseline,
representing the delay of the electrical impulse at the A-V node. Contraction of both
ventricles is represented as a QRS complex. Following the QRS complex is a gently up-
sloping ST segment, which precedes a T wave depicting ventricular re-polarisation. The
ventricular QRS complex masks the T wave for atrial repolarisation. One cardiac cycle is
represented by the P wave, QRS complex and a T wave. The ECG is, therefore, a great
diagnostic tool, portraying the functional differences between a normal and an abnormal
heart. In the case of asymptomatic conduction defects, e.g., isolated cardiac conduction
defects, it is the only reliable means of detecting disease.
1.2.4 Metabolism
In the adult heart, fatty acids are the preferred choice of substrate for energy production in the
form of adenosine triphosphate (ATP). Furthermore, fatty acid oxidation, an aerobic process,
reportedly accounts for more than 60% of the ATP energy required for contraction (King and
Opie, 1998). Glycolysis, the breakdown of glucose, is the other source of ATP in cells, and, in
the heart, when present in high concentrations, fatty acids limit glucose entry, which is then
directed to the liver for storage as glycogen (Sack and Kelly, 1998). The only time the normal
mammalian heart uses glucose is during embryonic and foetal development, which soon after
birth switches to fatty acids utilisation (these observation are expected as the adult heart has
an increased energy requirement compared to the foetal heart) (Sack et al, 1996, Sack and
Kelly, 1998). However, during stress, e.g., myocardial ischaemia and cardiac hypertrophy,
fatty acid oxidation becomes very costly as it utilises the already limited oxygen and, the heart
reverts back to the foetal program, i.e., using glucose to generate ATP energy.
An interesting finding at autopsy in a heart that had suffered a myocardial infarction, which
resulted in the myocardial cell damage, was that the conduction system remained unharmed
(Thornell and Sjostrom, 1975). Thus, based on the premise that the cardiac conduction system
has an abundance of glycogen (James, 1970; Davies, 1971), this observation has led to the
hypothesis that glycogen confers protection to the conduction system during ischaemia.
Perfusion experiments performed over the years have shown that in the failing heart, glycogen
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is the only source of glycolytic flux and confers protection to the failing heart (as reviewed by
Opie 1991, King and Opie, 1998). However, the argument is that this protective function is,
+unfortunately, short lived as the accumulation of lactic acid and hydrogen ions (H ), the by-
products of anaerobic glycolysis, results in severe damage of the tissue (King and Opie,
1998). Furthermore, these authors argue that, the extent of protection during heart failure is
directly proportional to the proximity of the tissue to the glycogen source, which would
explain why, despite damage to the rest of the surrounding myocardial tissue, the conduction
system remains unscathed (King and Opie, 1998).
1.3 IMPULSE CONDUCTION DEFECTS
Disruptions in the spread of the electrical impulse in anyone of the components of the cardiac
conduction system may result in heart rhythm disturbances (arrhythmias), most often leading
to a slow heart rate (bradyarrhythmia). These arrythmias may progress to heart block, which
may be fatal if not treated by timely implantation of an artificial pacemaker (Brink and
Torrington, 1977; Alpert et al., 1984). The variety of known defects range from sinus
bradycardia, A-V block and defects of the ventricular conduction system, presenting as either,
RBB block (RBBB) or LBB block (LBBB), in the absence of other cardiac diseases (isolated
cardiac conduction disease) or associated with other structural heart diseases (Fahy et al.,
1996).
Cardiac conduction defects, particularly ventricular conduction defects, collectively referred
to as bundle branch block (BBB), observed in the general population, were often interpreted
as indicating serious heart disease, for example, myocardial ischaemia, myocardial infarction,
cardiomyopathy, hypertension or congenital defects (DeForest, 1955; Alpert et al., 1984). In
the absence of other structural heart disease, the aetiology of BBB was often described as an
age-related degeneration of the ventricular conduction system, as it was mostly seen in the
older age group. (Lenegre, 1964). In support of this idea, Ostrander (1964) suggested that
RBBB and LBBB observed in an epidemiological study of the Tecumseh population of
Michigan, USA, who ranged between 20yrs and 80yrs of age, were due to acquired lesions
that progressed with age. In most cases, the presence of partial (incomplete) BBB reportedly
antedates progression to complete heart block (CHB) (Sarachek and Leonard, 1972; Schaal et
al., 1973), nevertheless, the prognosis for RBBB is better than for LBBB (Ostrander, 1964,
Fahy et al., 1996). Of the conduction defects seen in theyoung, Ostrander (1964) suggested
that these were possibly congenital anomalies, which were frequently a benign finding.
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Complete heart block is an event rarely seen in young adults. However, a number of families
have been described where the tendency is apparently inherited and affects the young.
Consequently, the familial occurrence of conduction defects has since become recognised as
showing variations in the mode of inheritance (autosomal dominant or recessive), age at onset
(congenital or adult onset), localisation of the defect and prognosis (Gazes et al., 1965;
Simonsen and Madsen, 1970; Steenkamp, 1972; Sarachek and Leonard, 1972; Husson et al..
1973; Schaal et al., 1973; Vallianos and Sideris, 1974; Esseher et al., 1975; Fairfax and
Lambert, 1975 and James et al., 1975, Greenspahn et al., 1976; Stéphan, 1979). In the
following section, an overview of familial ventricular conduction defects, manifesting as
congenital or adult onset CHB, will be presented.
1.3.1 Familial congenital cardiac conduction defects
Building a perfect heart is hard and it is a process highly susceptible to genetic and
environmental influences. Consequently, congenital heart anomalies are the most common
form of human birth defects and remain the leading cause of death within the first year of life
(Olson and Srivastava, 1996; Rossant, 1996; Srivastava, 1999 and Yamagishi et al., 1999).
The strict definition of congenital diseases is "those defects seen at birth" (James et al., 1975).
In other instances, however, this term is loosely used to describe anomalies seen during the
first year of life, as has been the case with some congenital familial cardiac conduction
defects (Sarachek and Leonard, 1972; Husson et al., 1973; Schaal et al., 1973). To resolve
these discrepancies, Yater's criteria, namely, the presence of a slow pulse during childhood
and proof of heart block in the absence of any previous diagnosis associated with other
cardiac defects, is often used for diagnosis (Sarachek and Leonard, 1972). In the sections that
follow, a review of known familial congenital conduction system diseases will be presented.
However, prior to that a brief review on the development of the normal embryonic and foetal
heart will be presented to help understand how diseases might affect the developing heart.
Development of the heart
The primitive heart tube (embryonic heart) is the first organ to develop and function in the
foetus (Rossant, 1996). The formation of the embryonic heart requires the commitment of
precursor cells, from the different embryonic lineages, namely, mesoderm and neural crest,
and their differentiation to the cardiac lineage followed by the co-ordinated assembly of the
different cells (Srivastava et al., 1995, Olson and Srivastava, 1996, Rossant, 1996).
Subsequently, the mature four-chambered heart is formed when the primitive heart tube
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undergoes looping, for right-left symmetry and the formation of the atria and ventricular
cavities and septation required to separate the oxygenated from the de-oxygenated blood,
postnatally (Srivastava et al., 1995).
The embryonic heart has no clearly recognisable conduction system, but comprises alternating
slow- and fast-conducting segments, and an inflow tract that generates impulse, which results
in an ECG similar to that found in the fully developed heart (Davies, 1971; Moorman and
Lamers, 1994). The developmental appearance of the fast-conducting ventricular conduction
system is nevertheless, closely associated with ventricular septation, one of the late
developmental stages (Moorman and Lamers, 1994; Schott et al., 1998). One of the long-
standing debates on the development of the cardiac conduction system was whether the
bundle of His is an outgrowth from the A-V node. Evidence from histopathologic studies
suggested that these two components were derived from different cell lineages (James et al.,
1975). The separate appearance of the ventricular conduction system to the A-V node in the
developing heart is evidence supporting the idea that the components of the conduction
system are derived from different cell lineages and subsequently, assembled through a process
of accretion (Moorman et al., 1998; Gourdie et al., 1999).
Cardiac morphogenesis is regulated by multiple signals, unfortunately, little is known of the
underlying genetic pathways. However, with the growing interest in heart development and
the identification of mutant gene of a few congenital heart defects (CHD), this lack of
knowledge will soon be replaced by, at the least, clues to the regulatory pathways controlling
embryonic heart development.
Generally, CHD represent defects in the development of specific regions of the heart, while
the rest of the heart develops rather normally (Kennel et al., 1981; Schott et al., 1998;
Srivastava, 1999) and are often associated with specific morphogenic defects in other organs
(DeForest and Hanover, 1955, Olson and Srivatsava, 1996; Belmont, 1998). Likewise,
familial congenital conduction system defects are often associated with cardiac or
extracardiac manifestations (Husson et al., 1973; James et al., 1975; Van der Merwe et al.,
1991, James et al, 1994). One of the known causes of congenital defects, resulting in multi-
organ system defects, is the arrest of development at early embryonic stages resulting from
defects in the precursor cells prior to differentiation (Olson and Srivastava, 1996; Belmont,
1998). On the other hand, CHD are due to errors in the late developmental stages, which
involve the moulding and shaping of the heart, e.g., septation (James, 1970; Olson and
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Srivastava, 1996). Two familial CHD that involve multi-organ systems with conduction
system defects as one of their characteristic features, the Holt-Oram symdrome and atrio-
septal defects (ASD) will be discussed.
Holt-Gram syndrome- MIM 142900
The Holt-Oram syndrome (HOS) belongs to a class of combined cardiac and limb
(extracardiac) deformities commonly referred to as 'heart-hand' syndromes and inherited as
an autosomal dominant trait. These are genetically heterogeneous with variation in the
severity of limb deformities, atrial septal defects and cardiac conduction disease (OMIM).
The "heart-hand" syndrome type III (HOS III), for example, is a cardiac conduction disease
accompanied by skeletal muscle malformations and is characterised by a range of conduction
anomalies, namely, a slow heart rate, A-V block and sinus node dysfunction (Basson et al.,
1995). The cardiac and skeletal muscle cells are derived from the same somatic germ layer
(mesoderm) but different precursors, thus, the resulting defects in cardiac and skeletal muscle
are indicative of a developmental errors that occurred prior to commitment of the precursor
cells to the specific lineages.
The HOS III-causative gene was identified as TBX5, a transcription factor-encoding gene (Li
et al., 1997). Transcription factors are regulatory proteins controlling the expression of other
genes, including developmental genes. Thus, defects in the transcription factors regulating the
commitment and differentiation signals of precursor cells will affect multiple of
developmental pathways. The TBX5 gene belongs to the T-box family of transcription factors
essential for early development including specification of the mesoderm and regulation of
heart and limb morphogenesis (reviewed by Smith, 1999).
Atria-septal defects
Cardiac septation occurs in the later stages of development and involves the partitioning of
the primordial single atrium and ventricle into the four chambers of the mature heart.
However, following septation a hole is maintained between the atria to bypass the as yet non-
functional lungs, until after birth. Ten to fifteen hours after birth the hole is functionally
closed in normal and permanently closed 2-3 weeks later. This final moulding and shaping of
the heart is an error prone process (James, 1970, Schott et al., 1998) and results in atrio-
ventricular defects (ASD) with progressive conduction system disease as a characteristic
feature (Schott et al., 1998).
Stellenbosch University http://scholar.sun.ac.za
14
Unlike HOS, ASD feature conduction anomalies associated with another cardiac
manifestation. However, similar to HOS, mutations in a transcription factor, NKX2-5, were
identified as the cause of autosomal dominant ASD with A-V conduction delays (A-V block)
as the other characteristic feature (Schott et al., 1998). The Nkx2-5 gene was shown to be
important in cardiac septation and in the development of the A-V node.
Hereditary developmental conduction system defects are not necessarily congenital, i.e., they
need not cause disease early in life (Simonsen and Madsen, 1970; Steenkamp 1972). This
statement is supported by the observation that individuals born with ASDs, that were
subsequently surgically repaired, had conduction defects manifesting in adulthood (Schott et
al., 1998). Therefore, partial absence of conduction tissue need not present with symptoms
until adult life, which was explained by Steenkamp (1972) as a result of progressive
degeneration of the conduction system. In their study, Schott et al. (1998) showed that the
transcription factor NKX2-5 is not only required during development but also for
maintenance of the A-V node postnatally and into adult life.
Although the pathogenesis of the congenital and adult onset familial heart block may be
different, the increasing evidence that true familial congenital heart block may not only
manifest later in childhood, but even in adult life, suggests that, in some cases, the two forms
of heart block may be the same disease (Brink, 1997). One theoretical explanation for such
delayed appearance of heart block is gradually progressive narrowing disease of the A-V node
artery, although it has not been shown that such a process has a familial incidence (James el
al., 1975). The cardiac conduction system might be congenitally abnormal but disease may
only manifest as the ageing process occurs (Schaal et al., 1973) and may also be influenced
by environmental factors.
1.3.2 Familial bundle branch block - Adult onset
Phenotype
Adult onset BBB is proven when the initial manifestations occur in adulthood and conduction
had previously been shown to be normal (Simonsen and Madsen, 1970; Kennel et al., 1981).
It may be considered familial when one or more first-degree relatives develop a similar
condition in the absence of other recognised causes of acquired heart block (Kennel et al.,
1981). In the absence of other heart disease, conduction system diseases are normally
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asymptomatic, with the ECG the only means of detecting any abnormalities. Defects in the
ventricular conduction system are characterised by wide or narrow QRS complexes,
depending on the site of the lesion (block), namely the RBB or LBB, respectively (concepts
by Mahaim, as reviewed by Lenêgre, 1964).
The disease is progressive in nature, as both RBBB and LBBB antedate CHB (Schaal et al.,
1973). However, timely implantation of an artificial pacemaker improves the prognosis (Brink
and Torrington, 1977; Alpert and Flaker, 1984). For most affected individuals, the only
symptom is when CHB supervenes with either syncope or Stoke's-Adam's seizures, which is
associated with risk of sudden cardiac death. However, the aetiology of the underlying
conduction defect remains unknown.
Classical Diagnosis
Bundle branch blocks are caused by partial blocks of the depolarising impulse in the RBB or
LBB, causing a delay of the electrical impulse to that side (Dubin, 1989). Therefore, in BBB,
the ventricles do not fire simultaneously, and produce two co-joined QRS complexes resulting
in a "widened QRS" pattern on ECG. More specifically, RBBB is represented by R,R' in the
VI and V2 chest leads, with R' indicating the delayed ventricle (Figure 1.3). Similarly,
observation of R,R' in the Vs and V6 chest leads is indicative of LBBB. Clinically, BBB is
defined as a prolonged QRS complex (;::::0.12 seconds). However, QRS complexes of less than
0.12s with an R,R' pattern have been reported and these are referred to as incomplete BBB.
Currently, the only available form of treatment for bundle branch defects is timely
implantation of a pacemaker, which allows affected individuals to enjoy a near normal
lifestyle (Brink and Torrington, 1977).
Pathology
The progressive nature of the adult type of BBB is more compatible with the gradual fibrosis,
rather than with the complete absence, of the main stem of the conduction system, as
suggested by autopsies of infants with familial congenital CHB (Vallianos and Sideris 1974).
Although a variety of general terms had previously been used in different earlier studies to
describe conduction defects (Brink et al., 1994), it was Brink and Torrington (1977) who
described two familial conduction system defects in South Africa and gave them the
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Figure 1.3: The EeG tracings showing a typical pattern of right bundle branch block in
standard leads I, VI and V6 (Brink, 1997).
The QRS complex is more than 012s wide with a delayed wave due to late right ventricular
depolarisation as is evidenced by the terminal slurred R wave in standard lead VI and a
slurred Swave in standard leads V6 and 1.
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appropriately descriptive names, progressive familial heart block, types I and II (PFHBI and
PFHBII, respectively).
Progressive familial heart block type 1-MIM 113900
Progressive familial heart block type I is a primary ventricular conduction system defect
characterised by a broad QRS complex (Brink and Torrington, 1977), an indication of BB
disorder. The disease was described as progressive in nature, as some of the individuals with
RBBB later developed CHB. Transmission of the disease in families was autosomal dominant
with three high-risk periods for onset of CHB, namely, at or soon after birth, during puberty
and the early 20's and again towards middle age (Brink and Torrington, 1977). Furthermore,
based on the observation that the mean age for pacemaker implantation decreased with three
successive generations studied, Brink and Torrington (1977) suggested genetic anticipation to
be involved in the disease pathology. Follow-up studies on the same families led to the
extension of the family pedigrees, where to date there are three apparently unrelated
pedigrees, designated pedigrees 1, 2 and 5 (Brink et al., 1994) (Figure 1.4). The largest,
pedigree 2, has been extended to an extensive nine generations all traced back to one ancestor,
a Portuguese settler (Torrington et al., 1986; Van der Merwe et al., 1986, Van der Merwe et
al., 1988; Brink et aI., 1994). A decade after Brink and Torrington's initial report, while
assessing the mean age for pacemaker implantation, Van der Merwe et al., (1988) noted that,
with successive generations, which comprised the last generation from the previous study,
plus two new ones, it became much lower, confirming Brink and Torrington's observation.
Hereditary bundle branch defect - MIM 113900
Despite several reports of familial RBBB world-wide (Brink et al., 1994), hereditary bundle
branch defect (HBBD-I13900), also referred to as inherited cardiac conduction disorder
(ICCD) (De Meeus et al., 1995), described by Stéphan in a Lebanese kindred, is the only
other known conduction system disease with similar features to PFHBI (Stéphan, 1979). Like
PFHBI, the disease is inherited as an autosomal dominant trait characterised by RBBB, which
in most instances progressed to CHB with syncopal attacks. Age at onset varied between
congenital and adult onset, whereas in PFHBI, there was an additional high-risk period,
namely, during puberty and the early 20's (Brink and Torrington, 1977).
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Progressive familial heart block type 1/ MIM 140400
Progressive familial heart block type II is also inherited in an autosomal dominant fashion. In
contrast to PFHBI, PFHBII is characterised by sinus bradycardia with left posterior
hemiblock, narrow QRS complex on ECG. Clinically, however, PFHBII, like PFHBI,
presents with sycopal attacks and Stoke's-Adam's seizures when CHB supervenes (Brink and
Torrington, 1977). Until recently, it has been proposed that PFHBI and PFHBII may be the
same disease, possibly caused by different mutations within the same gene. However, linkage
analysis studies performed recently, using chromosome 19q13.3 spanning microsatellite
markers, have excluded the PFHBI locus as the causative gene for PFHBII (Fernandez,
personal communication).
Although the clinical features of these bundle branch defects have been well characterised, the
aetiology remains unknown, with pacemaker implantation the only form of treatment
available, that sees the patients returning to near normalcy (Brink and Torrington, 1977;
Brink, personal communication). The present study will focus on PFHBI and the application
of the positional cloning approach in an effort to identify the PFHBI-causative gene.
1.4 PROGRESSIVE FAMILIAL HEART BLOCK I
1.4.1 Clinical History
Progressive familial heart block type-I is a primary disease of the ventricular conduction
system with risk of untimely sudden death, that is inherited as an autosomal dominant trait in
several South African Caucasian kindreds of Afrikaner descent (Brink and Torrington, 1977).
To date, three apparently unrelated pedigrees, designated 1, 2 and 5, have been established
and pedigree 2 has an extensive nine generations all traced back to one ancestor, a Portuguese
settler who came to South Africa in 1696 (Figure 1.4). Within the Afrikaner sub-population,
PFHBI has a prevalence of 1:500 and a penetrance value of 0.96 (Torrington et al., 1986;
Brink et al., 1994).
1.4.2 Age at Onset
Three high-risk periods for onset of CHB in PFHBI have been reported, namely, 1) during the
first year of life, 2 ) during puberty and the early 20s and 3) towards middle age (Brink and
Torrington, 1977). These high-risk periods are an indication, and offer a warning, that in
familial cases, an early normal ECG does not exclude the presence of an underlying
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Figure 1.4Family pedigrees 1,2 and 5 segregating with PFHBI (Brink et al., 1995).
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conduction tissue disorder, as it may develop later in life (Brink and Torrington 1977, Van der
Merwe et al, 1991 and Brink, 1997).
1.4.3 Diagnosis
Clinically, the disease is characterised by broad QRS complexes (>0.12s) on ECG, with an
R,R' in the VI and V2 chest leads, indicating RBBB (Figure 1.3). Progression from milder to
more severe forms of heart block, e.g., CHB is one of the detrimental features ofPFHBI, with
timely pacemaker implantation the only form of treatment currently available (Brink and
Torrington, 1977; Van der Merwe et al., 1988). The observation by Van der Merwe et al.
(1988) that age of pacemaker implantation decreased with successive generations led the
authors to propose that the severity of the disease had increased with successive generations, a
phenomenon referred to as genetic anticipation (Howeler et al., 1989).
1.4.4 Pathology of PFHBI
The only post-mortem tissue sample ever to be examined from the PFHBI families was from
a 2 year-old patient who had a third-degree heart block at birth and had a pacemaker
implanted. At 22 months, four months prior to his death, the patient's left ventricle began to
dilate and progressed to severe dilatation. Autopsy findings showed fibrosis of the conduction
tissue main bundle and proximal part of the bundle branches in the presence of dilated
cardiomyopathy (Van der Merwe et al., 1991), the latter, however, is a rare feature in PFHBI.
Therefore, although the clinical profile of PFHBI has been well characterised, the aetiology
remains unknown. Molecular biology-based approaches offer a strategy to help identify the
disease gene with the hope of elucidating the underlying cause.
1.5 THE POSITIONAL CLONING APPROACH
Positional cloning (Collins, 1992) has revolutionised human genetics and medicine, as it
allows mapping of the disease-causing gene to its correct chromosomal location, relying only
on the position of the gene in the genome, without an absolute requirement of functional
knowledge. To achieve this, a collection of pedigrees in which the disease gene is segregating
is required and, to establish linkage, the families are genotyped using multiple polymorphic
markers that span the genome, which often places the candidate locus within a region of 5-
lOcM (lcM is approximately equivalent to 1Mb) (Schuler et al., 1996). Additional fine
mapping using flanking genetic markers is then applied, approaching the gene from both
directions, while reducing and redefining the target interval. However, fine mapping is
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generally limited to genetic intervals of about 1cM, following which physical mapping
strategies are used to clone the gene (Collins, 1992). Genes known to reside within the target
interval are considered positional candidates and are therefore screened for possible disease-
causing mutations (Strachan and Read, 1996). The development of the positional cloning
approach into the most powerful gene cloning strategy stems partly from the advances made
in terms of the genetic markers developed to date (discussed below). In the following
sections, a brief history of the advances made with respect to the types of polymorphic
markers used, which also highlights the robustness of the currently popular type of marker,
the microsatellites, is presented.
1.5.1 Genetic Maps and Polymorphic Markers
Genetic markers and maps of human chromosomes provide the initial resources for localising
Mendelian traits and disease susceptibility genes to their precise chromosomal regions by
linkage analysis. Earlier application of genetic markers to generate linear genetic maps of
chromosomes, and their use in tracing inheritance patterns, was confined to simpler
organisms, such as Drosophila melanogaster, which only has four chromosomes, in which
crosses could be manipulated in the laboratory, Mendel-style, unlike humans (Sturtevant and
Morgan, 1913). Genetic linkage analysis involves comparing the inheritance of alleles at a
specific marker with that of the disease, where co-inheritance of the disease gene and marker
allele indicates that the two are physically close, hence linked on the specific chromosome
(Terwilliger and Ott, 1994). Since the first application of linkage analysis in humans by Bell
and Haldane (1937), other developments included the statistical approach to linkage analysis,
the LOD score (Morton, 1955) and computer-based analysis using a limited number of blood
group and serum protein markers (reviewed by the Murray et al., 1994). Despite these
successes, for many years the lack of informative and evenly spaced markers was limiting
(Lander and Schork, 1994).
1.5.2 Advances in genetic markers
The advent of recombinant deoxyribonucleic acid (DNA) technology revolutionised medical
genetics and medicine in two ways. Firstly, was the identification of DNA-based
polymorphisms, referred to as restriction fragment length polymorphisms (RFLPs), which
could be used as markers (Solomon and Bodmer, 1979, Botstein et al., 1980). Secondly,
subsequent cloning and characterisation of previously unknown genes underlying human
inherited traits helped elucidate the molecular basis of disease mechanisms. The earlier
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successful method, termed functional cloning, identified the disease-causing gene based on
pre-existing knowledge about the biochemical function of the gene product. However, for the
vast majority, approximately 4,500, of single gene (Mendelian) disorders, such detailed
functional insight, unfortunately, does not exist, hence functional cloning becomes limiting.
The major breakthrough for human genetics, however, was the subsequent development of
positional cloning (Collins, 1992), which led to the mapping of unknown genes for rare
Mendelian disorders, regardless of knowledge of biochemical function. A vast source of
markers became available with the realisation that many naturally occurring DNA repetitive
sequences were polymorphic and thus could be used as markers. The first group of repetitive
DNA sequences identified was the variable number of tandem repeat (VNTR) minisatellites
(Jeffreys et al., 1985; Nakamura et al., 1987), which like the RFLPs, were detected by DNA
hybridisation on Southern blots. Although, subsequently, less time consuming PCR-based
methods of detection were developed, RFLPs and VNTRs still suffered other disadvantages.
For example, RFLPs are bi-allelic, and thus not very informative and, although VNTRs are
highly informative as markers, with heterozygosity indices of >97%, they are confined to the
telomeric ends of chromosomes, which renders them limiting for the generation of high-
density maps (Royle et al., 1988). Subsequently, a more robust group of markers, the
microsatellites, was identified (Litt and Luty, 1989; Weber and May, 1989). In the following
sections, an overview of the currently used markers, microsatellites, focussing on their
robustness and preferential use as markers in gene mapping is presented.
1.6 MICROSATELLITES
Microsatellites are short tandem repeats (STRs), 1-5bp in length, which are classified as
mono-, di-, tri-, tetra- and pentanucleotide sequences. They are randomly distributed within
the human genome, they are embedded in unique sequence and are polymorphic, as they show
variation in the number of the repeated units at a specific locus among individuals within a
population (Cooper and Clayton, 1988). Mono-, di- and tetranucleotide STR are limited to the
non-coding regions of the genome, as the presence of such polymorphic sequences in coding
regions would affect the coding sequence and hence the gene products. In contrast,
trinucleotide STRs are found in both the coding and non-coding regions. Several
neurodegenerative diseases are associated with the abnormal expansion of trinucleotides in
coding regions illustrating the detriment of these polymorphic sequences in genes (section
1.8.5). The microsatellite STR sequences are stably inherited in families from one generation
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to the next, which allows their use as genetic markers in tracing inheritance patterns in human
pedigrees (Litt and Luty, 1989; Weber and May, 1989).
Although micro satellites are less informative as markers than VNTRs, with heterozygosity
indices ranging between 34% and 90%, other compensatory features exist, e.g., their random
distribution within the human genome. In addition, their robustness as genetic markers is
based on the fact that these repeats are often embedded in unique sequence and are contained
in 100bp-500bp fragments, in contrast to VNTRs, which are contained in =l kb fragments.
These properties make the microsatellites more amenable to PCR-based analysis and easier
verification of genotyping data (Litt and Luty, 1989; Weber and May, 1989; Alford et al.,
1994).
1.6.1 Dinucleotide STRs
The dinucleotide STR of the form (dC-dA)n .(dG-dT)n, hereafter designated (CA)n, with
repeat number (n) ranging from 10-60, is the most abundant, with one STR locus
approximately every 30kb, and is the most commonly used form of genetic marker (Litt and
Luty, 1989; Weber and May, 1989). Due to the fact that the (CG)n dinucleotide STRs, with n
>6, are rarely seen, a possible explanation was thought to be that they are selected against as
long stretches of CG nucleotides present a deleterious structural conformation, Z-DNA
(Hamada and Kakunaga, 1984). However, Tautz and Renz (1984) suggested that, in vivo,
these sequences were not in Z-DNA form. The informativeness of the (CA)n STR is directly
proportional to the repeat length (with heterozygosity indices varying between 34% and 74%).
It is also positively influenced by the complexity of the repeat, with the degree of
informativeness decreasing in the order of perfect, imperfect and compound repeats (Weber,
1990). Although the (CA)n STR has proven an outstanding choice of marker, it has a high
frequency of strand slippage artifacts on PCR amplification (which were seen as shadow
bands on electrophoretic separation), making it difficult to genotype (Edwards et al., 1992b).
This led to a search for STR genetic markers that, in addition to being polymorphic and
randomly distributed within the genome, would be robust to genotyping. The trinucleotide
and tetranucleotide STRs fit these criteria, and have heterozygosity indices of between 37% -
83%. Despite the fact that they are not as frequently distributed as the (CA)n STR, for fine
mapping purposes, trinucleotide and tetranucleotide STRs serve as invaluable genetic markers
complementing the (CA)n STR (Zuliani and Hobbs, 1990, Edwards et al., 1992a, Sheffield et
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al., 1995). The trinucleotide STRs are, however, infamous for their pathogenicity when
abnormally expanded in some disease-causing genes.
1.6.2 Trinucleotide and Tetranucleotide STRs
The trinucleotide and tetranucleotide STRs (discussed below), like the (CA)n, are highly
polymorphic, and they are distributed randomly within the intronic regions of the human
genome, on average every 300kb (Edwards et al., 1989, Edwards et al., 1992a). In contrast, a
different class of trinucleotide STRs is distributed in both exonic and intronic regions and
their polymorphic nature in coding regions may be detrimental, in which case they are
referred to as pathogenic micro satellites (section 1.8.5). Together, the non-pathogenic
trinucleotide and the tetranucleotide STRs occur with a frequency of one STR, of
approximately seven repeat units in length, every 10kb (Edwards et al., 1991). Like the (CA)n
repeat, tri- and tetranucleotide STRs are generally stably inherited in families from one
generation to the next (Chakraborty et al., 1997). In contrast to (CA)n, trinucleotide and
tetranucleotide STRs can be PCR-amplified with increased fidelity, showing less strand-
slippage mismatch, in vitro (Edwards et al., 1992b). In the same study, Edwards et al. (1992b)
suggested a positive correlation between the repeat unit length and the complexity of the
repeat and the ease of genotyping (Sheffield et al., 1995). For tetranucleotide STRs, repeat
unit lengths of greater than six are considered informative (Sheffield et al., 1995). Triplet
repeats of eight or more in non-coding sequences are likely to be polymorphic (Gastier et al.,
1996). Though repeat size has been shown to be a strong indicator of polymorphic length
variability for (CA)n STR (Weber, 1990), it is possible that the repeat sequences found in
coding regions are under strong selective constraints to avoid either expansion or contraction
(Reddy et al., 1997).
There is a wide selection of commonly occurring tetranucleotide STR sequences. The Utah
Marker Development Group (1996) performed studies to test, firstly, which of a selection of
the tetranucleotide STRs, namely, AAAG, AGAT, AAGG, AAA T, GAT A, GGAA, GAAT,
GGA Tand GTATT, were abundant and, secondly, which of those were ideal for development
as markers i.e., gave clear results on genotyping. Of the STRs analysed, the most abundant
were AAAG (38%), AGATT (29%), AAGG (10%) and AAAT (5%), the remainder were a
combination of di- and trinucleotides (The Utah Marker Development Group, 1996).
Furthermore, the AGAT, AAGG, AAAG and AAAT STRs gave the cleanest and most
interpretable results.
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1.6.3 Origin of Microsatellites
The hypothesis cited the most in the literature to explain the origin of microsatellites is the
strand slippage mechanism during replication in vivo, whereby the initial expansion of short
repeat sequences occurred relatively slowly on an evolutionary time-scale (Levinson and
Gutman, 1987; Schlotterer and Tautz, 1992, Meisser et al., 1996). Once the critical number of
repeat units was reached, the mutation rate increased resulting in observed length
polymorphism of microsatellites within populations.
The second proposed mechanism for the ongm of a fraction of micro satellites is
retrotransposition (Beckman and Weber, 1992). This theory is based on the observation that
more than 80% of the A-rich STRs, namely, A, AN, AAN, AAAN (where N represents
nucleotides T, G or C), are located immediately 3' to Alu-elements, which are primate
specific sequences (Zuliani and Hobbs, 1990; Beckmann and Weber, 1992). It is thought that
Alu-elernents are retrotransposons, that is RNA transcripts that have been converted to
complementary DNA (cDNA), which is highly mobile and can re-insert into different regions
of the genome. As a consequence of the RNA origin of these Alu-elements, they contain a 3'
poly (A) tail. The A-rich STRs are thought to be tandem degenerations of the poly (A) tail
(Economou et al., 1990, Zuliani and Hobbs, 1990). Owing to a high frequency of
recombinational events associated with Alu-elements, sequences in close proximity to the
Alu-elements may also be more susceptible to slipped-strand mispairing during replication, a
widely accepted hypothesis for evolution of STRs (Levinson and Gutman, 1987; Meisser et
al., 1996). The finding of microsatellites with repeat motifs other than (A), 3' to the Alu
elements, led to the conclusion that the Alu-related poly (A) sequences can evolve into more
complex microsatellites (Beckmann and Weber, 1992).
These sequences are thus maintained because of the weak selective constraints associated
with the non-coding regions of the genome (Cooper and Clayton 1988, Baron et al., 1992,
Charlesworth, 1994). The extent to which microsatellites are conserved across species is as
yet unknown. Stallings et al. (1991) suggested that in closely related species (e.g., humans
and primates) the (GT)n/(CA)n repeat sequences are conserved, but not in evolutionary distant
species (e.g., humans and rodents). If the microsatellite sequences are conserved, then what is
their functional significance in eukaryotic genome?
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1.6.4 Functions of Microsatellites
Although their function in the genome is unknown, the postulated significance of conserved
STRs in intronic regions includes involvement in transcription regulation. For example, at
least one protein is known to bind to an (AAT)» repeat motif, commonly found in introns
(Sheffield et al., 1994). Moreover, the observation that microsatellites are absent in bacteria
may be an indication of their involvement in the packaging and condensing of DNA into
eukaryotic chromosomes, particularly in replication. During the cell cycle, they may provide a
DNA conformation that can be condensed and de-condensed during different stages of the cell
cycle (Vogt, 1990).
Further speculation on the function of microsatellite sequences is that they are hotspots for
recombination (Stallings et al., 1991; Weber et al., 1993). There are two schools of thought,
one for and the other against microsatellites' role as recombination hotspots. On the one hand,
evidence in support of microsatellites as recombination hotspots comes from the observation
of a (QT)7 repeat sequence in the genome of SV40, a virus known to frequently integrate into
the rat genome (Stallings et al., 1991). Furthermore, there is a lack of these sequences in the
P-satellite regions of the Drosophila polytene chromosomes, which do not undergo
recombination. On the other hand, evidence against is supported by the fact that the telomeres
of chromosomes, where the minisatellites are clustered, are known as recombination hotspots.
Microsatellites, in contrast, are not confined to the telomeres but are randomly distributed
throughout the genome, including regions where recombination is suppressed. Therefore,
based on the latter observation microsatellites will tend to accumulate in regions with very
low recombination frequencies and weak selective constraints on array length. (Stallings et
al., 1991). The use of microsatellites as genetic markers to trace inheritance patterns,
however, relies on their crossing over during meiosis and, thus, as recombination hotspots.
Recently, different micro satellite mutations have been reported in tumour cells, where, for
example, the number of repeats had increased or been reduced, or there had been loss of one
STR allele (loss of heterozygosity), or the presence of an additional allele. These changes
have been proposed as possible mechanisms for tumour initiation. However, a body of
evidence strongly excludes the proposal that microsatellite (di-, tri-, and tetranucleotide
repeats) instability seen in tumour cells is a mechanism of tumour initiation, but is rather a
feature of tumour progression due to genomic instability (Canziani et al., 1994; Dam et al.,
1995; Tischfield, 1997).
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However, there are also microsatellite sequences associated with diseases and these are
composed exclusively of trinucleotide STRs, referred to as pathogenic micro satellites.
1.6.5 Pathogenic microsatellites
Generally, microsatellites have mutation rates inversely proportional to their repeat unit size,
with the dinucleotides' mutation rates reported as twice that of tetranucleotide STRs and the
trinucleotide STRs intermediate between the two (Chakraborty et al., 1997). In contrast,
disease-associated (pathogenic) trinucleotide STRs have 3.9 to 6.9 times higher mutation rates
than the tetranucleotide STRs (Chakraborty et al, 1997). To date, at least 13 inherited human
diseases are caused by mutations of CG-rich triplet repeat sequences, characterised by
abnormal expansion of the normal allele (e.g., in myotonic dystrophy (MIM 160900), the
normal allele of 5-30 (CTG) repeats is expanded to >50-2000 in the affected individual
(OMIM). The general trend seen in these diseases is that they are normally autosomal
dominant, neurodegenerative diseases, caused by the unusual expansion of a CAG repeat in
coding regions, or a CGG repeat in the non-coding regions (5' and 3' untranslated regions
UTRs) with evidence of anticipation (Warren, 1996). An exception to the rule however, is
Friedreich's ataxia, which is inherited as an autosomal recessive trait caused, in 97% of
patients, by the abnormal expansion of an intronic GAA repeat and which shows little
evidence of genetic anticipation (Campuzano et al., 1996).
1.6.6 Genetic Anticipation
Abnormal expansion of the trinucleotide STRs at their respective loci (coding or non-coding
regions) shows marked intergenerational instability, with offspring inheriting either the
smaller or larger alleles than their parents. Expanded alleles have been found to either expand
further or contract between generations. Concomitant with this gain in repeat-unit number
with subsequent generations is increase in disease severity and penetrance and earlier age of
onset, the phenomenon of genetic anticipation (Howeler et al., 1989).
One proposed mechanism on how triplet repeat expansions, in the different regions of genes,
might cause disease is that, as the sequence becomes larger, it might interfere either with
transcription or lead to further deviation of the gene product from normal (Jennings, 1995).
For example, the abnormally expanded GAA repeat in Friedreich's ataxia supposedly adopts a
triple helical conformation in vitro, which Ohshima et al., (1999) suggested is responsible for
suppression of gene expression implicated in the disease pathogenesis.
Stellenbosch University http://scholar.sun.ac.za
29
Although their function in the genome is not yet known, microsatellites (di-, tri and tetras) are
useful as polymorphic markers in a number of applications in genetics and medicine, namely:
• Sub-chromosomal localisation of inherited human disease genes
• Construction of haplotypes to trace the inheritance of a disease chromosome ill
families
• Paternity tests
• Personal identification in forensic sciences
• Molecular anthropology, to trace the origins of a population using mitochondrial DNA
and Y chromosome microsatellites for maternal and paternal lineage, respectively
(Edwards et al., 1992).
1.6.7 Genome-wide linkage maps
Genome-wide linkage maps, consisting of genetic markers, mostly microsatellites, developed
by different laboratories, Généthon (CA)n, CHLC (tri- and tetranucleotide STRs) and the Utah
Marker Development Group (di-, tri- and tetranucleotideSTRs), but typed on a common set of
families, are available for utilisation by the research community (CHLC www, Généthon
www, The Utah Marker Development Group). To date, more than 100 previously unknown
disease-causing genes have been mapped by positional cloning using these resources, for
example, long QT syndrome (Wang et al., 1995), retinitis pigmentosa (Bardien et al., 1995)
and adult polycystic kidney disease (PKD Consortium, 1994).
The presence of family pedigrees, in which PFHBI segregates, lends the search for the PFHBI
gene to the positional cloning approach (linkage analysis, genetic fine mapping and the
identification of candidate genes and detection of disease-associated mutations). The present
study gives an overview of PFHBI, a ventricular conduction system disorder and the
positional cloning approach followed in an effort to identify the PFHBI-causing gene.
1.6.8 Genetic Linkage analysis in PFHBI
A random genome search using linkage analysis mapped the PFHBI locus to a 10cM region
between the apolipoprotein C2 (APGC2) and kallikrein (KLK1) loci on chromosome 19q13.3
(Brink et al., 1995). Subsequently, De Meeus et al. (1995), working independently, reported
on a cardiac disease, designated ICCD in a Lebanese kindred, that showed similar clinical
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features and mapped to a 13cM interval overlapping the PFHBI locus, between markers
D 19S606 and D 19S5 71. Genetic fine mapping efforts, using chromosome 19q13.3
dinucleotide STRs polymorphic markers, identified recombination breakpoints in the PFHBI-
affected families, which reduced the PFHBI interval to 7cM, between markers D 19S412 and
D 19S866, centromeric and telomeric, respectively (De Jager, personal communication and
Christoffels, 1997) (Figure 1.5). This new PFHBI interval still had a region of overlap with
the ICCD interval (common marker D19S606) (Figure 1.5), thus, it is not inconceivable that
PFHBI and ICCD are the same disease, possibly caused by different mutations in the same
gene (Brink, personal communication).
Although the PFHBI search area had been reduced to 7cM, more markers residing within the
target interval were required to genetically fine map this region further. This would then allow
for a more focussed physical mapping effort.
To this end, using an integrated approach, both (CA)n repeats and trinucleotide repeat markers
were developed from cosmid clones harbouring insert DNA from the PFHBI target interval,
for the purpose of reducing the target interval, by high level definition of the telomeric and
centromeric limits. At the same time, genome database searches were performed to identify
any polymorphic markers lying within the target region.
Once the disease locus has been mapped, the next formidable task becomes the identification
of candidate genes within the refined target interval. Concurrently with the development of
genetic maps, has been the development of physical maps of the human genome consisting of
overlapping DNA clones contained in large insert vectors, e.g., yeast artificial chromosomes
(YACs), bacterial artificial chromosomes (BACs) and PI bacteriophage artificial
chromosomes (PACs), which serve as substrates for chromosome walking, chromosome
jumping and exon trapping methods to identify gene transcripts (Strachan and Read, 1996).
However, these positional cloning methods used for gene identification are often long and
tedious.
The whole genome sequencmg initiative of the Human Genome Project (Waterston and
Sulston, 1998; Marshall, 1999) has resulted in the availability of comprehensive whole
genome maps with identified genes and consequently, positional candidate gene-based
strategies may supersede these time-consuming transcript identification positional cloning
approaches.
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Figure 1.5 Schematic representation of a segment of chromosome 19q13.3 indicating the
positions of the genetic markers, genes and cosmid clones spanning the PFHBI target
interval (http://www-bio.llnl.gov/genome-binl).
The lcM region represents the region of chromosome 19q13.3 common in all PFHBI-affected
individuals (common core haplotype). The arrows indicate the area in which new
polymorphic markers were sought. The genes in bold are the plausible candidates for the
PFHBI-causative gene.
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1.7 THE POSITIONAL CANDIDATE GENE APPROACH
In a search for a disease-causing gene, the selection of candidate genes IS based on
understanding the mechanisms driving the normal function of an organ or tissue, which when
defective can cause disease, i.e., functional candidate genes. However, once a disease locus
has been mapped, genes at the same sub-chromosomal location as the disease locus are
referred to as positional candidates and the confidence levels in a gene's candidacy are
substantially increased if its function can be associated with the disease's molecular
pathophysiology (Strachan and Read, 1996). Such genes are referred to as positional
candidates and represent plausible candidate genes.
Chromosome 19 is a relatively small, approximately 60Mb, GC-rich and gene-rich
chromosome, containing a number of disease genes as well as members of numerous gene
families (Gordon et al., 1995; Mohrenweiser el al., 1995; Schuler et al., 1996) (Figure 1.6).
The PFHBI locus on chromosome 19q13.3 has a number of known genes and it was in this
region that positional candidate genes were sought.
The most compelling positional candidates are those genes with:
• appropriate function or tissue expression pattern,
• homology to a gene implicated in an animal model of the disease and
• known homologues in other species based on comparative genomies (animal models), or
homology, or functional relatedness, to a gene implicated in a similar human disease
phenotype, or with appropriate tissue expression or function.
1.7.1 Candidate genes
The plausible positional candidates within the PFHBI locus (Figure 1.5) include genes
encoding for:
• glycogen synthase (GSYI)- a skeletal muscle gene that is expressed in the heart,
• a potassium ion channel (KCNA 7) - K ions control excitability of cardiac muscle cells
(Klocke et al., 1993),
• histidine-rich calcium-binding protein (HRC) - with postulated function III cardiac
calcium ion fluxes
Although none of the genes within the designated PFHBI locus have a direct association with
known cardiac conduction system pathology, in the present project, two genes GSYI and HRC
were selected, as they are attractive candidates for the PFHBI-causative gene.
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1.7.1.2 Glycogen synthase (GSYI)
Glycogen synthase (GSY) catalyses the rate-limiting step in the synthesis of glycogen.
Glycogen, ubiquitous in mammalian tissues, represents a readily mobilisable form of glucose
and thus serves to maintain energy homeostasis within cells. The glycogen in liver serves an
additional unique purpose of buffering blood glucose (Kaslow and Lesikar, 1984). The GSYI
and GSY2 genes have since been mapped to chromosomes 19q13.3 (Lehto et al., 1993) and 12
(Nuttall et al., 1993), respectively. Liver GSY2 is only expressed in the liver, in contrast to
muscle GSYI, which is expressed in skeletal muscle, heart, kidney and fat (Kaslow et al.,
1985). Expression studies by Browner et al., (1989) comparing GSYI mRNA levels in foetal
heart and foetal skeletal muscle showed that GSYI was more abundant in the foetal heart. This
observation, in the light that one of the characteristic features of the conduction system genes
is that they continue to be expressed postnatally (Gorza et al., 1994), made GSYI an attractive
candidate for PFHBI. The GSYI gene has been implicated, but not confirmed, as a cause of
the insulin resistance in non-insulin-dependent diabetes mellitus (NIDDM) in the general
population (Orho et al., 1995).
Although the role of glycogen in the conduction system is not yet known, it can be assumed
that it is likely to serve a purpose. As discussed in section 1.2.4, glycogen occurs in
abundance in the cardiac conduction system (James, 1970; Davies, 1971). Furthermore, the
glycogen-rich conduction system remains unscathed during myocardial infarction (Thornell
and Sjostrom, 1975), a period when glycogen is the only source of glycolytic flux (Opie,
1991; King and Opie, 1998). Therefore, it is possible that mutations in GSYI, negatively
affecting glycogen synthesis, cause the conduction system to be more susceptible to stress-
induced damage. Thus, it would be worth investigating genes coding for enzymes involved in
glycogen metabolism for possible role in PFHBI pathophysiology. The human muscle GSYI
and its gene product have been characterised. The gene consists of 16 exons, spanning
approximately 27kb, encoding a 737 amino acid protein. The functionally important domains,
namely the nine phosphorylation sites, are coded for by exons 1 (2 of 9) and 16 (remaining 7)
and exon 12 codes for a highly conserved region (Orho et al., 1995). Consequently, it could
be proposed that any sequence variation occurring in these regions might have a deleterious
effect on function of the protein.
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1.7.1.3 Histidine-rich calcium-binding protein (HRC)
The histidine-rich calcium-binding protein (HRC) is a luminal sarcoplasmic reticulum (SR)
protein identified by its ability to bind low-density lipoprotein (LDL) with high affinity and
also calcium ions (Hofmann et al., 1989), whose function is as yet unknown. The gene was
shown to be expressed in both skeletal and heart muscle and subsequently localised to human
chromosome 19 (Hofmann et al., 1991). The mouse hrc orthologue was mapped to
chromosome 7 and because of known synteny between the two chromosomes, human HRC
was specifically placed on 19q 13.3, the PFHBI target area (Hofmann et al., 1990).
Calcium ions are involved in range of signalling cascades as secondary messengers in cells of
most tissues. The regulation of calcium is in turn mediated by calcium-binding proteins,
which in the heart are located within the sarcoplasmic reticulum (Opie, 1997). In the heart,
Ca 2+ regulate the contraction and relaxation phases of the cardiac cycle, where the release of
Ca2+ from the SR is controlled by entry of low levels of Ca2+ into the cell during
depolarisation (calcium-induced calcium release). For example, the SR protein, calsequestrin,
releases Ca2+ into the cytosol in response to the amounts of cl+ entering a cardiac myocyte
with each wave of depolarisation (Opie, 1997). The cardiac conduction system has no known
contractile function and although it contains a sparse population of myoctes, and sometimes
SR, their role in the conduction system has not been clearly defined, but they possibly fulfil
some function.
The histidine-rich calcium-binding protein encoding gene, HRC, was initially selected as a
candidate because it is expressed in the heart and also because of its postulated function in
Ca2+ regulation in the SR (Hoffman et al., 1989). In addition, analysis of the published HRC
gene sequence showed that exon 1 of HRC contains stretches of two trinucleotide (GAG)n and
(GAT)n STRs (coding for glutamic acid and aspartic acid residues, respectively). The
presence of these repeat motifs, together with the fact that genetic anticipation had been
described in PFHBI, led to the search for abnormally expanded repeats in exon 1 of HRC.
Both De Meeus and Christoffels analysed these two repeat loci in the ICCD and PFHBI-
affected patients and their unaffected close relatives, respectively, but did not detect any
unusually expanded (GAG)n or (GAT)n STRs (De Meeus et al. 1995; Christoffels, 1997).
These results excluded triplet repeat expansion in exon 1 of HRC as the disease-causing
mechanism in both ICCD and PFHBI. The HRC, however, has six exons, therefore, five other
exons had not been analysed for the presence of potentially disease-causing mutations.
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1.8 THE PRESENT STUDY
The sub-chromosomal location of the PFHBI locus was established, on chromosome 19qI3.3,
by linkage analysis (Brink et al., 1995). Furthermore, the original target area spanning IOcM
was reduced to 7cM by genetic fine mapping using dinucleotide polymorphic genetic markers
available on the databases (De Jager, personal communication). However, to physically map a
gene within such a large genetic interval would be an arduous task.
Therefore, to increase the resolution of the current genetic map, trinucleotide and
tetranucleotide genetic polymorphic STRS were considered as resources, to complement the
dinucleotide markers available, thereby allowing saturation fine mapping. Unfortunately,
there were no known trinucleotide or tetranucleotide markers within the target interval.
Therefore, as part of an integrated approach, development of tetranucleotide polymorphic
markers, using cosmid clones spanning the PFHBI target interval obtained from the Lawrence
Livermore National Laboratory (USA), was undertaken using either sub-cloning-based or
vectorette PCR-based strategies. The (AAAT)n STR was selected because it was one of the
most abundant tetranucleotide repeats which gave the clearest results on genotyping (The
Utah Marker Development Group, 1996).
The PFHBI target interval on chromosome 19q13.3 is a gene-rich area and among the
plausible positional candidates are the genes encoding GSYI and HRC (Figure 1.5).
Following a traditional positional cloning approach, concurrently with the development of
tetranucleotide genetic markers, the GSYJ and HRC candidate genes were screened for
PFHBI-causing mutations in families where PFHBI segregates. A variety of mutation
detection methods were applied for the different candidates based on available sequence
information. Based on homology searches and available literature, only the most conserved
exons of both GSYJ and HRC were selected for mutation screening. The PCR-SSCP analysis
was the method of choice for mutation screening of the selected GSY J exons as primer
sequences had been published. In contrast, the available sequence information on HRC was
limiting, as only a few bases of intronic sequence flanking all 6 exons had been published.
This lack of extensive intronic sequence would hinder complete exon screening.
Consequently, selected exons were screened by direct sequencing, which would enable the
acquisition of more intronic sequence, thus allowing complete exon and intron exon junction
screening.
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It was anticipated that, in conjunction with the complementary approaches used concurrently
by other members of the PFHBI group, the present project would speed the search for and
identification of the PFHBI-causative gene and associated mutations.
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2.1 SELECTION OF FAMILIES
Individuals participating in this study belong to the families, in which PFHBI segregates,
which were initially described by Brink and Torrington (1977). These families were
subsequently extended and divided into 3 apparently unrelated pedigrees, designated
pedigrees 1,2 and 5, (Torrington et al., 1986; Brink et al., 1994) and also include additional
family members who have since come to our attention (Figure 1.3). From each pedigree, a
panel comprising PFHBI-affected individuals and their first-degree relatives, which included
siblings, children and married-in individuals used as control samples, was selected for
mutation screening analysis of the candidate genes (Figure 2.1).
2.2 DEFINITION OF PHENOTYPE
Progressive familial heart block I was diagnosed on an ECG by the presence, of RBBB,
RBBB complicated by left anterior or posterior hemiblock (LAHB/LPHB) or CHB with a
broad QRS-complex, in the absence of other cardiac diseases, in a family setting (Brink and
Torrington, 1977).
2.3 BLOOD COLLECTION
The University of Stellenboseh's institutional ethics committee approved the present study
(Project 86/085). Prior to the start of this study, blood samples had been collected from
members of families in which PFHBI segregates, after contact by one or more of the
following, Prof. P.-L van der Merwe, Department of Cardiology, Prof. Paul Brink,
Department of Internal Medicine, Tygerberg Hospital, their own physicians or Genetics
Service nurses. Informed verbal consent was obtained from the participants, or their parents in
the case of minors. Twenty millilitres of peripheral blood were collected, in 5ml aliquots, into
four EDTA tubes per individual and DNA isolated from the white blood cells.
2.3.1 Isolation ofnuclei
Blood from two EDTA tubes was transferred into a 50ml Falcon tube, 20ml ice-cold cell lysis
buffer (Appendix) was added, the solution was mixed and incubated on ice for 10 minutes.
The mixture was centrifuged in a benchtop centrifuge (model TJ-6, Beckman Instruments
Inc., Palo Alto, California, USA) at 3000rpm for 10 minutes at room temperature. To wash
the pellet, lOml cell-lysis buffer was added, the sample left on ice for 10 minutes and
Stellenbosch University http://scholar.sun.ac.za
40
centrifuged as before. The supernatant was again discarded and the process repeated until the
pellet was pale pink to white, after which it was resuspended in 4501-l1Na-EDTA solution
(Appendix) and 501-l110% SDS. The intact nuclei were either used immediately to prepare
DNA or were stored at -70°C until required.
2.3.2 DNA extraction from nuclei
A 1001-l1aliquot of proteinase K (lOmg/ml) (Boehringer Mannheim, Mannheim, Germany)
°was added to the nuclei suspension and the mixture incubated overnight at 37 C, with gentle
agitation. The sample was transferred to a 50ml propylene tube before the addition 2ml sterile
dH20 and 5001-l13M Na-acetate. Organic extraction of DNA was achieved by the addition of
2.5ml phenol/chloroform solution (Appendix) to the sample, which was then mixed by
incubation on a Voss rotator (Maldon, England) for 10 minutes. The mixture was transferred
to a Corex tube and centrifuged in a SorvalI RC-5B centrifuge using an SS34 rotor at 8000
°rpm for 10 minutes at 4 C. The aqueous phase, containing DNA, was transferred to a clean
Corex tube, taking care not to disturb the interface. Octanol/chloroform (Appendix), 2.5ml,
was added, the contents of the tube mixed well and centrifuged as above. The aqueous phase
was again transferred to a clean tube, 7.5ml ice-cold ethanol (96%) was added and the
solution gently mixed until DNA strands appeared. Using a yellow Gilson pipette tip, the
DNA strands were collected and transferred to a clean eppendorf tube, this was followed by a
washing step with 1ml ethanol (70%) and centrifugation in a microfuge (Beckmann,
Germany) at 14000 rpm for 3 minutes at room temperature. Ethanol was carefully decanted,
taking care not to disturb the pellet. The ethanol wash was repeated. The remaining ethanol
was carefully blotted out using paper towel and the DNA-containing pellet air-dried for 1hr.
DNA was resuspended in 5001-l1l x TE (pH8.0) (Appendix), the solution heated for 10
°minutes at 65 C and mixed on the Voss rotator (Voss of Maldon, Protea Dento-Medical
°Services, Cape Town, RSA) at 4 C for 3 days. The optical density of the DNA solution was
determined in a spectrophotometer (Spectronic 1201, Milton Roy) at 260nm and the
concentration adjusted to 0.2I-lg/1-l1either by further dilution with lxTE or by another ethanol
precipitation step and subsequent resuspension in the appropriate volume of 1xTE, with
rotation mixing as before.
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1.30 I 1.302 1.304 1.305 5.101 5.102
1.401 1.402 1.409 1.410 5.201 5.202 5.203
1.501 1.502 1.503 1.504 1.510 1.511
5.301 5.302
PEDIGREE 1 PEDIGREE 5
4.303 (A)
9.305 (U)
10.301 (A)
12.302 (U)
6.30 6.307 6.314 6.313
6.405 6.406 6.407 6.409 6.412 6.413 6.414 6.415
PEDIGREE 2II __Clinically affected
D 0 Clinically unaffected
~ ~ Deceased
Figure 2.1 PFHB1-affected/amily branches/rom pedigrees 1,2 and the complete pedigree
5.
The panel of PFHBI-affected individuals and their .first-degree relatives whose DNA samples
were analysed/or disease-causing mutations by PCR-SSCP and direct sequencing. Additional
members from other pedigree 2 sub-families (not shown) were included (boxed). A =
clinically affected, U = clinically unaffected.
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2.4 PRIMER DESIGN AND SYNTHESIS
Oligonucleotide primer pairs were required for polymerase chain reaction (PCR)
amplification of exons and/or introns of candidate genes for mutation screening and for
amplification of vectorette libraries to probe for the presence of AAAT tetranucleotide
sequences. Primer pairs for which published sequences were available were custom
synthesised (DNA Laboratory, Dept. Biochemistry, University of Cape Town, Cape Town,
R.S.A.). Alternatively, primers were designed from the published gene sequence with the
assistance of OLIGOV2 and PRIMER programs. Primer sequences used in the amplification
of targeted regions of candidate genes are listed in Table 2.1, while those used in the
development and characterisation of the (AAAT)n tetranucleotide repeat are given in Table
2.2. An additional oligonucleotide, with the sequence (AAAT)IO, was designed and used as a
radio-labelled probe for the identification of the AAAT repeat motif.
2.5 POLYMERASE CHAIN REACTION AMPLIFICATION
2.5.1 Non-radioactive ree
Non-radioactive PCR was used for the amplification of selected exons of GSYI for mutation
screening, to generate template both for sequencing regions (exons/introns) of HRC and also
for regions of cosmid insert harbouring the (AAAT)n repeat motif. The general method
followed was: 200ng of human genomic DNA was aliquoted into a 0.5ml eppendorf
centrifuge tube. To this, was added a reaction cocktail containing: 150ng of each primer,
75lJ-M each of dATP, dGTP, dTTP and dCTP (Promega Corp, Madison, Wisconsin, USA),
MgC12 (Table 2.1), 5lJ-lof a lOx Taq DNA polymerase buffer supplied by the manufacturer
(Promega Corp, Madison, Wisconsin, USA) (containing 500mM KCl, 100mM Tris-Cl, pH =
9 @ 25°C, 1% TritonX-100), 0.5U Taq DNA polymerase (Promega Corp, Madison,
Wisconsin, USA) and 5% formamide (Sigma Chemical Company, St Louis, Missouri, USA)
and ddH20 to 50lJ-1.The reaction mixture was subsequently overlaid with 30fll mineral oil to
prevent evaporation during amplification.
Amplification was carried out in a Gene E Thermal Cycler (Techne Ltd., Cambridge, UK) for
thirty cycles. Each cycle typically comprised a 30s denaturation step at 94°C, annealing of
primers at 3_5°C below the lowest Tm (Table 2.1) for 30s and a 60s extension step at 72°C.
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For specific amplification conditions refer to table 2.1. An additional final extension step at
°72 C for 5min was included for the amplification of HRC regions, in which the expected
amplification products were >500bp long in size (Table 2.1). Subsequently, aliquots of each
sample were electrophoresed on agarose gels (section 2.6.1) to verify the success of the PCR
and the samples stored at room temperature until further analysis.
Non-radioactive PCR of the selected HRC regions was performed in a similar manner, except
that 0.5U of BIOTAQ™ DNA polymerase (Bioline, UK Ltd, UK) and lOx NH4 reaction
buffer (containing 160mM (NH4)2S04, 670Mm Tri-HeI, pH 8.8 at 25°C, 0.1% Tween-20).
2.5.2 Radioactive rc«
For genotyping the AAAT repeat identified during the course of this study, radioactive PCR
was performed as follows: a cocktail containing 60ng of each primer, 11lCi U_32p[dCTP]
(Amersham International, UK), 51lM unlabelled dCTP, 200llM of each of dATP, dTTP and
dGTP, 1.5mM MgC12, IIII of lOx Taq DNA polymerase buffer supplied by the manufacturers
(Promega Corp, Madison, Wisconsin, USA) (containing 500mM KCl, 100mM Tris-Cl, pH =
9 @ 25°C, 1% TritonX-100), 0.5U Taq DNA polymerase (Promega Corp, Madison,
Wisconsin, USA) and 5% formamide (Sigma Chemical Company, St Louis, Missouri, USA)
and ddH20 to a final volume of 10111was added to 100ng of genomic DNA template aliqouted
in a 0.5ml eppendorf tube. Samples were amplified in a GeneE Thermal Cycler using similar
cycling time as for the non-radioactive PCR. When the amplification reaction was completed
6111of loading dye (Appendix I) was added to each sample prior to analysis on a denaturing
polyacrylamide gel (section 2.6.3) or they were stored at room temperature until required.
2.5.3 Direct Sequencing
Preparation of template
Direct cycle sequencing of amplified products was performed in both directions. First, 45-
90111 of PCR amplification product was gel extracted and DNA purified using the QIAquick
gel extraction kit (QIAGEN, Germany) with minor modifications to the manufacturer's
instructions. To elute the DNA in a more concentrated form, 30111ddH20 and not 501111xTE
elution buffer were applied to the spin-column. This DNA was then used as template for the
sequencing reaction.
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Table2.1: Primer sequences, annealing temperature, magnesium chloride concentration and expected product size following PCR
amplification of specific exons/regions of candidate genes GSYI and HRC.
Gene Exon/Region Forward Primer 5'-3' Reverse Primer 5'-3' Tm MgCh Size
F R
GSYI 4a gcagtagtggtgacagattg ttcctggcatactcgcagtc 57°C 1.5mM 379 bp
5a ccaatccttctaaccgactg gcctacctcattcacgtctg 58°C 3.0mM 225 bp
113 tacccttcttgtggctcctg agccctgaccaaatgccctc 60°C 1.25 mM 159 bp
123 gcacttgggctgagtccttc gatgccatgaccacgctgtc 60°C 1.25 mM 200 bp
16A3 ccctggtttgcacccacatc gacttagttacgctcctcgc 60°C 1.25 mM 358 bp
HRC 2F-3Rb ccccgcagGTCCACAGG gaggtctcacCTGGCACT
58°C
1.5 mM ~940 bp
4F-5Rb cgcctccagCACTGTCAG cacttacCTGA TAAAGGGTG 6.0mM 538 bp
59°C
4F-6Rb cgcctccagCACTGTCAG CGGGGAGCACGTTTATTCGG 3.0mM 854 bp
60°C
2F-2Rc ggacaggagagaggagg tggcctgcccttgctctg 1.5 mM 300 bp
3F-4Rc
75/61°C
aagtgcgttagagttcc accaggattcaccacgc
5F-6Rc gctatactgagtggctgcc cggggacgtttattcgg 2.0mM 353 bp
64°C
- - - L_ - ---
Tm = annealing temperature. MgCl2 = magnesium chloride. a = primer sequences obtained from the literature (Orho et al., 1995). b
= primers designed from published gene, both intronic and exonic, sequences (Hofmann et al., 1991), lower and upper case letters
indicate intronic and exonic sequences, respectively. c = primers designed from sequence obtained by direct manual sequencing.
Primer sequences are shown in 5 '-3' orientation. GSY1 = human muscle glycogen synthase gene and HRC = histidine-rich calcium-
binding protein encoding gene. bp = base pairs.
44
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Table2.2: Oligonucleotide primer sequences, peR amplification conditions and the observed product sizes used in the isolation and
characterisation of AAAT STR in the sub-clonedfragments and cosmidvectorette libraries.
Cosmid Primer Upstream (5'-3') Downstream (5'-3') Tm MgCh Size (bp)
pair
T3 -T7 aattaaccctcactaaaggg gtaatacgactcactatagggc 50°C 1.5mM
29395 395F-395R cgatcacaccactgcac gtgatctagaccagtacaac 48°C 1.5mM ~137
24493 Alula A4c-224 aaataaataaataaatc teteeettete gaatggtaacc gttc gtac 34°C 1.5mM ~250
493R-224 tacatgctacacgtggat tctcccttctcgaatggtaaccgttcgtac 65°C 1.5mM ~500
493R-493F tacatgctacacgtggat atgcctcttacctgtcacc 60°C 1.5mM ~190&
~220
20381 Rsalb A3c-224 aaataaataaataaatg tctcccttctcgaatggtaaccgttcgtac 38°C 1.5mM ~800
381R-224 ctgcaacacatctcacagtc tctcccttctcgaatggtaaccgttcgtac 62°C 1.5mM ~800
381R-381F ctgcaacacatctcacagtc ccttcactcactcatgcatc 60°C
1.5mM ~514
381F' ctgcaacacatctcacagtc ccagctctgtgttcctca
60°C
1.5mM ~339
10108d tctcccttctcgaatggtaaccgttcgtac 1.5mM
55°C
.. -
Tm = annealing temperature, T3 and T7 = pBluescript T3 and T7 promotor region sequences, respectively, used to sequence the
positively hybridising sub-cloned insert DNA. a = cosmid 24493 vectorette library generated by digestion with restriction enzyme
Alu!' b = cosmid 20381 vectorette library generated by digestion with restriction enzyme Rsal. c = Oneof a set of 4 anchored (A)
primers: 1= (A3T)4-A, 2 = (A3T)4-T, 3 = (A3T)4-G, 4 = (A3T)rC d = vectorette-specific sequencing primer 10108.
45
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Cycle sequencing
Five microlitres of the concentrated template DNA was sequenced using the fmol sequencing
kit (Promega US) according to the manufacturer's instructions. Specifically, the sequencing
reaction mixture contained 51-l1template (DNA), 51-l15x sequencing buffer, 5% DMSO (2:3
dilution in ddH20, Sigma, U.S.A), lOpmol of primer, 0.51-l1U_32p[dCTP] (Amersham
International, UK), ddH20 to 161-l1and 5U of sequencing grade Taq polymerase (Prornega,
USA). Four microlitres of the above cocktail mixture was added to four previously prepared,
pre-chilled 0.5ml eppendorf tubes, each containing 21-l1aliquots of a cocktail composed of all
four deoxynucleotides, as well as one specific dideoxynucleotide, namely, ddATP, ddTTP,
ddGTP or ddCTP and 201-l1mineral oil. Samples were then placed into a pre-heated GeneE
o
Thermal Cycler (Techne Ltd., Cambridge, UK) and held at 95 C, for 2 minutes before
commencing cycling, using a thermal cycling profile similar to that of the original PCR
amplification. When the sequencing cycle was completed, 41-l1sequencing stop solution
o
(Prornega, USA) was added to each tube. These samples were either stored at -20 C until
required or denatured at 95
0
C in a heating block for 2 minutes and a 41-l1aliquot immediately
loaded on a pre-electrophoresed denaturing polyacrylamide gel (section 2.6.3).
2.6 GEL ELECTROPHORESIS
2.6.1 Agarose gel electrophoresis
Agarose gels was used for verification of success of PCR amplification, preparative gels for
sequencing template and for analysis of the purified cosmid and plasmid DNA. Five
microlitres of either PCR product or cosmid/plasmid DNA were mixed with ll-ll of
bromophenol blue loading dye. The samples were subsequently loaded and electrophoresed in
1.5% to 2% (depending on the size of the amplified product) or 0.7% to 1% (for cosmid and
plasmid DNA) horizontal agarose gels of 12cm x 5cm xIcm dimensions, containing Il-lg/ml
ethidium bromide (EtBr) and IxTBE electrophoresis buffer (Appendix I). The samples were
co-electrophoresed with a sample of bacteriophage ADNA digested with restriction enzyme
Pstl used as a molecular size marker (Appendix I). The gel was subsequently visualised on
longwave ultraviolet transilluminator (3UV™ Transilluminator model LMS-26E) and a
photograph was taken using an ITC camera (Berkenhoff and Drebes, Germany) and a Sony
video graphic printer (UP-860CE).
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2.6.2 Non-denaturing polyacrylamide gel electrophoresis
Non-denaturing polyacrylamide gels were used for verification of restriction enzyme digests,
using a 12% polyacrylamide solution (Appendix I) and for single strand conformation
polymorphism (SSCP) mutation analysis.
Mutation analysis by SSCP
For each panel of samples analysed, four different non-denaturing polyacrylamide gel
conditions were used, as standard, for PCR-SSCP mutation screening, namely, 5% or 10%
non-denaturing polyacrylamide gel, either with or without 10% glycerol. A 0.35x MDE™
(FMC Bioproducts, USA) gel was used for further analysis of samples showing mobility
shifts to achieve better resolution of conformational changes observed on non-denaturing
polyacrylamide gels.
Casting the gel
The gel (Appendix) was cast between 390mm x 290mm x 1mm glass plates, which were first
washed with Cal-liquid hand soap (Cal-Chem, R.S.A), rinsed in tap water and wiped dry with
paper towel, after which the surfaces were sprayed with 70% ethanol and wiped clean as
before. Gelbond ™ PAG polyester film (FMC, Bioproducts, Rockland, Maine, USA) was
attached to the back plate by its hydrophobic side, to facilitate this, 70% alcohol was lightly
sprayed onto this plate. The hydrophilic side of the Gelbond ™ was exposed so that, when the
gel solution was poured, the two would bond covalently, thus creating a solid support for the
gel for subsequent silver staining. The front plate was wiped with paper towel spotted with
Wynn's CTHRU windshield rain dispersant (Wynn Oil S.A. Pty Ltd,SA).
One-millimetre spacers were placed on either side of the gel-bond-covered back plate and the
front plate then placed on top with the CTHRU-coated side on the inside. The edges, on the
sides and bottom of the plates, were sealed with gel-sealing tape (SIGMA, Germany) after
which the casting rubber boot (S2 casting boot, Life™ Technologies, UK) was fitted for
further sealing. The gel solution was poured with the glass plate assembly slanted at an angle.
Immediately thereafter, the glass plates assembly was laid down horizontally, a square-tooth
comb fitted (to create wells), the plates clamped and the gel allowed to set for -Thr.
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Electrophoresis
Thereafter, the casting boot, the sealing tape at the bottom of the plates and the comb were
removed, in this order. The glass plate assembly was mounted vertically on the
o
electrophoresis apparatus (Omeg Scientific, R.S.A), moved to the cold room (4 C) and
0.5xTBE (Appendix) buffer added to the reservoir tanks. The wells were washed with buffer
to remove any residues, and the denatured PCR sample (section 2.8.1.2) immediately loaded.
Electrophoresis was carried out in 0.5x TBE buffer, at a constant power of 50W for 2-7hrs at
o
4 C, depending on the type of gel being used. Subsequently, the glass assembly was
dismantled and the gel silver stained (discussed in the next section).
Silver Staining
Following electrophoresis of non-radioactive samples on the non-denaturing gels, the glass
assembly was dismantled and the gel still supported by the Gelbond TM, was silver stained by
incubation in solution B (Appendix I), on a Labcon shaking platform (Labdesign Engineering,
R.S.A) for 10 minutes at room temperature, followed by a brief ddH20 rinse and incubation in
solution C (Appendix I) on the Labcon shaking platform, for a minimum of 20 minutes or
until the bands became visible.
2.6.3 Denaturing gel electrophoresis
Template Sequencing
The 0.5mm 5% polyacrylamide denaturing sequencing gel (Appendix I) was cast as described
in section 2.6.2, but without the use of Gelbond™ film and using 0.5mm thick spacers and a
shark's-tooth comb. Pre-electrophoresis was carried out in pre-heated 0.5x TBE buffer at
o
1800V for -30 minutes, the samples (section 2.5.3) were heat-denatured at 95 C for 2
minutes, 4Jll loaded in the wells and electrophoresis continued for 2hrs. For long sequence
reads, electrophoresis proceeded until the bromophenol blue dye had migrated more than two
thirds down the gel. At this point, the gel was switched off and a 4Jll aliquot of the same
sample, heat-denatured, was loaded on a different lane. Electrophoresis was resumed and
allowed to proceed until the second bromophenol blue front had migrated more than two
thirds down the gel, for short sequence reads.
After electrophoretic separation had been completed, the plates were dismantled, the gel was
carefully lifted off the glass plates using 3MM Whatman paper cut to the same size and then
covered with cling-film (GLAD™). Subsequently, the gel was dried for an hour on a Drygel
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Sr Slabgel Dryer (model se 1160) and thereafter, placed in a cassette and exposed to an X-ray
film (Cronex-t, Protea Medical) overnight at room temperature.
The X-ray film (Cronex-t, Protea Medical) was developed, in the dark, by immersion in
developing solution (Appendix I) for 4 minutes, stop solution (Appendix) for 0.5 minutes and
fixing solution (Appendix I) for 2 minutes. The X-ray film (Cronex-t, Protea Medical) was
then rinsed off with running water and hung to dry at room temperature.
DNA Sequence analysis
The information from the sequenced HRC regions, from both the PFHBI-affected individual
and an unaffected close relative, were read manually and the sequences analysed for any
variations. Furthermore, these sequences were compared to the wild type gene (HRC)
sequence deposited in GENBANK (http://www2.ncbi.nlm.nih.govD to ascertain the
authenticity of the obtained sequence and also confirm the observed sequence variations.
To design primers from the acquired sequence information, HRC intronic regions (section
2.8.2) or vectorette peR (section 2.7.7), the long and short sequence runs were read manually
and the region of overlap between the two established, thus generating one long sequence.
The 3' -end of the longer sequence was then used to design new Pf.R primers.
To determine if complete sequencing of the vectorette library fragment generated by
amplification using the putative repeat-flanking primers F and R (section 2.7.7) had been
achieved both the sequences were read and the complement of the R sequence (R') was
established. Subsequently, a region of overlap between the F and R' sequence information
was established and the two sequences then merged.
Genotyping of (AAA 1)n repeat locus
Following the sequencing of the recombinant plasmid containing the (AAAT)n repeat (section
2.5.3), primer pairs for amplification of (AAAT)n repeat locus for genotyping were designed
from the repeat-flanking sequences read from the manual sequencing autoradiograph. The
chosen sequences (Table 2.2) were analysed to avoid the possibility of self-complementarity
or primer-dimer formation using OLIGOV2 prior to synthesis. The primers were then used to
peR amplify 40 DNA samples of unrelated individuals of Mixed Ancestry (section 2.5.2).
The amplified samples were then analysed on a denaturing polyacrylamide gel (section 2.6.3).
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To determine the genotype, the PCR-amplified samples (section 2.5.2) were heat-denatured,
loaded into the wells of the gel (section 2.6.3) and electrophoresis carried out for ~lhr or until
the bromophenol blue front had reached the bottom of the gel. The dried gel was then
exposed, overnight, to an X-ray film (Cronex-4, Protea Medical) to visualise the different
alleles and hence determine if the repeat was polymorphic.
2.7 DEVELOPMENT OF AAAT POLYMORPHIC STR MARKERS
Tetranucleotide (AAA T)n repeat polymorphic markers were sought as part of an integrated
approach to find more genetic markers, within the chromosome 19q13.3 target search area,
for the purpose of narrowing the region, by identification of recombination breakpoints.
Twentyfive cosmid clones containing inserts spaced at 500kb intervals across the
chromosome 19q 13.3 region were obtained, as agar stabs, from the Lawrence Livermore
National Laboratory (LLNL) (California, USA). The LLNL were responsible for developing
the physical map of chromosome 19 and thereafter sequencing this chromosome. The cosmids
used in this study were selected from the maps published by LLNL (http://www-
bio.llnl.gov/genome-bin/). The cosmids were derived by subeloning fragments of human
chromosome 19q 13.3 into the Lawrist-16 vector and the recombinant cosmids propagated into
the DH5u strain of Esherichia coli (E. coli) (De Jong et al., 1989). These cosmids were used
as resource for identifying tetranucleotide repeat sequences.
2.71 Cosmid culture preparation
To prepare cosmid cultures, a sterile plastic loop was dipped into the agar stab culture, or used
to scrape the top of frozen glycerol stocks prepared from the stabs, and subsequently
inoculated into 2ml of Luria Bertani (LB) broth containing kanamycin (Kn) (50Ilg/ml) in
15ml tubes. The culture was then incubated at 37°C for 7-8hrs or overnight, with vigorous
shaking. Using a sterile plastic loop, a sample of the 2ml culture was streaked onto
°LB/agar/Kn (50Ilg/ml) plates, which were incubated at 37 C overnight. A single colony was
picked from the overnight agar plate, inoculated in 250ml LB/Kn (50Ilg/ml) medium and
incubated at 37°C overnight with vigorous shaking. The cells harvested from this culture
served as the source of cosmid DNA. Plasmid vector, pBluescript SK, cultures were prepared
in a similar manner, but using LB/ampicillin (Amp) (50Ilg/ml) selective medium. However,
some (6/25) of the cosmid clones were no longer viable and could thus not be pursued for
culture preparation
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2.7.2 DNA Purification
Cosmid DNA Maxi/Midi Prep
The QIAGEN™ commercial DNA purification kits (QIAGEN, Germany) was used to isolate
cosmid DNA from bacterial genomic DNA with slight modifications to the manufacturer's
o
protocol. Cells were harvested from the 250ml overnight culture by centrifugation at 4 C for
10 minutes at 6000 rpm in a Sorvall RC-5B centrifuge using a GSA rotor and the supernatant
was discarded. The cell-containing pellet, obtained from 250ml of cell culture, was
completely resuspended in 50ml of buffer PI (Appendix I) containing RNAse A (lOOflg/ml).
To lyse the cells, 50ml of buffer P2 (Appendix I) were added to the suspension, which was
then gently mixed and incubated for 5 minutes at room temperature. Fifty millilitres of chilled
buffer P3 (Appendix I) was added to the lysed cells, which were then incubated on ice for 10
minutes. Separation of cosmid DNA from precipitated bacterial DNA was achieved by
centrifugation at 20000x g (11000 rpm) in a Sorvall RC-5B centrifuge using a GSA rotor for
30 minutes. The cosmid DNA-containing supernatant was promptly transferred into a sterile
GSA tube, re-centrifuged as before for 15 minutes or until supernatant was clear and the clear
supernatant transferred into a clean tube immediately.
Gel Filtration Chromatography
Ten millilitres of buffer QBT (QIAGEN, Germany) (Appendix I) were used to equilibrate the
QIAGEN-tip 500 before loading the clear DNA-containing supernatant (cf cosmid DNA
maxi/midi prep). Thereafter, the column was washed twice with 30ml buffer QC (Appendix I)
to remove contaminants from the DNA. DNA elution was achieved by adding 15ml of buffer
QF (Appendix I) to the column and the eluate collected in an SS34 tube. To precipitate the
DNA, 10.5ml isopropanol (0.7 volumes, equilibrated at room temperature) were added to the
eluate, which was immediately centrifuged at ~15000 g in a Sorvall RC-5B centrifuge using a
. 0
SS34 rotor for 30 minutes at 4 C. The supernatant was carefully removed and the DNA-
containing pellet washed with 5ml ethanol (70%) by centrifugation at 15000xg in a Sorvall
o
RC-5B centrifuge using an SS34 rotor, for 10 minutes at 4 C. Ethanol was decanted and the
remnants blotted with paper towel. The pellet was air-dried for 5 minutes and resuspended in
200/50fll lxTE (Appendix I) buffer (pH 8.0). Absorbance was read on a Milton Roy
Spectrophotometer 1201 at 260nm to determine the DNA concentration. DNA was analysed
on a 0.7 % agarose gel containing 0.01% EtBr and 1 x TBE to check its integrity (section
2.6.1). The DNA prepared at this stage was referred to as cosmid DNA and used as starting
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material for dot blots (section 2.7.3.1), Southern blot (section 2.7.3.2), sub-cloning (section
2.7.3.3) and vectorette-PCR (section 2.7.7.1) manipulations that followed.
Plasmid DNA Miniprep (rplasmid)
In order to characterise recombinant plasmids that hybridised with the (AAAT)lo (section
2.7.3.3), a single white colony was inoculated in 5ml LB/Amp/Tc selective medium in a 15ml
o
propylene tube and incubated with shaking at 37 C overnight. The cells were centrifuged in a
o
Sorvall RC- SB centrifuge using an SS34 rotor at 2500 rpm for 15 minutes at 4 C and the
supernatant discarded. The pellet was resuspended in 200111of GTE solution (Appendix I),
containing lysozyme (5mg/ml) and transferred to a 1.5ml eppendorf tube. Four hundred
microlitres of freshly prepared cell lysis NaOH/SDS solution (Appendix I) were added to this
suspension, which was incubated for 5 minutes at room temperature. Thereafter, three
hundred microlitres of ice-cold 3M KAc solution (Appendix I) were added to precipitate
bacterial genomic DNA, the mixture was placed on ice for 5 minutes and then centrifuged in a
microfuge (Beckmann, Germany) at 14000 rpm for 5 minutes.
The supernatant, containing rplasmid DNA, was transferred into a clean 1.5ml eppendorf tube
and purified of protein and RNA contaminants by organic extraction in the following manner:
600111phenol/chloroform (24: 1) solution (Appendix I) was added to the supernatant, mixed by
inversion and incubated at room temperature for 5 minutes prior to centrifugation at 14000
rpm for 5 minutes. The top aqueous phase containing recombinant plasmid DNA was
transferred into a clean 1.5ml eppendorf tube, 300111chloroformlisoamylalcohol was added,
the mixture vortexed and then centrifuged as above. The top layer was again transferred to a
clean 1.5ml-eppendorf tube and DNA was precipitated by addition of 600111isopropanol and
incubation at room temperature for 30 minutes. Thereafter, the contents of the tube were
centrifuged in a microfuge (Beckmann, Germany) at 14000 rpm for 5 minutes and the
supernatant was discarded. The pellet was washed with 20011170% ethanol by centrifugation
at 14000 rpm for 5 minutes, lyophilised in a Speedy- Vae concentrator (Savant Instruments,
USA) for 5 minutes and resuspended in 200111TE (pH 8.0)/1 OOllg/ml RNAseA. Sample
analysis was done by electrophoresis on a 0.7% agarose gel (section 2.6.1).
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2.7.3 Preparation of Membrane Filters
2.7.3.1 Dot blots
Dot blots were prepared as the initial screen to identify cosmids harbouring the (AAAT)n
tandem repeat sequence, in order to avoid pursuing clones that did not contain repeat
sequences. On a Hybond™ N+ nucleic acid transfer membrane (Amersham, UK), the
identification numbers of the different cosmids were marked with a pencil at appropriate
positions. In an eppendorf tube, 200ng of cosmid DNA was denatured by the addition of an
equal volume of O.4N NaOH and incubation at room temperature for 5 minutes. The mixture
was snap-cooled on ice for 2 minutes and spotted on the appropriately marked position on the
TM + .
Hybond N filter, which had been placed on 3MM-chromatography paper (Whatman,
England). Fifty nanograms of human genomic DNA was also spotted onto the filter as a
positive control and ddH20 as a negative control. The filter was air-dried for 15 minutes and
baked for 2hrs in an 80°C vacuum oven (Towson and Mecer Ltd, England). Thereafter, the
filter was either re-hydrated in 2x SSC (Appendix I) prior to the pre-hybridisation step of the
screening process (section) or covered with cling film (GLADwrap™) and stored at 4°C until
required.
2.7.3.2 Southern blots
The purified DNA of cosmid clones identified by dot blot hybridisation as harbouring the
(AAAT)n tandem repeat was digested with Sau3AI (Amersham, UK), a four base pair frequent
cutter, to generate clonable-sized fragments. The digestion reaction, which was incubated for
°3hrs at 37 C, contained 5).1gcosmid DNA, 15U Sau3AI (3U/).1gDNA), lax buffer as specified
by the manufacturer (Amersham, UK) and ddH20 to a final volume of 30).11.Following
incubation, the total volume of the digestion reaction was loaded on a 0.7% agarose gel
containing 0.01% EtBr and Ix TBE alongside a size marker e"DNA digested with PstI
(Boerhinger Manheim)) and electrophoresis carried out at 35Y overnight.
The gel was visualised on longwave ultraviolet transilluminator (3UY™ Transilluminator
model LMS-26E) with a fluorescent ruler aligned next to the gel to measure the distance
migrated by the fragments from the wells and a photograph was taken using an ITC camera
(Berkenhoff and Drebes, Germany) and a Sony video graphic printer (UP-860CE). Briefly,
following electrophoretic separation of the digested cosmid DNA fragments, the gel was
depurinated by submersion and gentle agitation in 0.2M HCI for 10 minutes. The HCI was
decanted, the gel rinsed three times in ddH20 before placing it on a platform covered with
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3MM Whatman paper for alkaline transfer of DNA fragments from the gel onto a Hybond™
+
N nucleic acid transfer membrane filter (Arnersham, UK), following the manufacturer's
protocol and hereafter referred to as a Southern blot.
Subsequently, the blotting apparatus was dismantled to remove the membrane filter, which
was then placed between two sheets of 3MM Whatman paper (Whatman, England) and the
o
DNA fixed by baking the filter for 2hrs at 80 C in a vacuum oven (Towson and Mercer Ltd,
England). Thereafter, the Southern blot was either re-hydrated in 2x SSC (Appendix I) in
preparation for probing with a radioactively labelled oligonucleotide (section 2.7.5) or stored
o
at4 C.
2.7.3.3 Colony blots
o
Plates containing recombinant clones (section 2.7.6.5), were placed at 4 C for at least lhr
o
after overnight incubation at 37 C and prior to transferring part of each colony, in duplicate,
onto membrane filters. For each master plate, two pieces of Hybond N+ (Amersham, UK)
membrane were cut to the size of the petri plate and marked with a pencil as master or
duplicate, for replica plating. The first or master filter, was carefully placed on the plate with
the colonies for 1 minute and holes keyed in with a 18 gauge needle, to act as reference for
the orientation of the filter on the plate, taking care not to make any lateral movements. The
filter was carefully removed and placed, colony side up, on a fresh LB-agar/ Amp/Tc plate. To
make a duplicate filter, the second filter was carefully placed on top of the first and holes
keyed in the same position as the first filter. The fresh plate with the sandwiched duplicate
o
filters was incubated for 5hrs at 37 C, as was the original plate.
Following incubation, the filter sandwich was removed from the plate and the two halves kept
together. Thereafter, the filters were consecutively treated with 10% SDS (Sigma, USA) for 3
minutes, denaturing solution (Appendix I) for 5 minutes and neutral ising solution (Appendix
I) for 5 minutes, in three separate containers layered with 3MM blotting paper (Whatman,
England), which had been previously soaked, but not submerged in these solutions. The filters
were then separated and transferred to a container with 2x SSC-soaked (Appendix I) 3MM
blotting paper (Whatman, England) for a 5 minutes wash. Subsequently, the separated filters
were transferred onto a clean sheet of blotting paper, where they were left to air-dry for 30
o
minutes prior to fixing the colonies by baking for 2hrs in a 80 C vacuum oven (Towson and
Mercer Ltd, England). Thereafter, the filters were either re-hydrated in 2x SSC in preparation
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for pre-hybridization (section 2.7.5) or covered with cling film (GLADwrap™) and stored at
°4 C until required.
2.7.4 End-Labelling of (AAA T)10 Oligonucleotides
Incorporation of Radioactivity
The (AAAT)n tetranucleotide sequence, repeated ten times (AAAT)lo, was end-labelled with
y_32p[dATP] radioactive isotope and subsequently used as a hybridisation probe for the
identification of (AAA T)» repeat motif-harbouring cosmid inserts on dot blot, Southern blot
and colony lift membrane filters. The end-labelling reaction mixture contained I f.ll of
(AAAT)lo oligonucleotide (50pmol), 1Of.l1y_32p[dATP], 2f.l1T4 polynucleotide kinase (20
units) (Promega, USA), 5f.l1of lOx T4 polynucleotide kinase buffer (Promega, USA), and
32f.l1ddH20. The labelling mixture was incubated for 2hrs at 37°C.
Removal of Unincorporated Radioactivity
Gel filtration chromatography, Sephadex G-25, was used to separate the radiolabelled probe
from the unincorporated y_32p[dATP]. The Sephadex G-25 column was prepared in the
following manner: the bottom of a lml disposable syringe was sealed with sterile silanised
glass wool. In the syringe, a Sephadex G-25 resin suspended in lxTE (Appendix I) was
loaded using a lml pipette until the bed volume was 0.9ml. The column was equilibrated with
50f.l1STE (pH 8.0) (Appendix I) by centrifugation at 16000g for 3 minutes in a swing-out
rotor (Beckman model TJ-6 centrifuge) at room temperature. The column was washed by the
addition of 50f.l1STE and centrifuged as before and this repeated 3 more times. The label mix
(50f.l1)was applied to the column and centrifuged as before. Finally, 50f.l1STE (pH 8.0) was
added to the column and the radiolabelled probe eluted by centrifugation at 16000g, for 3
minutes in a swingout rotor (Beckman model TJ-6 centrifuge).
Calculation of Incorporated Radioactivity
The amount of label incorporated was determined by trichloroacetic acid (TCA) precipitation.
A mixture containing 1f.llof the labelled oligonucleotide (2.4.2), 5f.l120x SSC and 4f.l1ddH20
+was prepared and 4.5 f.llthereof spotted onto two pre-wetted, 1cm x 1cm, Hybond N filters.
The membranes were air-dried for 1 minute. One of the filters (representing total counts) was
placed into glass vial and 5ml of scintillation fluid added. The second filter washed once with
IOml TCA (10%), to reduce non-specific binding of unincorporated nucleotides, and
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subsequently washed five times with lOml (5%) TCA under vacuum to collect the
precipitated DNA. The washed filter (representing incorporated counts) was air-dried for 1
minute and placed in a glass vial and 5ml of scintillation fluid added. Both these vials were
placed in aP-counter (Tri-carb 460 CD, Liquid scintillation system, Packard) and the
percentage of incorporation calculated (Appendix I). Furthermore, radioactivity incorporated
into the oligonucleotide probe, in counts per million, was calculated by multiplying the cpm
of the washed filter with the total reaction volume of the labelled probe. The amount of
radioactivity incorporated had to be at least lxl06 cpm/ml of hybrid isation solution.
2.7.5 Hybridisation of membrane filters with an end-labelled (AAA T)10 probe
The filters (dot blot, Southern blot and colony blots) were re-hydrated in 2x SSC (Appendix I)
for 5 minutes. Filter-stripping of previously used (probed) blots was performed by pre-
o
washing at 50 C with 5x SSC, 0.5% SOS and lmM EDTA solution for 30 minutes before
pre-hybridisation, All hybridisation experiments were performed at an empirically determined
o
temperature of 42 C.
Pre-hybridisation
Subsequent to pre-wetting or pre-washing of previously probed blots, the filters were placed
in a heat-sealable plastic bag, with only one end open. Twenty millilitres of pre-warmed
o
(42 C) pre-hybridisation liquid (Appendix I) was poured into the bag and air bubbles were
removed before heat-sealing and incubation in a shaking waterbath (Heto Lab equipment,
o
Denmark) at 42 C for 6hrs. Thereafter, one comer of the bag was cut open and the pre-
hybridisation fluid discarded before adding the hybridisation mix containing the radio-
labelled probe.
Hybridisation
Twenty millilitres of fresh hybridisation solution (Appendix I), containing the radioactivity
labelled probe, were added to the bag, air bubbles squeezed out, the bag re-sealed and
o
incubated at 42 C, in a shaking waterbath (Heto Lab eqiupment, Denmark) overnight. After
incubation the hybridisation solution was discarded and the filters washed.
Post-hybridisation washes
The filters (section 2.73) were submerged in a flat-bottomed plastic box containing a solution
of 2x SSC- 0.1% SOS (Appendix I) and incubated for 30 minutes at room temperature with
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gentle shaking. This washing step was repeated 4 times, adding fresh 2x SSC-0.1 % SDS
solution for each wash. The filters were dried at room temperature on a sheet of 3MM-
chromatography paper (Whatman), sealed in a plastic bag and exposed to an X-ray film
(Cronex-4, Protea Medical) for an autoradiographic image.
2.7.6 Subeloning of (AAAT)n-containingfragments
For subeloning purposes, incompatible vector and insert DNA molecules were made
compatible by partial fill-in reaction. This reaction entails, first, digesting each of the
molecules with a different restriction endonuclease generating 5' protruding ends, which are
incompatible. Subsequently, the incompatible 5' single stranded overhangs are partially filled-
in with complementary dNTPs to generate compatible cohesive termini.
2.7.6.1 Preparation of insert DNA fragment for cloning
Sau3Al restriction enzyme digestion of cosmid DNA
Cosmids identified by Southern blot hybridisation as containing positively hybridising
fragments were digested with Sau3AI (Amersham, UK) on a large scale to generate 5'-
overhangs on the insert DNA fragments. The digestion reaction, containing 251lg cosmid
DNA, 75U Sau3AI (Amersham, UK), lOx buffer as specified by the manufacturers, ddH20 to
50111was incubated at 37°C for 3 hrs. The digested fragments were separated on a 1x
TBE/0.7% agarose preparative gel, containing 0.01% EtBr and 1x TBE, by electrophoresis
carried out at 35V overnight. The gel was visualised on an UV-transilluminator and the band
of interest identified by comparing its molecular weight to that of the fragment identified on
the Southern blot autoradiograph, was excised with a sterile blade and placed in a 2ml
eppendorftube. The QIAquick gel extraction kit (QIAGEN, Germany) was used to purify the
DNA fragment, for sub-cloning, from the gel slice according to the manufacturer's protocol.
2.7.6.2 Preparation of vector DNA
Sail restriction enzyme digestion of pBluescript SK DNA
The plasmid vector, pBluescript, molecular weight 2.9kb (Figure 2.2), was linearised by
digestion with Sall restriction enzyme (Promega, USA). The digestion reaction mixture
contained 10llg vector DNA, 4111(lOOmM) spermadine, 200 U Sall (Promega. USA), 10111
lOx buffer as specified by the manufacturers (Promega, USA) and ddH20 to a final volume of
100111.The reaction mixture was incubated at 37°C for 3hrs. To verify that the vector had
been linearised, 5111of digestion reaction mixture was analysed on a 0.7% agarose gel (section
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2.4.3), with an equal volume of an uncut vector sample and ApstI size marker in adjacent
lanes. Thereafter, vector DNA in the remaining sample was precipitated by the addition of
250fll 100% ethanol, hereafter, the mixture was vortexed briefly and incubated for 30 minutes
o
at -80 C, prior to centrifugation in a microfuge (Beckmann, Germany) at 14000 rpm for 15
minutes at room temperature. The resulting supernatant was carefully decanted and the pellet
washed twice with 200fll 70% ethanol, by centrifugation in a microfuge (Beckmann,
Germany) at 14000 rpm for 10 minutes. The ethanol was decanted and the pellet lyophilised
in a Speedy-Vac® concentrator (Savant Instruments, USA) for 5 minutes and resuspended in
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Nael134
Ssp 12850 Ssp 122
Sspl445
Pvul2416
Kpnl657 T7 t
pBluescript SK (+/-)
2958 bp
Sacl759
T3t
Pvull9n
Afl1II1153
Figure 2.2a: The cloning vector pB/uescript SK (+/-), with the positions of the MCS and the
T3 and T7 primers indicated (Stratagene Catalog, 1999).
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T3 priming region
Si- g gaaac agcta tgacc atgat tacgc caagc tcgaa attaa ccctc actaa
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ggggg cccga cgtcc ttaag ctata gttcg aatag ctatg gcagc tggag ctccc
I I I I I I
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I I
ggggc ccggt accca atteg cccta tagtg agtcg tatta caatt cactg gcegt
ceccg ggcca tgggt taagc qggat atcac tcagc ataat qttaa gtgac cggca
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Figure 2.2h pBluescript vector multiple cloning site (826 hp to 601 hp)
759 hp to 657 hp: polylinker site (relevant enzyme recognition sequences shown)
792 hp to 772 hp: T3priming position
625 bp to 646 bp: T7priming position
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40111 ddH20. As the generated 5' -overhanging ends, generated by San digestion of plasmid
vector and Sau3A 1 digestion of insert DNA were incompatible to effect ligation, patrial fill-in
reactions were first performed for both insert and vector DNA.
2.7.6.3 Partial fill-in reaction of 5' -overhanging ends of insert and vector DNA
Insert DNA had Sau3AI generated cohesive termini (5'-GATC-3'), in contrast to vector DNA
which had Sail cohesive termini (5'- TCGAC-3 '). Thus, filling in the single stranded
extensions with dATP and dGTP for the insert and dTTP and dCTP for the vector would
generate compatible cohesive termini thus allowing ligation of the two molecules (Figure
2.3). The fill-in reaction mixture consisted of 40111of insert DNA, 0.51l1 dGTP (IOmM), 0.51l1
dATP (IOmM), 2111 (lOU) Klenow fragment of DNA polymerase (Promega USA), 5111lOx
Klenow buffer and ddH20 to 501l1. The same reaction mixture was prepared for the vector,
using pBluescript SK DNA and dTTP and dCTP nucleotides. Incubation was carried out at
o
37 C for 2hrs, after which 1III (0.5M) EDTA was added to quench each reaction.
Organic Extraction
Subsequent to partial fill-in reactions, both vector and insert were purified by orgarue
extraction. To each partially filled-in DNA molecule (501l1 reaction mixture), 50111TE (pH
8.0), O.IM NaCl (1.51l1 of 0.5M) and 1001lI phenol/chloroform (24:1) solution were added
with careful mixing, after which the both samples was centrifuged in a microfuge (Beckmann,
Germany) at 14000 rpm for 5 minutes. The DNA-containing top aqueous phase was
transferred into a clean 1.5ml eppendorf tube, taking care not to disturb the interface. A IOOIlI
aliquot of chloroform/isoamylalcohol (Appendix) was added, the sample vortexed for 15
seconds and then centrifuged as before. The top layer was carefully transferred to a clean
I.5ml eppendorf tube, after which 300111 100% ethanol was added and the sample incubated at
o
-80 C for 15 minutes, prior to centrifugation in a microfuge (Beckmann, Germany) at 14000
rpm for 15 minutes and the supernatant carefully removed. Both insert DNA- and vector
DNA-containing pellets were washed with 200111 70% ethanol by centrifugation in a
microfuge (Beckmann, Germany) at 14000rpm for 10 minutes at room temperature,
lyophilised in a Speedy-Vac® concentrator (Savant Instruments, USA) for 5 minutes and
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Plasmid vector with SalI restriction enzyme site Insert DNA with Sau3AI restriction enzyme site
CAGCTG- +-
~ Sail Digestion with restriction enzyme
TCGAC'----
G
~ Sau3AI
--G
--CAGCT
GATe
CTAG
~
dTTP
dCTP
TCGAC
CTG-~
Partial fill-in using deoxynucleotides ~
dATP
dGTP
GTC
--CAGCT
Ligation /
GATC-
AG-
-GA
-CTAG
Figure 2.3: Schematic representation of partial fill-in reactions to create compatible ends in
preparation for ligation of insert DNA to linearised plasmid vector pBluescript.
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each resuspended in 40111 ddH20 to give a final concentration of 200ng/1l1 and lOOng/ill for
insert and vector DNA, respectively.
2.7.6.4 Ligation
The partial fill-in reactions created compatible cohesive termini in preparation for ligation of
insert to vector to form a chimaeric molecule. Serial dilutions were made to determine the
ideal dilution which would give the 2: 1 insert:vector ratio required for optimising ligation
(Table 2.3). Controls reactions included exclusion of: i) insert DNA to determine the number
of false recombinants formed as a result of the vector re-ligating to itself, i.e. establish the
efficiency of the partial fill-in reactions. ii) vector DNA was excluded to assess the viability
of the of the E. coli XL 1 Blue strain competent cells. The ligation reactions were incubated at
° °16 C overnight in a Endocal refrigerated circulating bath (Neslab) and thereafter, stored at 4
until required for transformation (2.7.6.5).
2.7.6.5 Transformation
Preparation of competent cells
The XL I-blue strain of E. coli was streaked from glycerol stocks onto LB/agar/tetracycline
(Tc, 15Ilg/ml) (Appendix I) plates and incubated at 37°C overnight. From these plates, one
°colony was inoculated into 2ml LB/Tc broth and incubated overnight at 37 C, with vigorous
shaking. Four hundred microlitres of the overnight culture were added to 40ml LB/Tc
(l5Ilg/ml) medium to give a 1/100 dilution, incubated at 37°C with vigorous shaking for
approximately 2hrs, or until culture absorbance measured at 600nm was between 0.2-0.4 OD
units. Ten millilitres of the culture, were added to each of two 15ml propylene tubes, which
were centrifuged in a Sorvall RC-5B centrifuge using an SS34 rotor at 4000g for 8 minutes at
°4 C, after which the supernatant was discarded. The pellet was resuspended in 5ml pre-chilled
CAP (Appendix I) solution, which was then incubated on ice for 30 minutes, before
centrifuging as before for 6 minutes. The supernatant was removed and the cells gently
resuspended in lrnl ice-cold CAP. The cells were transformed with the ligation cocktail
containing chimeric DNA molecules (section 2.7.6.4) as described below or stored in 50111or
100111aliquots at -70°C.
Transformation of competent cells
Five microlitres of ligation mixture (section 2.7.6.4) were added to pre-chilled 15ml
propylene tubes, followed by the addition of a 50111aliquot of competent cells and the
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Table 2.3: Ligation reactions of insert DNA to pBluescript vector.
Insert Vector A TP IOxD IOxB Ligase ddH20
1. IJlI (lx) I JlI I JlI I JlI I JlI I JlI 4JlI
2. IJlI (lO-') I JlI I JlI I JlI I JlI I JlI 4JlI
3. IJlI (10--'") I JlI I JlI I JlI I JlI 1JlI 4JlI
4. IJlI (l0--') I JlI I JlI I JlI I JlI I JlI 4JlI
5.0 I JlI I JlI I JlI I JlI 1JlI SJlI
6.1JlI(lx) 0 1JlI 1JlI 1JlI 1JlI SJlI
Reactions 1-4 = serial dilutions to determine the ideal (2: 1) insert to vector ratio for
optimisation of ligation of insert DNA to plasmid vector.
Reaction 5 = Control to checkfor the efficiency of the partial jill-in reactions of vector DNA.
Reaction 6 = control to checkfor competency ofE. coli XLI Blue strain.
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resulting mixture incubated on ice for 30 minutes. Thereafter, the cells were heat-shocked by
incubation in a waterbath at 42°C for exactly 45 seconds and were then placed on ice for 1
°minute. Five hundred microlitres of LB, pre-warmed to 42 C, was added to the transformation
°mixture and the cells incubated at 37 C with shaking for 1-2hrs to allow phenotypic
expression before antibiotic challenge.
Analysis of Transformants
Antibiotic (Amp and Tc) selection and blue-white colour screening using IPTG and X-Gal
were used for the isolation and identification of transformants, respectively. Antibiotic
selection would allow only those cells (Tc resistant) containing the chimeric plasmid vector
(Amp resistant) to grow. In addition, the plasmid vector has a multiple cloning site (MCS)
within the lacZ gene (Figure 2.2) which, when induced by the inducer analogue, IPTG, will
be expressed, giving the P-galactosidase product which reacts with X-Gal by breaking the link
between the two components giving a blue colour. However, in the transformed cells
containing the recombinant plasmid, the lacZ gene is interrupted, thus it is not expressed, and
the transformants grow as white colonies. Fifty microlitres each of IPTG (20mg/ml) and X-
Gal (20mg/ml) were spread on LB/agar/Amp/Tc plates using sterile glass balls and allowed to
dry for ~30 minutes. Two hundred microlitres of the transformation mixture were then spread
on these plates, again using sterile glass balls and the plates incubated at 37°C overnight.
°Following incubation, the colony plates were placed at 4 C prior to the preparation of colony
lifts, referred to as colony blots (2.7.3.3).
2.7.6.6 Identification and Characterisation of AAAT repeat motif
To verify that the white colonies picked from the plates contained cloned insert, recombinant
plasmid DNA was extracted (section 2.7.2) and digested with KpnI and Sad vector restriction
enzyme sites on either side of the MCS (Figure 2.2). This digestion of recombinant plasmid
DNA would result in the release of insert from the vector. The digestion reaction contained
5fll rplasmid DNA, 3-5U KpnI (Promega, USA), 3-5U Sad (Promega, USA), 1fll 10x buffer
according to the manufacturer's (Promega, USA) specifications and dH20 to l Ol'I. The
reaction mixture was incubated at 37°C for 2hrs. Thereafter, 5fll of sample was withdrawn,
2fll loading dye added and the sample loaded on a 0.7% agarose gel (section 2.6.1) for
analysis of digest reaction products. The DNA size marker APst1 was electrophoresed
alongside the sample, as well as an undigested recombinant plasmid. Following the
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identification of insert, the corresponding recombinant plasmid clones were sequenced
(section 2.5.3).
2.7.7 Vectorette-based ren amplification
Vectorette PCR is a linker-specific amplification technique originally used for the isolation of
terminus-specific sequences from large cloned DNA inserts (Riley et al., 1990). The modified
procedure used in this study relies on three PCR-amplification reactions to obtain sequences
flanking a known sequence, in this case, an (AAAT)n repeat motif. First, a repeat-anchored
primer is used together with a vectorette-specific primer to identify, in a vectorette library, a
fragment harbouring the repeat motif of interest, which is then sequenced to obtain sequence
flanking one side of the repeat motif. This acquired sequence is used to design a primer,
which is then used together with the vectorette-specific primer to amplify the sequence
flanking the other end of the repeat. Subsequently, primers generated from the repeat-flanking
sequences are used for routine PCR amplification and subsequent analysis of the repeat locus
(Lench et al., 1996).
2.7.7.1 Construction of vectorette libraries
Preparation of insert
Five separate vectorette libraries were constructed for each selected cosmid clone (Figure 2.4)
using the following restriction enzymes: Alul (Boerhinger Mannheim, Germany), EcoRV
(Promega, USA), Pvull (Boerhinger Mannheim, Germany), Rsal (Boerhinger Mannheim,
Germany) (blunt end cutters) and Sau3Al (Boerhinger Mannheim, Germany) (cohesive end
cutter). A range of different restriction enzymes was used to increase the chance that the
restriction fragment containing the microsatellite repeat was of an amplifiable size (Lench et
al., 1996). Each reaction mixture contained 1III DNA, lOx buffer (as specified by the
manufacturer), 20U restriction endonuclease and dH20 to SOil!.The reactions were incubated
o 0
at 37 C overnight and subsequently heat inactivated by incubation at 65 C for 10 minutes.
o
The digestion reactions were stored at -20 C until required for use in ligation to the vectorette
linkers (described below).
Preparation of vectorette cassettes
Vectorette cassettes or linkers were prepared by mixing 1pmol of either the top strand with
blunt (VTB) or cohesive (VTC) ends together with equal amounts of the bottom strand (VB)
o
oligonucleotides in a 1.5ml eppendorf tube. The mixture was then incubated at 37 C to
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facilitate annealing of the top and bottom strands, thus forming a double strand molecule, the
vectorette linkers (Figure 2.4).
Top strand linkers
Blunt end: 5' AAG GAG AGG AeG eTG TeT GTe GM GGT AAG GAA eGG AeG AGA GAA
GGGAGAG3'
Cohesive end: 5' GAT eAA GGA GAG GAe GeT GTe TGT eGA AGG TAA GGA AeG GAe GAG
AGA AGGGAGAG 3'
Bottom strand linker
Blunt end: 5' crc Tee eTT crc GAA TeG TAA ceo TTe GTA eGA GAA TeG cro Tee TeT
ccr r 3'
The sequence in green represents the non-homologous region of the linkers creating a
"bubble" structure on annealing of either of the top linkers to the bottom linker. The
sequence in black is homologous and forms a double strand region on either end of the
bubble, thus creating a vectorette cassette. The 5 =overhanging end sequence, generating a
cohesive end, is indicated in blue.
Ligation
For each restriction enzyme digestion of insert prepared, a cocktail mixture containing 2f..l1
vectorette cassettes (Ipmol/ul), 4f..l110mM ATP, l ul lOx "one-Phor-all" buffer (Pharmaci
Biotech, USA), 0.5f..l1T4 DNA ligase (lU/f..lI) (Promega, USA) and ddH20 to 10f..l1was
prepared. Ten microlitres of the cocktail mixture was then added to 40f..l1of each insert
digestion reaction, aliquoted into a 1.5ml eppendorf tube and incubated at 37°C for 2 hours.
Following incubation, 200f..l1of ddH20 was added to the ligation mixture, henceforth referred
to vectorette libraries (Figure 2.4), mixed by vortexing and stored at -20°C.
2.7.7.2 Identification and characterisation of (AAAT)n repeat motif
Each vectorette library was PCR-amplified using one of a panel of four anchored primers,
namely (AAAT)4A, (AAAT)4T, (AAAT)4G, (AAAT)4C and the universal primer 224
(complementary to the bottom strand, VB of the vectorette linkers) (Figure 2.4). Products can
only be synthesised from primer 224 if an initial round of synthesis has taken place from the
anchored primer producing a complementary strand. In this way, specific amplification
products can be synthesised from the insert repeat sequence (Riley et al., 1990). PCR
amplification products were analysed on a 2% agarose gel (section 2.6.1) prior to sequencing
of generated template.
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Figure 2.4: Schematic representation of the vectorette PeR-based strategy used to identify
and characterise the (AAAT)n repeat motif harboured in cosmids for the development of
genetic polymorphic markers.
A = Generation of cosmid vectorette libraries using restriction enzyme-digested cosmid DNA
and vectorette linkers. B = Pïltc-ampltftcauon of the vectorette libraries using a repeat-
anchored primer and a vectorette peR primer (1) and the subsequent amplification to identify
and characterise the harboured repeat .. The positions of the peR-amplification amd
sequencing primers are indicated by colour codes: Repeat-anchored primer, vectorette peR
primer 224, and the repeat-flanking primer pair F and
R.
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2.8 MUTATION SCREENING OF CANDIDATE GENES
2.8.1 Glycogen Synthase ~SYl)
2.8.1.1 Selection of exons for mutation screening
The muscle glycogen synthase gene orthologues, GSYI, nucleotide sequences from human
muscle, rat and mouse, the liver paralogues, GSY2, from human, rat, and the two yeast
homologues, GSYI and GSYII, were obtained from the Genome database (GDB,
http://www.gdb.org). These sequences were transcribed and translated (using Swiss Prot) into
amino acid sequences. The degree of homology between the specific exons of GSY 1 and those
of its paralogues in human, rat, mouse and yeast as well as the liver orthologues in human, rat
and yeast were analysed using BLAST homology search. In addition, to identify highly
conserved protein coding sequences, the above-mentioned DNA sequences were translated
using Swiss Prot and the protein sequence homology analysed by CLUSTAL V, a multiple
sequence alignment program. A selection of the most conserved coding region (exons 4, 5,
11, 12 and 16) was then screened for PFHBI-causing mutations by PCR-SSCP analysis.
2.8.1.2 PCR-SSCP Analysis
In order to investigate the selected exons of GSYI for any nucleotide sequence change, PCR
SSCP analysis was performed as follows. Three to five microlitres of a non-radioactively
amplified PCR product was aliquoted into a 1.5ml eppendorf centrifugation tube and an equal
volume of SSCP loading dye (Appendix) added. In the case of RE-based PCR-SSCP analysis,
8/-l1of the precipitated restriction enzyme digested PCR product (section 2.8.1.3) was used.
o
The mixture was heat-denatured at 95 C for 2 minutes, prior to loading the each sample into
the wells of a non-denaturing polyacrylamide gel. Generally, four different gel conditions
(Appendix) were used for optimum SSCP screening of each panel. In the event that a mobility
shift was observed, O.3SxMDE™ (FMC Bioproducts, USA) gels were used to confirm the
results. Control samples which were co-electrophoresed included a non-denatured sample as
control for the electrophoretic migration of the double-stranded DNA, amplified samples from
unaffected individuals (close relatives) as negative controls and "'PstI as molecular size
marker. Electrophoresis was carried out in O.SxTBE (Appendix I) buffer, at a constant power
o
of SOW for 2-7hrs at 4 C, depending on the concentration of gel used.
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2.8.1.3 Restriction enzyme-based PCR-SSCP analysis
The DNA analysis program GENEPRO was used to identify restriction enzymes sites in GSYI
exons 4 and 16 that were 361bp and 379bp in size, respectively, that on digestion would
generate ideal size fragments (150bp-220bp) for analysis by PCR-SSCP. Hinfi (Boerhinger
Mannheim, Germany) and Hpall (Boerhinger Mannheim, Germany) restriction endonucleases
were selected for exon 4 and for exon 16 Mboll (Amersham, UK) and Styl (Biolab, UK)
restriction enzymes were ideal. The restriction enzyme digestion reaction mixture contained
13111 PCR-product, 3-5U restriction enzyme (Appendix I) with the lOx buffer as specified by
the manufacturers and ddH20 to 25111and was incubated at 37°C overnight.
Verification of Restriction Enzyme Digestion
The digestion reaction was verified by analysing 5111of sample mixed with 2111loading dye,
on a 12% non-denaturing polyacrylamide gel (section 2.6.2). Electrophoresis was carried out
in l x TBE buffer at 150V for 2hrs. To visualise the bands, the gel was silver-stained as
described in section 2.6.2.
Precipitation of digested sample
The remaining 20111 of digested sample was transferred to a clean 1.5ml-eppendorf
centrifugation tube and precipitated using 10111ammonium acetate and 60111100% EtOH. The
sample was mixed well and centrifuged in a microfuge (Beckmann, Germany), at 14000 rpm,
for 30 minutes at room temperature. The supernatant was decanted and discarded and the
resulting pellet washed, twice, with 20011170% ethanol by centrifugation in a benchtop
microfuge (Beckmann, Germany) for 5 minutes at 14000 rpm. Ethanol was decanted, the
pellet lyophilised in a Speedy- Vac® concentrator (Savant Instruments, USA) and
resuspended in 13111ddH20. An 8111aliquot of the precipitated restriction enzyme digested
PCR product was then analysed for SSCPs on non-denaturing (section 2.6.2).
2.8.2 Histidine-rich calcium binding protein r"RC)
The HRC gene has 6 exons, whereby the amino (N) terminal is coded for by exon 1 and the
conserved carboxy (C) terminal coded for by exons 2-6 (Hofmann et al. 1991). Based on the
premise that the conserved regions in protein sequences are functionally important, the C-
terminal encoding exons (2-6) were selected for mutation analysis. Primer sequences were
designed using both intronic and exonic sequences to amplify the regions shown in Figure
2.5a (see Table 1 for the specific amplification conditions). The resulting products were
screened for mutations by direct sequencing. However, as parts of exonic sequences were
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used together with the published intronic sequences to design pnmers, complete exoruc
screening was hindered. Consequently, the intronic sequence obtained from the initial round
of sequencing was used to design another set of primers that would facilitate screening of the
previously missed intron/exon junctions (Figure 2.5b). Observed sequence variations were
confirmed by restriction enzyme digestion, if they affected a restriction enzyme recognition
site or by PCR-SSCP.
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Figure 2.5: Schematic representation of the HRC gene illustrating the intron/exon
organisation (not drawn to scale).
A = Mutation screening ofHRC 's exons 2-6, indicating primer positions and orientation for
peR amplification and the sequenced peR product.
B = Mutation screening in HRC intron/exon junctions using primers designed from intronic
sequence obtained in A, above.
Gene structure: rectangles = exons, lines = introns. Arrows (colour-coded) = primer pairs
used for amplification and the amplified product indicated by the same colour line.
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3.1 Development of (AAAT) Polymorphic Markers
n
The PFHBI locus has been fine-mapped to a 7cM interval on chromosome 19q13.3 between
markers D 19S412 and D19S866 (Figure 1.5). Therefore, new markers within this region were
required, specifically between the sub-interval D19S412 and D 19S866, in order redefine the
centromeric and telomeric limits, respectively, thereby providing a smaller and more focussed
gene search area. To this end, cosmids within these two target regions were selected for use in
developing novel (AAAT)n STR genetic markers.
The identification and characterisation of (AAAT)n STRs involved, firstly, screening cosmids
containing human chromosome 19q13.3 inserts, with a radioactively labelled (AAAT)1Oprobe.
The cosmids were screened both by dot blot hybridisation of undigested DNA and Southern blot
hybridisation of Sau3A I-digested DNA. Following the identification of clones harbouring the
repeat sequence, two different strategies, one cloning-based (3.1.2.1) and the other vectorette
peR-based (3.1.2.2), were applied to reveal the repeat and the unique repeat-flanking sequences,
which were subsequently used to design Pf.R primers for genotyping the (AAAT), repeat locus
in human genomic DNA.
3.1.1 Identification of (AAAT) -harbouring Cosmid Clones by Dot Blot and Southern Blot
n
Hybridisation
Dot Blot Hybridisation
Of the 25 cosmids containing eI9qI3.3-spanning inserts, 19 were spotted onto a membrane filter
and hybridised with the radioactively labelled (AAAT)IOprobe. The remaining six clones did not
yield any cultures and thus could not be pursued. A total of sixteen of these clones gave positive
signals, of varying intensities, for the presence of the repeat (Figure 3.1). Of these 16 clones, one
clone gave a very strong signal (24680), four clones gave strong positive signals (10501, 22363,
23078 and 24493) and eleven clones gave positive signals (8946, 15217, 18073, 18618, 19161,
20381, 22135, 24596, 25235, 27268 and 29395). The three remaining clones gave ambiguous
signals (14187, 14960 and 15743).
Southern Blot Hybridisation
Of the 16 cosmids, which gave positive signals on dot blot hybridisation, Il were available as
Sau3Al-digested DNA on a Southern blot membrane (8946, 15217, 19161, 20381, 23078,
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24493, 24596, 24680, 25235, 27268 and 29395). Cosmids 10501, 22363, 18073, 18618 and
22135 were not available on this Southern blot, but two additional cosmids, 27993 and 29025 had
been included. After hybridisation with the radiolabelled (AAAT)]Oprobe, fragments generated
from eight of the digested cosmids gave strong positive signals (15217, 20381, 23078, 24493,
24596, 25235, 27268 and 29395) (Figure 3.2). Weak positive signals were seen in with fragments
from cosmids 19161 and 29025. Cosmid 8946 gave a very weak signal and no signals were
detected in cosmids 24680 and 27993 (Figure 3.2).
Of the 11 clones used in both the dot blot (Figure 3.1) and the Southern blot (Figure 3.2), nine
(15217,19161,20381,23078,24493,24596,25235,27268 and 29395) gave clear positive
results on both dot blot and Southern blot hybridisation. For most cosmids on the Southern blot,
the (AAAT)]() radiolabelled probe hybridised to more than one fragment, although with varying
signal intensities. For example cosmid 20381, 27268 and 29395 (Figure 3.2, lanes 6, 8 and 9)
each had an intense and a very faint signal, cosmid 25235 (Figure 3.2, lane 2) had a single intense
signal while cosmid 23078 (Figure 3.2, lane 1) gave multiple high intensity signals. Four of the
cosmids that gave clear positive results, 20381, 24493, 27268 and 29395 (Figure 3.2, lanes 6, 12,
8 and 9) lay within the targeted intervals for development of polymorphic markers (Figure 1.4).
Based on the results obtained from hybridisation of the cosmids with the (AAA T)1O probe
(Figures 3.2 and 3.3), and their relative position in the PFHBI target area (Figure 1.4), the
following three cosmids, 20381, 24493 and 29395 (Figure 3.2, lanes 6, 12 and 9), were selected
and used for development of (AAA T)11 polymorphic markers.
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Figure 3.1: Detection of AAAT STR-harbouring chromosome 19qI3.3-spanning cosmid
clones.
Dot blot analysis of denatured cosmid DNA samples spotted onto a membrane filter and probed
with the !y-32PJdATP labelled (AAAT)JO oligonucleotide.
a) bj
Lane: 1.27268 7.15217 1. 29395 7. +ve control
2. 25235 8. 18618 2. 23078 8. 14187
3. 24493 9. 19161 3. 15743 9.22363
4. 24680 10.8946 4. 14960 10. 10501
5. 24596 11.20381 5.22135 Il. -ve control
6. +ve control 12.-ve control 6. 18073
+ve control = human genomic DNA, -ve control = ddll-O.
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Figure 3.2a: Identification of digested cosmidfragments harbouring the (AAA1)n STR
Southern blot filter with Sau3AI-digested cosmid DNA probed with the [r-32PjATP labelled
(AAA T)JO oligonucleotide. The arrows on the left indicate the approximate sizes of the positively
hybridising fragments. The APStI size marker fragments, in bp, (boxed) were determined by
comparison of the autoradiograph with the EtBr-stained agarose gel previously photographed
with a ruler placed alongside from which the Southern blot was generated.
Lane: M: APstI marker 7. 8946
1. 23078 8.27268
2. 25235 9. 29395
3.24596 10.29025
4. 19161 11.24680
5.27993 12.24493
6. 20381 13. 15217
Cosmids in bold were selected for the development of (AAA T)n polymorphic markers.
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Cosmids
14187
18073
18618
22363
P 15217 AAAT
22135
14960
18567
27513
7cM 24493 AAAT
34439
24680
29395 AAAT
29025
27268 AAAT
8946
15743
20381 AAAT27993
19161 AAAT
C19 24596 AAAT]0501
25235
23078 AAAT
22702
Figure 3.2b: Summary of Southern blot results (shown infigure 3.2a)/or cosmid screening
for an (AAAT)n STR within the 7cM PFHBI target interval.
Cosmid clones that gave positive signals on hybridisation with the (AAA1) 10 oligonucleotide are
highlighted in bold, and the cosmids pursued for marker development in the present study are
shown in red.
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3.1.2 Characterisation of the (AAAT) motif
n
3.1.2.1 Sub-cloning Method
The + Ikb fragment of cosmid 29395, which gave a strong signal on Southern blot hybridisation
(Figure 3.2, lane 9), was sub-cloned into the plasmid vector pBluescript and used to transform E.
coli strain XL l-blue. Colony blots of the resulting recombinant plasmid transformahts revealed
several duplicated positive signals (Figure 3.3), indicating successful sub-cloning of the target
fragment.
To confirm successful sub-cloning of the insert, recombinant plasmid DNA minipreps from the
ten positively hybridising colonies was digested with KpnI and SacI restriction endonucleases,
located on opposite ends of the multiple cloning site, to release the +Ikb insert. The subclaning
of the insert fragment from cosmid 29395 was successful in nine of the ten colonies (Figure 3.4).
Following identification of an insert fragment, miniprep DNA was used as template for
sequencing the insert. This revealed an interrupted (AAAT)n repeat motif, comprising a run of
four AAAT motifs, followed by the sequence AATAAAAT AAT, after which there was another
run of three AAAT repeat motifs (Figure 3.5a).
To determine if the identified interrupted AAAT STR was polymorphic, the locus was amplified
in a panel of 40 healthy individuals of Mixed Ancestry using the PCR primers designed from the
unique sequence flanking the repeat (in figures 3.5a and b). In all the control individuals, an
amplified product of the expected size of 137bp (based on the sequence read, in figure 3.5b) was
obtained, but there was no polymorphic size variation (Figure 3.6a). Genotyping of cosmid 29395
DNA with the same flanking primers revealed a faster migrating PCR-amplified fragment on
electrophoresis than that generated from genomic DNA samples, indicating that the harboured
repeat was of a smaller size than that in genomic DNA of the control panel (Figure 3.6b). To
confirm that the repeat was also not polymorphic in the PFHBI pedigrees, a small group of these
family members were genotyped, but no polymorphic variation was observed (results not shown).
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Figure 3.3: Colony blots of transformant colonies containing (AAA1Jn motif-bearing
recombinant DNA (29395).
Duplicate filters of transformant colonies were probed with the !y_32PJATP labelled (AAAT)J()
oligonucleotide. The position of the positive signals corresponds to the faces of two fillers that
were sandwiched together during hybridisation (section 2. 7.5).
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lanes: 1 2 3 4 5 6 M 7 8 9 10 11 12
1.Okb
L
2.9kb ccc
insert
Figure 3.4: Restriction enzyme digestion analysis of recombinant plasmid for the presence of
the sub-cloned insert.
Recombinant plasmid DNA from 10 positive colonies identified on the colony blots digested with
Kpnl and Sac! to release the insert. Lanes 1 and 12 = covalently closed circular (ccc)
recombinant plasmid DNA. Lanes 2 - 11 = Digested, linearised (L) rplasmid DNA (L) (~2.9kb)
and the insert DNA (+1kb). Lane M = APst! size marker.
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Figure 3.5a: Autoradiograph of the partial sequence of the sub-cloned 1kbfragment of cosmid
29395 sequenced using pBluescript primer T3.
The partial sequence of the region harbouring the AAAT repeat motif is shown on the right, and
the positions of the forward and reverse primers used for genotyping this target area are
indicated on the left of the figure. F = forward primer sequence, R' = complement of the R
primer sequence.
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5'-GGGCTGCAGG AATTCGATAT CAAGCTTATC GATACCGTCGATCACACCAC 50
TGCACTCAGC TGAGCAACAG AGCAAGACTC TGCT AATA A ATAAATAAAT 100
AAATAATAAAATAATAAATAAATAAATAGACATTTGATGTGGTAGGAGTT 150
TACATGTTGT ACTGGTCT AG ATCACT AGAT CACACTTGT A AGCAGA TACA 200
TACTGATATG AC-3' 212
Figure 3.5b.Partial sequence of the cloned insert.from cosmid 29395, harbouring the
interrupted (MA tï,STR.
Readingfrom the 5 -direction: Bases J -37 are part of the vee/or sequence; bases 38-4 J (in italics)
are the partially filled in nucleotides of the vector (TC) and insert (GA), respectively; the
sequences used to design the primer pair 29395F and 29395R to amplify the locus are
underlined; the sequence in pink represents the region homologous to Alu-elements. The
interrupted repeat was composed of a run of AAA T motif repeated four times followed by the
sequence AATAAAATAAT after which was another run of MAT motif repeated three times.
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Figure 3.6: Autoradiograph of the interrupted AAAT repeat-region genotyped with primers
29395F and 29395R.
a) Representative results of the amplified repeat region genotyped in 24 of the control panel of
40 unrelated individuals of Mixed Ancestry, the repeat was not polymorphic. The size of the
137bp PeR-amplified allele was calculatedfrom the sequence infigure 3 5b.
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b
lanes 1 2 3 4 5
Total human
genomic DNA
Cloned insert of
human DNA
bj Comparison of the amplified products of the repeat region genotyped in three members of the
panel of unrelated individuals and the chromosome 19q13.3 insert in cosmid 29395. Lanes 1-3 =
unrelated individuals from Mixed Ancestry panel, lanes 4-5 = ]x and 10-1 dilution of cosmid
29395 DNA, respectively.
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Following the same procedure used for cosmid 29395, the approximately 1kb fragment harboured
by cosmid 24493 (Figure 3.2, lane 12) was sub-cloned into plasmid pBluescript. Colony blots of
the resulting transformants were prepared and after hybridisation with the radio-labelled
(AAAT)lO oligonucleotide, eighteen duplicate positive signals were generated (data not shown)
Plasmid DNA was extracted from all these clones and the DNA from 4 of these 18 clones was
digested with vector-specific restriction enzymes to release the insert and the presence of insert
was confirmed in two of the four clones (results not shown). One of these two clones was then
sequenced from both the 5' and 3' directions using pBluescript T3 and T7 primers, respectively.
Although read lengths of approximately 250 nucleotide bases were obtained using each primer,
no (AAA T), motif, either single or tandemly repeated, was identified in the regions analysed
(results not shown). It was therefore possible that the target sequence lay within the un-sequenced
region of the insert.
Consequently, at this point, two options were available for characterisation of the repeat motif in
cosmid 24493. Firstly, new PCR primers could be designed from the 3' -most sequences
generated from the T3 and T7 sequencing primer reads, to allow sequencing further into the
insert. The alternative was to use vectorette PCR (section 2.7.7) to directly target the (AAAT)n
motif, and it was the latter approach that was followed.
3.1.2.2 Vectorette peR-based method
Two cosmids were selected for the development of polymorphic (AAAT)n repeat markers,
namely 24493 (as detailed in the previous section, 3.1.2.1) and 20381, which also gave a positive
signal on Southern blot hybridisation (Figure 3.2, lane 6).
In order to increase the chances of obtaining an (AAAT)n STR contained in a suitably-sized
fragment, five separate vectorette libraries were generated from each cosmid with the restriction
endonucleases AluI, EcoRV, PvuII, RsaI and Sau3A I. Each library was then probed for the
presence of (AAAT), STR by PCR amplification with the vectorette PCR primer 224 and each
one of the four repeat anchored primers (AAAT)4-A, (AAAT)4-T, (AAAT)4-G and (AAAT)4-C.
In the sections that follow, the results obtained with the development of AAAT STR from
cosmids 24493 and 20381 are presented.
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Figure 3. 7: Accompanying diagram for the identification and characterisation of the
(AAA1)n repeat motifs harboured in cosmids 24493 and 20381 using vectorette PeR-based
strategy.
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24493
On amplification of the cosmid 24493 vectorette libraries, two specific peR products,
approximately 247bp and 264bp in size, were generated from the AluI and RsaI libraries,
respectively, using the (AAAT)4-e primer (Table 3.1). Three products were generated from the
Sau3A 1 library, a fragment of approximately 339bp amplified with the anchored primer
(AAAT)4-G and two fragments of approximately 450bp and 339bp amplified with the (AAAT)4-
e anchored primer (Table 3. t). Other diffuse products were also generated from the A/uI, EcoRV,
Pvull and Sau3A t libraries (Table 3.1), but these were considered to be the result of non-specific
priming and were not pursued further.
Using the vectorette sequencing primer 10108, both the 247bp (Figure 3.8a) and 264bp (results
not shown) fragments were sequenced and found to have the same sequences, however, the
264bp fragment had an extended 5' -end. A primer, designated repeat-flanking sequence primer F
(F), was designed from the 3'-most sequence read of the 247bp A/uI fragment (Figure 3.8b).
Primer F was then used, together with vectorette Pf.R primer 224, to generate new sequencing
template (template 2) from the Alul vectorette library. The resulting product (template 2) of
approximately 450bp was sequenced using sequencing primer 10108. A sequence read of
approximately 260 bases was obtained, however, no (AAAT)n motif was identified (Figure 3.9a).
Therefore, a new primer, designated repeat flanking primer R (R) was designed from the 3' -end
of template 2 sequence (Figure 3.9b).
Amplification of AluI library DNA using the designed primer pair F and R generated two
products approximately 190bp and 220bp in size (Figure 3.1Oa, lane 1). Sequencing of the 220bp
product with primers F or R revealed no AAAT tandem-repeat motif (Figure 3.10b). Further
analysis of the sense (Forward) and antisense (Reverse) strands showed that they had a region of
overlap, indicating that the DNA template had been sequenced in its entirety. A single AAAT
motif embedded in the sequence 5'GGATTTG3' was, nevertheless, observed (Figure 3.10c).
Amplification of human genomic DNA (an individual from the PFHBI panel) using F and R also
generated two fragments, of approximately 190bp and 220bp in size, as generated by
amplification of the cosmid vectorette library (Figure 3.1Oa, lane 2).
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Table 3.1: Polymerase chain reaction amplification products (template 1) generated from five
different cosmid 24493 vectorette libraries using repeat-anchored primers (AAAT)"N (N = A,
T, G or C) and vectorette PCR primer 224·
Anchored primers (AAAT)4-
Library -A -T -G -c
A/uI ± ± +
EcoRV ± ±
Pvull ± ±
RsaI +
Sau3AI ± ± + + (2)
Five cosmid 24493 vectorette libraries were generated using AJu!, EcoRV, Pvu!!, Rsa! and Sau3Al
restriction endonucleases. A = (AAAT)rA, T = (AAAT)rT, G= (AAAT)rG and e = (AAAT)rC (+) =
specific peR product(s) observed on electrophoresis on a 1.5% agarose gel; (:t) = non-specific peR
products; (-) = no peR product; (2) = two specific peR products.
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Figure 3.Sa: Autoradiograph of the sequence of cosmid 24493 Alul-generated PC"Rproduct
(temp/ate 1).
Partial sequence of the A luI fragment, template 1, amplified with anchored primer (AAAT)4-C
and vectorette peR primer 224 and sequenced with vectorette sequencing primer 10108. The
arrows indicate the portion at which the switch from reading short sequence to long sequence
runs occurs. The boxed sequence was used to design primer24493F.
f
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24493 #1
5'-TACTTCTCAG TGITTTCTAG TATATTCACA GACITGTGCA GCCATTTCCA 50
CAGTCAA ITT TAGAACATTG TCGTCACCCC AANNNGAAAC CCCA TGCCTC 100
TTACCTGTCA CCGCTAATCC TTCCATACCT CCCATCITCA GTTCTA-3' 146
Figure 3.8h.Partial sequence of the Alu/fragment of cosmid 24493 amplified with (AAAT).r-C
anchored primer and vectorette PCR primer 224 (template 1) and sequenced with primer
10108.
Part of the sequence at the 3 '<end,underlined, was used to design the forward primer (24493F);
N =A, T, Gor C (autoradiograph shown in Figure 3.8a).
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Figure 3.9a: Autoradiograph 0/ the sequence 0/ template 2, the peR product generated from the
cosmid 24493 AluI vectorene library using primer 24493F and primer 224.
Partial sequence of template DNA amplified with primer 24493F and vectorette peR primer
224, sequenced using the vectorette sequencing primer 10108. The arrows indicate the
portion at which the switch from reading short sequence to long sequence runs occurs. The
boxed sequence was used to design primer 24493R.
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24493 #2
5'-GGGTTTACAC LATGTGTGGC CAGGCTGGTC TTNAACTCCTGCACCTCAGG 50
AGATCCACCT GCCTTGGACA CCCCCAAAGC GTTGGGGTTA TAGGCGTAAG 100
CCACCGCCGC CCCGGCACAG GAATGGAGTTCTNATACATG CTACACGTGG 150
ATNAACTTNN AAAACATTAT ACTGACTGCA AAGAAGCCAC ACACGAAAGA 200
CACAATGGTA TGATCCATCT ATANAGTAGC ACATAGCATC ATATACAGG-3' 249
Figure 3.9b.Partial sequence of the template 2 amplified from cosmid 24493 Alol veetorette
library using primers 24493F and 224.
A reverse primer, 24493R (underlined), was designedfrom the 3 '-end of this sequence (sequence
autoradiograph shown in Figure 3.9a).
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Figure 3.10a: Polymerase chain reaction products amplified with primers designed from the
repeatj1anking sequence, 24493F and 24493R.
M = APst! size marker, box = marker fragment sizes in bp; lane 1 = PeR-products
(approximately 190bp and 220bp) generated from cosmid 24493 Alul-vectorette library; lane 2
= Products (approximately 190bp and 220bp) generated from human genomic DNA (PFHB!-
affected individual).
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Figure 3.1Ob:Autoradiograph of the sequence of PeR-product amplified/rom AluI vectorette
library using primer pair 24493F and 24493R.
F forward primer, R reverse primer. The arrows indicate the position at which the switch
from reading short sequence to long sequence runs occursfor theforward (~ and reverse
primer ( ...--0 J, respectively.
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24493 #3:
5'-CCTCTTACCT GTCACCGCTA AATCCTTCCA TACCTCCCAT CTTCAGTTCT 50
AGGCAGCCACT AATCTTTCTC TGTATATGGA TTTGCCTATTGTGGCTACTT 100
CA TAT AGA TG GAA TCA TACC AT ATGTGTCT TTCGTGTGTG GCTTCTTTCA 200
GTCAGTATAA TGTTTTCAAA GTTCATCCAC GTTAGCA-3' 237
Figure 3.10c: Complete sequence of -220bp peR product generated and sequenced with
repeat flanking primers 24493F and 24493R.
Underlined sequences represent primers 24493F (5 'end) and the complement of 24493R (3 'end)
used to generate this product, indicating that the complete sequence had been attained. The
AAAT (nucleotide bases 30-33) and ATTT (nucleotide bases 80-83) indicate the diffuse
AAAT/ATTT sequences identified.
The T tract of the reverse sequence was read from an autoradiograph other than that shown in
Figure 3.10b.
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20381
On amplification of cosmid 20381 vectorette libraries three RsaI-PCR specific products of
apparently the same size (-805bp), were generated using each of the repeat anchored primers
(AAA T)4-A, (AAAT)4-Tand (AAAT)4-G (Table 3.2, Figure 3.11a). No PCR products were
generated from the other vectorette libraries.
Two of the three approximately 805bp products amplified from the Rsal library (template 1),
namely those generated with the (AAAT)4-T and (AAAT)4-G anchored primers, were sequenced
using the vectorette sequencing primer 10108 (Figure 3.11b), and they were found to contain
similar sequences. A repeat flanking primer 20381F was designed from the 3' -most sequence of
template 1 generated using the repeat anchored primer (AAAT)4-G (Figures 3.12b and c) and
used to generate new sequencing template 2 from the cosmid 20381 RsaI library (Figure 3.11a,
lane 3). The sequence of template 2, of approximately 514bp, (Figure 3.12a) was used to design a
second primer, designated repeat flanking primer 20381R (Figure 3.12a and b). Further analysis
of this sequence revealed a single AAAT motif, embedded within the sequence 5' GAAATT3'
(Figure 3.12b).
Amplification of RsaI DNA library using the designed primer pair 20381F and 20381R generated
template 3 (approximately 500bp) (Figure 3.11a, lane 5). However, on sequencing of template 3
with the same primers, no AAAT single or repeat motif was revealed (Figure 3.13). Polymerase
chain reaction amplification of human genomic DNA from a PFHBI family member using
primers 20381 F and 20381R did not generate a product. Consequently, a new primer, designated
20381R', was designed from antisense (20381R) sequence read of template 3 (Figure 3.13) and
used together with primer 20381F to amplify the cosmid 20381 RsaI-library. Template 4 of
approximately 340bp product was generated (Figure 3.14a, lane 1). However, no AAAT single or
repeat motif was observed on sequencing of this fragment using primers 20381 F and 20381R'
(Figure 3.14b and c).
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Table 3.2: Polymerase chain reaction amplification of target sequence from five different
cosmid 20381 vectorette libraries using repeat-anchored primers (AAA T)4""N(N = A, T, G or CJ
and the vectorette PCR primer, 224·
Library _A
Anchored primers (AAAT)4-
-T -G -c
AluI
EcoRV
Pvull
RsaI
Sau3Al
+ + +
Five cosmid 20381 vectorette libraries were generated using Alu!, EcoRJI, Pvu!I, Rsa! and Sau3A1
restriction endonucleases. A = (AAAT)rA, T = (AAAT)rT, G= (AAAT)rG and e = (AAAT)rC. (+) =
specific peR product(s) observed on electrophoresis on a 1.5% agarose gel; ( -) = no peR product.
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Figure 3.lla: Amplification products generatedfrom cosmid 20381 Rsal-vectorette library.
Lanes 1 and 2 = template 1, peR-amplified using anchored primer (AAAT)4-T (lane 1) or
(AAAT)4-G (lane 2) together with vectorette primer 224; lane 3 = template 2, product amplified
with 20381F and vectorette primer 224; lane 5 = template 3, product amplified with 20381F and
20381R; M = ...lPstlsize marker with fragment sizes in bp indicated on the right.
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Figure 3.11b: Autoradiograph of the sequence of template 1amplifiedfrom the cosmid 20381
RsaI-vectorette library.
Two PCR products of approximately the same size, representing template 1, were generatedfrom
the cosmid 20381 Rsa] vectoretle library using the anchored primers (AP), (AAAT)4-T or
(AAAT)4-G together with the vectorette PCR primer 224, which were subsequently sequenced
with vectorette sequencing primer 10108. Both the (AAAT)4-T- (left) and (AAAT)rG-generated
(right) sequences were similar, but the (AAAT)rT-generated sequence migrated slower than
(AAAT)4-G-generated sequence, indicating a slight variation in size. The arrows indicate the
position of the sequence (long read) which was used to design primer 20381F (boxed) from
template 1amplified using either, repeat-anchored primer (AAAT)rT (left) or (AAAT)4-G (right)
and vectorette primer 224. X = adjacent sample overflow during gel loading.
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20381 #1
5'-TCAGGGCTCT CCCACCTACA CATCTGGCAC CTATTGTTTC CCTGCCTGTC 50
TTTGCGTGGC ACATGAGTGC GTGTTCTTCA GCACTTTGTT CNAATCTACC 100
CCCTCCCAGA AGCCTTGCTG CCCCCA TCT A A TTTCAGCCT TCTTCTTGGT 150
CCACCTGGCT TCCCCCTTCT GGCAGGACCT CAGAGGGAAG GCAGTGCCTT 200
CACTCACTCA TGCATCTCGC ATCTCTCAGA CTC-3' 233
Figure 3.11c: Partial sequence of 805bp fragment, template 1 of cosmid 20381 Rsa] library
amplified using anchored primer (MAT).rG and universal primer 224 and sequenced with
sequencing primer 10108.
A single (MAT) motif was observed. Underlined sequence represents designed primer 20381 F.
N = 0, A, Tor c..
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Figure 3.12a: Autoradiograph of sequence of template 2 of cosmid 20381.
Template 2 was amplifiedfrom the Rsa] vectorette library using primers 20381F and 224 and
then sequenced with primer 10108. The arrows indicate the portion at which the switch from
reading long sequence to extra (e)-long sequence runs occurs. The boxed sequence was used to
design primer20381R. The 3 'end of this sequence, boxed, was used to design primer 20381R.
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20381 #2:
S'ClT ACCAGCA CAACGTCTAT CGCGCACACA CCCAGAGCTG ATGCTGCTCA 50
CAGCCCCCAG TGGTCA TCCC CGCTGCCTCC AGGCAAAGTC TGA TCTTTTC 100
AGGCTCAGCT TTGAGCCCTG ACTGGACCTT CCCTTCTGAC ACCCA TCACA 150
GCCTCA TGCT CTTTTCTCCT CT AAGAAATT TTTGTCCTCA TGGTGGTCCA 200
CA TGCCCCCA GCTCTGTGTT CCTCACACCC ACT ATACCTG TGT A TCACCC 250
TCCCTTTCCA GAATGCTTTC CTTCCCACAC ATGACTCTGC TCAGCTCAGA 300
CTAGCCTCAT GTCTCTCAGA GCTCTGT ACT TAGAGACTGC AACACATCTC 350
ACAGTCAGCA T-3' 361
Figure 3.12b: Partial sequence of template 2 of cosmid 20381 (500bp).
Cosmid 20381 Rsallibrary PCR- amplified with anchored primer 20381F and universal primer
224 and the generated product sequenced with sequencing primer 10108. A single AAAT motif
was observed. The underlined sequence was used to design primer 20381R.
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20381#3
5' -CTT ACCAGCA CAACGTCT AT CGCGCACACA CCCAGAGCTG ATGCTGCTCA 50
CAGCCCCCAG TGGTCATCCC CGCTGCCTCC AGGCAAAGTC TGATCTTTTC 100
AGGCTCAGCT TTGAGCCCTG ACTGGACCTT CCCTTCTGAC ACCCATCACA 150
GCCTCATGCT CTTTTCTCCT CTAAGAAATT TTTGTCCTCA TGGTGGTCCA 200
CATGCCCCCA GCTCTGTGTT CCTCACACCC ACTATACCTG TGT ATCACCC 250
TCCCTTTCCA GAATGCTTTCC CTTCCCACA CATGGAACTC CTGCTCAGCC 300
TCATGAACT A GCTCATGTCT CTCAGAGCTC TGT ACTT AGA GACTGCAACA 350
CATCTCACAG TCAGCAT-3' 367
Figure 3.13: Partial sequence of template 3 of cosmid 20381 Rsa! library.
Partial sequence of peR product from cosmid 20381 Rsa! library amplified using 20381F and
20381R and sequenced using primer 20381R. A single AAA T motif was observed. Underlined
sequenced was used to design primer 20381R'.
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Figure 3.14a: Polymerase chain reaction amplification using primers 20381F and 20381R'.
Lane M = APStI size marker with the fragment sizes in bp, lane 1 = Cosmid 20381 Rsa! library,
lane 2 = Human genomic DNA. The arrow on the right indicates the approximately 339bp
products generated on PCR-amplification.
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Figure 3.14b: Autoradiograpb of sequence of template 4 of cosmid 20381 Rsa] library.
Template 4 was amplifiedfrom the Rsa! vectorette library using 20381F and 20381 Rand
sequenced with 20381F (F) or 20381 R (R). The arrows indicate the portion at which the switch
jromdhort sequence to long sequence runs occurs.for both theforward T't" ) and reverse (
... ) sequences, respectively.
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20381 #4:
5'-CCAGTCAGTG TCAAGCATAG AATGACTGAC ATGCCCCATC CTGTCTAGAA 50
GGGAGA TGGC AAGTGGCTCT GACCTGGGTG GGGAGGGGA T GTTGGGTGTG 100
GCCAGTTCCT CCCTAAAGGT ATCAGGGAAG GCTTCCTGGA GGAGGGGACA 150
TTGGAGCT AG TTCTTGAGGC TGAGCAGGAG TTCCTGTGTG GGGAAGGGAA 200
AGGCATTCTG GAAAGGGAGG GTGATACACA GGTAT -3' 245
Figure 3.14c: Partial sequence of template 4 of cosmid 20381.
Partial sequence of cosmid 20381 Rsa! library peR-amplified using 20381F and 20381R. No
AAAT, single or repeat motifwas observed
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3.2 CANDIDATE GENE SCREENING
At the chromosome 19q13.3 locus to which PFHBI has been mapped, there are a number of
genes that can be considered plausible candidates (Figure 1.5), because of their known or
postulated involvement in cardiac physiology. In the present study, selected exons of candidate
genes GSY1 and HRC were screened for the presence of possible PFHBI-causing mutations.
3.2.1 Glycogen Synthase (GSYI)
Human muscle GSY1 consists of 16 exons, encoding an 83.6kDa protein (Ohro et al., 1995). The
conserved amino acid sequences of human muscle (GSYl) and liver (GSY2) glycogen synthase
isozymes and their respective homologues from rat, mouse and yeast, translated from exonic
nucleotide sequences (http://www.ncbi.nlm.nih.govl) were analysed for conserved regions using
the CLUST AL V multiple sequence alignment-program. The output of this alignment revealed
that sequences expressed by exons 4, 5, 11, 12 and 16 were the most conserved both within and
across species (Figure 3.15). Highly conserved regions are thought to represent functionally
important protein domains, in which mutations may cause disease. Consequently, exons 4
(379bp), 5 (225bp), Il (l59bp), 12 (200bp) and 16 (361bp) were selected for mutation screening
by PCR-SSCP analysis (Orita et al., 1989) and the results are presented in the following section.
3.2.1.1 PCR-SSCP Analysis
Deoxyribonucleic acid samples of the PFHBI panel, comprising affected and unaffected
individuals from pedigrees 1, 2 and 5 (2.1), were analysed under four different gel conditions to
optimise detection of any conformation polymorphisms in GSY1 exons 4,5,11,12 and 16. No
mobility-shifts were observed in exons 4, 5, 11, 16 (Figure 3.16) and 12 (results not shown),
indicating the absence of any sequence variation in GSY1exons screened.
The ideal size of PCR product for detection of any sequence variations by PCR-SSCP, however,
is IOObp-200bp (Sheffield et al., 1993), which means that any sequence variations in larger
fragments analysed could be left undetected. Therefore, due to these limitations, the PCR-
amplified products of exons 4 (379bp) and 16 (361bp) were reanalysed using RE-based PCR-
SSCP.
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Figure 3.15: CLUSTAL Vmultiple sequence alignment of GSY1
Muscle glycogen synthase, GSY1 amino acid sequences transcribed and translatedfrom GSYI 's
16 exons and then aligned with the their homologues from human muscle GSY1 (GGSTe), rat
muscle GSYI (R_GGSTe), mouse muscle GSY1 (M_Gsy), the liver glycogen synthase, GSY2,
isozymes from human liver (Liver), rat liver (R_Liver) and the two yeast glycogen synthase
isozymes (Y_Gsy! and Y_GsyII).
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Exons:
4 5 11 16
~
~
0._
0._
379bp __.
225bp __.
159bp
__.
lanes: 1 tl12 2122 3233 42
Denatured samples: 1.6.313 (U)
2.6.314 (A)
3.6.412 (A)
4.6.413 (U)
5.6.414 (U)
6.6.415 (A)
7.4.303 (A)
8.9.305 (U)
9. 10.301 (A)
10.12.302 (U)
Figure 3.16: PCR-SSCP mutation screening of selected GSYI exons (4,5, 11 and 16)
Representative PCR-SSCP analysis results of PFHBJ pedigree 2 samples on a 10%
polyacrylamide gel with glycerol: Lanes 1 and 22 = undenatured samples of exons 4 and 11,
respectively; lanes 2-11, heat-denatured samples of exon 4; lanes 12-21, heat-denatured samples
of exon 5; lanes 23-32, heat-denatured samples of exon 11 and lanes 33-42, heat-denatured
samples of exon 16. The arrows on the right indicate single strand coriformersfor each exon and
the single bands at the bottom of each lane represent the double strand molecules. The arrows on
the left indicate .fragment sizes, in bp, of the double strand molecules of each exon. A = PFHBJ-
affected. U = unaffectedfirst-degree relative.
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3.2.1.2 Restriction enzyme-based PCR-SSCP Analysis
GENEPRO restriction enzyme site analysis was used to identify two restriction enzyme
recognition sequences, which, on digestion of GSYl exons 4 or 16 with the appropriate enzyme,
would yield DNA fragments of an ideal size, spanning the exon, for PCR-SSCP analysis. Hirfi
and Hpall restriction enzyme recognition sequences were detected in GSYl exon 4, which on
digestion of the PCR-amplified product would generate fragments of, 5' -47bp + 27bp + 120bp +
185bp _3' (379bp) and 5' -213bp + 65bp + 101bp _3' (379bp), respectively (Figure 3.17a). For
GSYl exon 16, Mboll and Styl restriction enzyme recognition sequences, which would generate
fragment of 5'_ 154bp + 207bp _3' (361bp) and 5'_ 193bp + 168bp _3' (361bp), respectively,
were identified (Figure 3.17a).
The restriction enzyme-digested PCR-amplified products of GSYl exon 4 and exon 16 of the
PFHBI panel were re-analysed for SSCPs under four different PAGE conditions. A mobility
shift, in the 120bp fragment generated by HinjI-digestion of PCR-amplified exon 4 DNA, was
observed in an unaffected individual (6.313) (Figure 3.17b). Further analysis of the same panel of
samples in 0.35x MDE™ (section 2.6) revealed a mobility shift in the 185bp fragment of the
Hirifl-digested exon 4 PCR product of individual 6.313 and, in addition, the same mobility shift
was seen in an affected individual (6.412) (Figure 3.17c). No mobility shifts were detected in the
Hpall (Figure 3.17b) and Mboll and Styl digested fragments of exons 4 and 16, respectively
(results not shown).
To further investigate the observed mobility shifts, Hirifl-based PCR-SSCP analysis was
performed in a larger sample (n = 40), constituting PFHBI-affected individuals and their
unaffected first-degree relatives. Analysis of the Hirifl-digested products in a 0.35X MOE gel, on
two separate occasions, revealed different sets of single-strand conformers. Furthermore, none of
the single strand conformers, for either the 120bp or the 185bp HinjI -digestion products, were
consistent and thus could not be scored for phenotype-genotype correlations (Figure 3.17d).
However, no single set of single strand conformation polymorphism was, exclusively, associated
with the affected phenotype, thus excluding the observed mobility shift as a disease-associated
mutation.
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GSY1 exon 4
47bp 27bp 120bp 185bp Hinp
213bp 65bp 101bp Hpall
GSY1 exon16
193bp 168bp Styl
154bp 207bp
Figure 3.17a: Restriction enzyme map of peR-amplified exons 4 and 16 ofGSYl.
The position of Hinf! and HpaI! recognition sequences (#) on exon 4(379bp) and Sty! and Mbo!!
recognition sequences on exon 16 (361bp), together with the size, in bp, of the digestion products
generated from peR-amplified genomic DNA, is shown.
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2 5
HJjI Hpall HinjI Hpall
" III
12 67
Digested and denatured samples:
Pedigree: 1
1. 1.305 (U)
2. 1.410 (U)
3. 1.504 (A)
4. 1.510 (A)
5. 1.511 (U)
II 12 1617 2122 2526 29
2
6.313(U)
6.412 (A)
6.415 (A)
12.302 (U)
9.305 (U)
5
5.101 (U)
5.202 (U)
5.301 (A)
5.302 (A)
Figure 3.17b: RE-based/PCR-SSCP analysis ojGSYI exon 4 digested with Hinfj and Hpajj,
Lane 1 = /1,Pst!size marker; lanes 2-6, 12-16 and 22-25, represent the Hinfl digested samples
from pedigrees 1, 2 and 5, respectively. Lanes 7-11, 17-21 and 26-29 represent the HpalI-
digested samples from pedigrees 1, 2 and 5, respectively. The first lane in each series represents
a restriction enzyme digested but undenatured sample. The arrows (left) indicate the single
stranded conformers for each digestion fragment, with the size of the undenatured double strand
molecule indicated on the right of the gel. The double arrows (right) indicate the single strand
conformers for all fragments greater than 100bp. A mobility-shift was observed lane 13(tI1 in the
101bp, Hinfl-digestedfragmentfrom an unaffected individual ( ::= *). A PFHBl-
affected. U = unaffectedfirst-degree relative.
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185bp
Figure 3.I7c: RE-based/PCR-SSCP analysis of pedigree 2, GSYI exon 4 digested with HinfL
SSCP analysis of exon 4 PCR-product digested with HinfI on a O.35x MDE gel. Mobility-sh(/ts
were observed in both unaffected (6. 313) and qffected (6. 412) individuals, lanes 6 and 7
respectively. Lane 1 = undenatured Hinfl-digested sample, lanes 2-8 = heat-denatured samples.
The arrows on the left indicate the double strand fragments of the digested products. The arrows
on the right indicate the single strand conformers of each digestion product (boxed).
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Figure 3.17d: RE-based/PCR-SSCP analysis ofGSYl exon 4 digested with Hinfj;
DNA samples offorty individuals from selected PFHBI families in pedigree 2, comprising both
the affected individuals and their unaffected relatives, were PeR-amplified and the product
digested with Hinfl. Thereafter, they were analysed for mobility shifts on a O.35x MDE gel.
Different conformation polymorphisms were observed, however, none of these was exclusively
associated with the disease phenotype.
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3.2.2 Histidine-Rich Calcium Binding Protein (HRC)
Exons 2-6 of HRC, encoding the conserved C-terminal (Hofmann et al., 1991), were screened for
possible PFHBI-causing mutations by direct sequencing. These regions indicated in figure 2.5,
were analysed for sequence variations by directly comparing sequences from PFHBI-affected
individuals with their unaffected first-degree relatives. In the following sections, the results
obtained for each region analysed are presented.
Two adjacent sequence variations, an A to T and a G to T substitution (AG to TT) were detected
in intron B of fragment 2-B-3 in an unaffected individual from pedigree 5 (Figures 3.19a and b).
Further analysis of this fragment by GENEPRO indicated that these sequence changes would
result in the loss of both Xholl [(A/G)GATC(T/C)] and Sau3Al (GATC) restriction enzyme
recognition sites in a homozygous TT (TTATC). Conversely, in an AG homozygote bath sites
would be present. However, no differences were observed in the PCR-amplified Xholl-digested
(Figure 3.18c) or Sau3A I-digested PFHBI affected and control samples (results not shown),
which included samples from unaffected first-degree relatives and one unrelated individual.
Two additional, adjacent sequence changes, both A to C transversions (GAA to GCC), were
detected in exon 3 of fragment 2-B-3 in an unaffected individual from pedigree 2 (Figure 3.19a).
These nucleotide changes would cause an amino acid substitution of a glutamic acid residue by
an alanine residue. No sequence variations were detected in fragments 4-D-5-E and 4-D-5-E-6.
The double A-C transversions in exon 3 (Figures 3.20a and b), however, did not affect a
restriction enzyme recognition sequence. Thus, further analysis of this sequence change was
performed using PCR-SSCP. No mobility shifts were detected on analysis of exon 3 in a panel,
which consisted of the pedigree 2 samples in which the sequence changes were observed and
additional paired PFHBI-affected and unaffected first-degree relatives from pedigrees 1 and 5
(Figure 3.19c).
For complete screening of the coding regions, as well as the intron/exon junctions missed in the
initial round of sequencing, primers were designed using the newly acquired intronic sequence, in
order to PCR-amplifY and sequence the regions designated l-A-2-B and D-5-E-6 (Figure 2.1).
Neither of these regions showed any sequence variations between affected and unaffected
individuals' samples (results not shown). The PCR-amplified fragment l-A-2-B, containing
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intron B, from pedigrees 5 and 2 was digested with Xholl and Sau3A 1 restriction enzymes,
respectively. The generated restriction enzyme digestion products were the same in both PFHBI-
affected individuals and their unaffected close relatives used as control samples (results not
shown).
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Figure 3.lBa: Autoradiograph of the sequence ofHRC region 2-B-3 in PFHBI pedigree 5.
To facilitate rapid detection of sequence changes, affected and unaffected individuals' samples
were loaded alongside each other in G, A, Tand C tracts, in addition to the normal sequencing
procedure in which the adjacent G, A, Tor C tracts represented one individual. F = sense strand
and R = antisense strand. a = PFHBI-affected (5.301); u = unaffected close relative (5.101).
Sequence variations were observed in the Forward T-tract (bold) between the affected and
unaffected individuals,
-..
,.-
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Figure 3.18b: Magnified sequence autoradiograph of URC fragment 2-B-3 magnified to
show the sequence variations seen in Figure 3.18a.
Partial sequence of the intronic sequence flanking the coding strand of intron B ofHRC in an
individual, heterozygous for the double GAIIT substitution (right) compared to that of a GA
homozygous individual (left). The A to T and the G to T substitutions result in the loss of the
XhoII and Sau3Al restriction enzyme recognition sites, respectively. F = sense strand and R
= antisense strand a = PFHBI-affected; u = unaffected close relative.
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lanes 1 2 3 M 4 5
Figure 3.I8c: Restriction enzyme analysis ofsequence variation in HRe fragment 2-B-3.
The PeR-amplified product of HRC fragment 2-B-3 digested with XhoII restriction
endonuclease. Lane 1 = control sample (unrelated to the PFHBI families), lanes 2 and 3 =
paired PFHBI-affected (1.504) and an unaffected first-degree relative (1.305) from pedigree 1.
Lanes 4 and 5 = paired PFHBI-affected individual (5.301) and an unaffectedfirst-degree relative
(5.101) from pedigree 5, in whom the sequence variations were observed (shown in figures 3.19a
and b).
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Figure 3.19a: Autoradiograph of the sequence ofHRC region 2-B-3 in PFHBI pedigree 2.
To facilitate rapid detection of sequence changes, affected and unaffected individuals' samples
were loaded alongside each other in G, A, C and T tracts, in addition to the normal sequencing
procedure in which the adjacent G, A, Tor C tracts represented one individual. F = sense strand
and R = antisense strand. a = PFHBI-affected (l0.301); u = unaffected close relative (9.305).
Sequence variations, indicated by the arrows, were observed in the Reverse G-tract (bold)
between the affected and unaffected individuals.
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Figure 3.19b: Magnified sequence autoradiograph of URC fragment 2-B-3 magnified to
show the sequence variations seen in Figure 3.19a.
Partial sequence of the exonic sequence flanking the anti-sense strand of exon 3 ofHRC in an
individual heterozygous for the double TT/GG substitution (right). a = PFHBI-affected; u =
unaffected close relative. The sequence in blue is the complement of the antisense (sense)
strand from which is the coding strand.
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Denatured samples:
1.1.305 (U)
3.5.202 (U)
5.6.308 (A)
7.9.305 (U)
9. Control (U)
2.1.504 (A)
4.5.301 (A)
6.6.406 (U)
8.10.301 (A)
Figure 3.19c: PCR SSCP analysis of HRC exon 3 (B-3-C) in a selection of PFHBI pedigree 2
family members.
Fragment B-3-C of HRC, which contains exon 3, was analysed for mobility shifts (on an 8%
mildly denaturing polyacrylamide gel) to confirm the sequence variations seen on sequencing
(shown in figures 3.20a and b). SSCP = single strand conformers; ds = double strand molecule.
A = PFHBI-affected, U = unaffected first-degree relative.
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4.1 DEVELOPMENT OF GENETIC POLYMORPHIC MARKERS
Initially, the PFHBllocus was mapped to a lOcM interval on chromosome 19q13.3 (Brink et
al., 1995), which through fine mapping efforts was subsequently reduced to 7cM (De Jager,
personal communication) (Figure 1.5). During the course of this project, the PFHBI target
area was further reduced from 7cM to 4cM, within which is a core haplotype spanning lcM
(Arieff, personal communication). Originally, di- and trinucleotide STR polymorphic markers
were sought throughout the greater 7cM-search region to generate high-density maps, which
would help refine the target region further, thus providing a more focussed area expediting the
positional cloning of the disease-causing gene. Cosmid clones, spaced at 500kb and spanning
chromosome 19q13.3, were used to develop STR polymorphic markers.
As part of an integrated approach, in an effort to increase the resolution of the genetic maps,
the development of tetranucleotide STR markers was also pursued in the present study.
Tetranucleotide STRs were selected because they have increased fidelity of peR
amplification, which results in better separation of alleles, and thus, they are easier to
genotype manually (Sheffield et al., 1995; The Utah Marker Development Group, 1995). The
(AAAT), STR, reportedly one of the abundant tetranucleotides that also give clear results on
genotyping (Economou et al., 1990 and The Utah Marker Development Group, 1995), was
selected for new marker development.
Sixteen out of nineteen cosmid clones that were hybridized with the radiolabelled (AAAT)lo
probe gave clear positive signal, while the remainder gave ambiguous results (Figure 3.1).
Eleven of the positively hybridising clones were available as Sau3A I-digested fragments on
the Southern blot and, on hybridisation with the radiolabelled (AAAT)lO probe, nine gave
positive signals (Figure 3.2). The Southern blot hybridisation result confirmed the dot blot
result, although in some instances the signal intensities did not correspond, as shown with
cosmid 29395 (Figures 3.IB, #1 and 3.2, lane 9). The intensity of the signal on hybridisation
of the probe to the appropriate template is influenced by the length of the STR, in addition to
the availability of single strand template, which is achieved by the denaturation of the double
strand DNA. Therefore, a possible explanation for the difference in signal intensity between
dot and Southern blot could be that because cosmid DNA on the Southern blot had been
digested into smaller fragments, which denature more readily, the (AAAT)n STR would have
been exposed to the probe. In contrast, total cosmid DNA was used on dot blots and although
the DNA had been denatured prior to blotting, it is possible that the repeat containing region,
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due to incomplete denaturation, was partly shielded from the probe, thus gtving a weak
positive signal.
The weak signals given by some clones on the Southern blot were interpreted as an indication
of shorter STRs (Figure 3.2 lanes 4 and 10). Multiple signals generated from the same cosmid
were interpreted as diffuse (AAAT)n repeats separated by Sau3A 1 sites (Figure 3.2, lanes 1
and 12). The (AAAT), sequence is associated with Alu-elements, which are common
sequences in the human genome (Zuliani and Hobbs, 1990), thus, it is not inconceivable that
there might be other similar sequences in close proximity, onto which the probe may
hybridise. eosmid clones with a single strong signal were selected as they possibly
represented a localised longer (AAAT), repeat, a category of repeat sequence that has been
reported to be more often polymorphic than an interrupted repeat sequence. Therefore,
cosmids 20381, 29395 and 24493 (Figure 3.2, lanes 6, 9, and 12, respectively), which gave
positive signals on both the dot blot and Southern blot, and in addition, are located within the
PFHBJ target area (Figure 1.5), were then pursued for development of the (AAAT)n
polymorphic markers following either sub-cloning or vectorette PCk-based strategies. The
hybridisation procedure allows one to reduce significantly the number of clones to be
followed (Baron et al., 1992).
4.1.1 Sub-cloning
The DNA fragment from cosmid 29395 that gave a strong positive signal (Figure 3.2, lane 9)
was sub-cloned and sequenced to reveal an interrupted (AAAT)n sequence (Figure 3.5a).
Analysis of the repeat-flanking sequences (Figure 3.5b) for uniqueness prior to designing
peR primers (blast@ncbi.nih.nlm.gov, 1997) showed that part of the 5' -flanking sequence
was homologous to an Alu-element. This finding was not a surprise, as (AAAN)n STR
sequences are normally found within the poly(A)-tail region, 3' of Alu-elements (Zuliani and
Hobbs, 1990; Beckmann and Weber, 1992). Furthermore, Beckmann and Weber (1992)
reported that these Alu-associated microsatellites comprised imperfect repeats. The
disadvantage of designing a peR primer from within an A lu-related sequence would be the
high background due to non-specific priming from other similar sequences within the human
genome. Alu-elements comprise approximately 1% of the human genome and are, on average,
spaced at 5000bp intervals (Batzer et al., 1990; Economou et al., 1990). This problem was,
however, circumvented, since there was sufficient sequence at the 5' -end of the interrupted
repeat not homologous to the Alu-element, to design a Pf'R primer (Figure 3.5b).
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The interrupted (AAAT)n repeat locus was PCR-amplified in a panel of 40 unrelated
individuals of Mixed Ancestry, which was available in our laboratory and represented a
general population sample, and then genotyped to determine whether the repeat was
polymorphic. The repeat was not polymorphic within this population (Figure 3.6a). The
informativeness of microsatellites is dependent on both the repeat length and whether the
repeat is perfect. In general, the informativeness of microsatellites is directly proportional to
the repeat length but it is negatively influenced by the complexity of the repeat, with the
degree of informativeness decreasing in the order of perfect, imperfect and compound repeats
(Weber, 1990 and Edwards et al., 1992b). More specifically, for tetranucleotide STRs, repeat
unit lengths of greater than 6 are considered informative (Sheffield el al., 1995). Therefore,
the fact that the repeat observed in cosmid 29395 was interrupted and the interrupted runs of
(AAAT)n motifs were less than 6 (n = 3 and 4) (Figure 3.5a) probably explains why the
repeat was not polymorphic.
An interesting observation was that the repeat locus amplified from cosmid 29395 DNA was
smaller than the one amplified in human genomic DNA (Figure 3.6b). The shorter allele in the
cosmid could be due to mutation subsequent to cloning, resulting in the deletion of part of the
repeat. Philibert et al. (1996) have demonstrated this instability in sub-cloned microsatellites,
where a sub-cloned CAO triplet repeat (a pathogenic STR) was shorter than the original
repeat because of a deletion that occurred on sub-cloning. Recently, Lee et al. (1999) have
confirmed the relative mutation rates of the non-pathogenic microsatellites (Chakraborty,
1997), by showing that in cultured mammalian cells the relative stability of di- compared to
tetranucleotide repeats is always higher and the pathogenic microsatellites (trinucleotide
STRs) have the highest mutation rates. An alternative explanation for the smaller size of the
repeat sequence in cosmid 29395 is that this region may have been shorter in the individual
from whom the original sequence was obtained and cloned, which might represent a
polymorphism specific to a particular population.
Although the interrupted (AAAT), STR was not polymorphic in the panel tested, it was
considered prudent to also genotype it in selected individuals from the PFHBI families.
However, here again the repeat locus was not polymorphic. The two bands seen in figure 3.6
represent one allele and its shadow band. Interestingly, for tetranucleotide STRs the two
bands are frequently of equal intensity (Economou et al., 1990).
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The cosmid 24493 fragment, of approximately 1kb in size, which gave a very strong signal on
the Southern blot (Figure 3.2, lane 12 middle band), was also sub-cloned and sequenced using
the T3 or T7 pBluescript primers. However, no (AAAT)n tandemly repeated motif was
observed, in the sequence read lengths of 250 bases that had been acquired with each primer,
which, therefore, covered about 500 bases of the cloned sequence. Consequently, since only
half of the fragment had been sequenced, it was possible that the repeat motif that gave such
an intense signal on the Southern blot lay within the unsequenced central region. At this point,
the two options available were to design primers from the recovered information and to
extend sequencing to reach the putative (AAAT), repeat, or to use vectorette PCR to directly
identify the repeat without sub-cloning. The latter method was applied for the development of
polymorphic (AAA T), repeat markers.
4.1.2 Vectorette peR
The vectorette PCR method allows for the rapid characterisation of micro satellites from large
cloned inserts, by targeting the sequence of interest directly, and thereby obviating the need to
sub-clone the inserts (section 2.7.6). To this end, characterisation of the (AAA T), repeat,
within cosmid 24493, was pursued using the vectorette PCR strategy. A PCR product was
generated on amplification of the A/uI vectorette library using anchored primer (AAA T)4-C
and vectorette primer 224 (Table 3.1) and subsequently sequenced using primer 10108.
Primer 24493F (repeat-flanking sequence) was designed from the resulting sequence (Figure
3.8b). The second repeat-flanking sequence primer 24493R was then designed from the
sequence of a PCR product amplified using primers 24493F and 224 (Figure 3.9b). To
characterise the putative repeat sequence harboured within this cosmid, primers 24493F and
24493R were then used to PCR-amplify and sequence the putative repeat locus in the cosmid
24493 A/uI library (Figure 3.10b). Unfortunately, no (AAAT)n repeat motif was detected
(Figure 3.1Oe). To verify that the region amplified from the cosmid library was human
genomic DNA, a DNA sample of an individual belonging to a PFHBI family was PCR
amplified with primers 24493F and 24493R and the generated products were identical in size
to those obtained in the cosmid (Figure 3.1Oa).
The (AAAT)n STR harboured in cosmid 20381, as indicated by the single strong signal on the
Southern blot (Figure 3.2, lane 6), was also characterised using the vectorette PCR method. A
Pï.R product was obtained on amplification of the RsaI vectorette library using the anchored
primer (AAA T)4-G and vectorette primer 224 (Table 3.2), which was subsequently sequenced
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and primer 20381F (repeat-flanking sequence) was designed from this information (Figure
3.l1c). The second repeat-flanking sequence primer 20381R was designed from the sequence
ofa PCR product amplified using primers 20381F and 224 (Figure 3.12c). To characterise the
putative repeat sequence harboured within this cosmid, primers 20381F and 20381R were
then used to PCR-amplify and sequence the repeat locus in cosmid 20381 RsaI library.
However, again no (AAAT)n repeat motif was detected and furthermore, PCR-amplification
of human genomic DNA with the same primer pair did not yield any product. The information
sequenced with primer 20381R was used to design a new primer 20381R' (Figure 3.13),
which was subsequently used with 20381F to PCR-amplify and sequence a new product
(Figure 3.14a). No (AAAT)n repeat motif was detected on sequencing of this new template
(Figure 3.14c), however, PCR-amplification of human genomic DNA using primer pair
20381 F and 20381 R' did generate a product identical in size to that seen in the cosmid
(Figure 3.14a).
Considering the intensity of the signals given by both cosmids 20381 and 24493 on the
Southern blot (Figure 3.2, lanes 6 and 12), it was surprising that no (AAAT)n STR was
identified. Nevertheless, there are a few possible explanations for the results obtained in the
present study. The polymerase chain reaction is influenced by a number of parameters,
including, the magnesium ion concentration and primer-annealing temperature. The vectorette
PCR relies heavily on the annealing of the repeat-anchored primer to the repeat sequence of
interest. Therefore, if the annealing conditions are not optimal, the anchored primer might
anneal at the incorrect place(s), and subsequent amplification may generate multiple spurious
products. However, this was unlikely to be the case with cosmids 20381 and 24493, as
specific, single band PCR products were obtained.
The use of AfT-rich PCR primers is generally not recommended, as they have relatively low
annealing temperatures, and thus stringency of the PCR may be reduced (Lindblad et al.,
1994). The composition of the primer sequence determines the Tm and, using the formula Tm
= 2(A + T) + 4(G + C), primers that are AfT-rich will have a lower Tm than GfC-rich ones
(Thein and Wallace, 1986). Thus, an ideal primer sequence should have at least 50-60% GfC
to increase the Tm, which will favourably influence the stringency and specificity of the PCR.
Hence, using primers that consist of more than 94% AfT nucleotide bases (e.g., (AAAT)4-N)
would result in a lowered Tm and lowered stringency of annealing. Therefore, it is possible
that because of the low Tm used in vectorette PCR (34°C and 36°C, see table 2.2), the
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generated product resulted from the transient annealing of the repeat-anchored primer to the
single AAA T motif identified in the different templates (Figures 3.11c and 3.I5c).
4.1.3 Subeloning vs vectorette PCR
Using the sub-cloning method, an interrupted (AAAT)n repeat was identified, however, it was
not polymorphic. The successful development of microsatellites using vectorette PCR has
been reported in the literature (Rothuizen and Van Raak, 1994; Lench et al., 1996), however,
most concerned the development STR other than the AlT -rich microsatellites. Although both
methods work well, the vectorette PCR-based strategy is more rapid than sub-cloning. In
retrospect, the suggestion for follow-up studies is to either use longer A/T-rich repeat-
anchored primers, which would increase the annealing temperature and hence the stringency
of the PCR or use other non-AfT-rich primer sequences.
4.2 CANDIDATE GENES: MUTATION SCREENING
4.2.1 Glycogen Synthase (GSYI)
Five GSYI exons, 4, 5, 11, 12 and 16, out of sixteen were selected, based on their
conservation across species (Figure 3.15), and analysed in PFHBI pedigrees 1, 2 and 5 for
disease-causing mutations by PCR-SSCP analysis. Although pedigrees 1 and 5 have the same
phenotype and share the same haplotype across the PFHBllocus, no ancestral link, with each
other or the larger pedigree 2, has as yet been established (Brink et al., 1995). Therefore, it
was considered prudent to analyse all three pedigrees in case the disease was caused by
different mutations in the same candidate gene. No mobility shifts were observed in any of the
five exons, in any of the individuals analysed by conventional PCR-SSCP (Figure 3.16).
However, the amplification products of GSYI exons 4 and 16, which were 379bp and 361bp,
respectively, were re-analysed by RE-based PCR SSCP for mobility shifts that might have
been missed, as the fragments were not of ideal size for conventional SSCP analysis. A
variety of conformers of the 185bp HinjI-digested fragment of amplified exon 4 were
observed in both PFHBI-affected and control samples, however, none of these segregated
with the disease (Figure 3.18). Further analysis of the HinjI-digested products of exon 4 on
the more SSCP-sensitive 0.35x MDE™ gel also showed different conformers. These
conformers were not consistent, hence impossible to score for phenotype-genotype
correlation. Furthermore, on analysis of the different conformers, no one set of conformers
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was seen only in PFHBI-affected individuals or exclusively in their close relatives and thus,
none of the observed conformers were associated with the disease. Taking into consideration
that none of the observed mobility shifts had accompanying heteroduplex complexes it was
thus concluded that, the reason for the observed variations is possibly because the PCR-
amplified Hil?fI-digested products was able to assume more than one stable form, which
appeared on the gel as mobility shifts. No mobility shifts were detected in the MboII- or StyI-
digested exon 16 fragments.
The PCR-SSCP method of mutation detection can detect approximately 80% of sequence
variants (Sheffield et al., 1993), however, the application of four different PAGE conditions
increases the likelihood of detecting mutations to close to a 100% (Ravnik-Glavac et al.,
1994). Therefore, the absence of mobility shifts in GSYI exons 4,5,11,12 and 16 analysed
under several different conditions, virtually excludes these exons from carrying the PFHBI-
causative mutation(s).
4.2.2 Histidine-rich calcium binding protein (HRC)
Exons 2-6 of HRC encoding the conserved C-terminus were selected and screened for PFHBI-
causing mutations. However, as only 10bases of intronic sequence, representing either the 3'
or 5' end of each exon, had been published (Hofmann et al., 1991), it was necessary to use
part of the exonic sequence to design PCR primers. Exons 2-5 were very small in length,
ranging between 37bp and 71bp, thus, on sequencing, some 5' - or 3' -most exonic sequence
might be completely missed because generally reads start at approximately 20-30 bases away
from the primer complementary sequence. Furthermore, disease-associated mutations in the
splice sites might also be missed. Therefore, primers were designed such that they would
amplify regions spanning two to three exons, including the intervening intron(s) (Figure 2.5),
with the advantages that adjacent intronic sequence would be obtained while screening some
of the splice sites for possible PFHBI-causing mutations. The acquired intronic sequence
information was then used to design new PCR primers for complete HRC exon screening,
including the previously missed intron/exon junctions, which would allow detection of their
respective splice-site mutations. From each of the PFHBI pedigrees (Figure 2.1), DNA
samples of an affected individual and an unaffected close relative were compared, in order to
detect sequence variations Figures 3.l9a and 3.20a).
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Pedigree 5Analysis
No sequence variations were observed in exons 2-6 of HRC in the pedigree 5 samples that
were analysed. An A to T and a G to T double substitution, creating the Xholl and Sau3A 1
restriction enzyme sites, respectively, was observed in intron B (nucleotide positions 16 and
17 at the 5'-end of intron B) (Figure 3.18). The first 22 bases at the 5'-end of introns are
considered critical for the exon-splicing machinery of cells, therefore, these sequence
variations were within the splice site critical region. However, these sequence changes were
not confirmed by digestion using the appropriate restriction enzymes and, thus, excluded as
being cause of PFHBI, in all three pedigrees.
Pedigree 2 Analysis
No sequence changes were observed in HRC exons 2, 4, 5 and 6 of the pedigree 2 samples
analysed. However, a GAA to GCC double substitution, which would cause a predicted
glutamic acid to alanine amino acid change, was observed in HRC exon 3 (region 2-B-3) in
PCR-amplified from an unaffected individual from pedigree 2 (Figure 3.19). The HRC region
2-B-3 of a different pair ofPFHBI-affected individual and a close relative, taken from another
family in pedigree 2, was PCR-amplified and sequenced. No sequence variations were
observed between the normal and affected individuals' samples. Reanalysis of HRC exon 3
(region B-3-C) in a selection of PFHBI pedigree 2 family members, including the ones that
had previously been sequenced, was done using PCR-SSCP and no mobility shifts were
detected.
Exon 1 of HRC was not screened for mutations in the present study, previously, De Meeus et
al. (1995) and Christoffels (1997) had analysed the GAG and GAT triplet repeats within this
exon for abnormal expansion, which might cause disease in the Lebanese and South African
kindreds. However, no unusual expanded alleles were detected. In the present study, focus
was on mutation screening of conserved exons of HRC (2-6) and, exon I, which is not highly
conserved, was not prioritised. The next logical step would be to screen the entire sequence of
exon 1, which would be a challenging task with the application of the conventional PCR-
SSCP analysis, considering its length of2001bp (Hofmann et al., 1991). However, to exclude
exon 1, mutation screening by other methods, e.g., RE-based PCR-SSCP, although a
cumbersome undertaking, could be performed.
However, recently, Dr Brian Black of the Cardiovascular Research Institute (UC, San
Francisco, USA) contacted our group when he independently decided that HRC was a
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plausible PFHBI candidate both by function and position. He has the complete sequence of
HRC, including the unpublished 5' and 3' UTRs, as well as the complete intronic sequences.
In a collaborative project, Dr. Black's group is sequencing HRC in its entirety, in an PFHBI-
affected individual and an unaffected close relative from each of pedigrees 1, 2 and 5.
4.3 Future Prospects
Although the PFHBI locus has been reduced to a 4cM region, within which lies a lcM-
spanning common core haplotype seen in all affected individuals, the causative gene has not
yet been identified. Therefore, there is still the need for more markers, or sequence tagged
sites (STS), within the target search area, which will be used to integrate the genetic and
physical maps. When this study was initiated, we had available cosmid clones spaced 500kb
apart across the 7cM target interval. Recently, however, we have obtained a BAC and a
cosmid contig spanning the 4cM-search area. With the imminent completion of the Human
Genome Project (Waterston and Sulston, 1998; Marshall, 1999), the total human genome
sequence will be electronically available on the databases. This means that the chromosome
19q 13.3 region sequence will be available for use to identify ESTs and other candidate genes
within the PFHBI locus. In addition, micro satellite sequences within the PFHBI locus will be
readily electronically accessible hence, future development of polymorphic markers is likely
to be in silica.
In the last 5 years, ion channel genes have been identified as the causative genes in long QT
syndrome (KVLQTI, HERG, SCN5A), Brugada's syndrome (SCN5A) and a cardiac
conduction disorder (SeNSA) (as reviewed by Keating and Sanguinetti, 1996; Jongsma,
1998; Barinaga, 1998; Schott et al., 1999). Located between the PFHBI positional candidate
genes, GSYI and HRC, is a potassium ion channel gene, KCNA 7 (Figure 1.5). This gene was
originally mapped in mouse chromosome 7 and, by known synteny between mouse and
human chromosomes, was subsequently placed onto human chromosome 19q 13.3 (Kalman et
al., 1998). Based on the role of ion channels in conduction of the electrical impulse in the
heart, KCNA 7 was considered a strong candidate even though its function had not yet been
established. Mutation screening of this ion channel gene was hindered by the lack of
nucleotide sequence. Recently, however, studies in the murine system have shown that the
mouse orthologue of KCNA7, kcna7 (kvI. 7), is a novel gene that is expressed in mouse heart
(Kalman et al., 1998). In contrast to the other six Shaker-related potassium ion channel genes
(kvI.I-I.6), which have only one exon, kvl.7 consists of two exons interrupted by a 1.9kb
intron. Furthermore, electrophysiological studies of this ion channel in mouse showed that it
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had rapid conduction properties similar to those found in the Purkinje fibres of the human
ventricular conduction system, although this has not yet been confirmed (Kalman et al.,
1998). Therefore, the human homologue, KCNA7 (Kv1. 7), remains a compelling candidate as
a causative gene for PFHBI. Recently, the PFHBI gene search group has entered into
collaboration with Dr Chandy (Kalman et al. 1998) to screen KCNA 7 for disease-causing
mutations.
Finding the PFHBI-causative gene will allow an improved DNA-based diagnosis that will
supersede the current use of genetic markers and can be extended beyond the present limit of
a family setting. Furthermore, it will help elucidate the underlying molecular mechanisms.
This may lead to the development of more directed therapies, which may have application not
only to the rarer forms of familial cardiac conduction disease but also to the more commonly
occurring sporadic cases in the general population.
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APPENDIX I
Buffers, solutions, markers, methods
1. BACTERIAL CELL GROWTH MEDIA
LURlA-BERTANI MEDIUM
NaCI
Tryptone
Yeast extract
ddH20 to Ilitre
Adjust to pH 7.2 with 5M NaOH and autoclave.
10 grams
10 grams
5 grams
LURlA-BERTANI AGAR
NaCI
Tryptone
10 grams
10 grams
Yeast extract 5 grams
Dissolve in 700mI ddH20 and adjust to pH 7.2 with 5M NaOH
Bactor-agar
ddH20 to llitre and autoclave.
15 grams
2. COSMID DNA EXTRACTION
Composition of QIAGE~ plasmid/cosmid purification kit buffers
BUFFER PJ (Resuspension buffer)
Tris-HCI (pH 8)
EDTA
50mM
RNase A
IOmM
IOOllglml
BUFFER P2 (Lysis buffer)
NaOH
SDS
200mM
1%
BUFFER P3 (Neutralisation buffer)
Potassium acatate (pH 5.5) 3.0M
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BUFFER QBT (Equilibration buffer)
Nael
MOPS (pH 7.0)
Ethanol
Triton X-IOO
750mM
50mM
15%
0.15%
BUFFER QC (Wash buffer)
Nael
MOPS (pH 7.0)
Ethanol
1.0M
50mM
15%
BUFFER QF (Elution buffer)
Nael
Tris-Hel (pH 8.5)
Ethanol
I.25M
50mM
15%
3. PLASMID DNA EXTRACTION
SOLUTION I (Resuspension buffer)
Glucose
Tris (pH 8.0)
EDTA
ddH20 to 500ml and autoclave.
50mM
25mM
0.5M
SOLUTION II (Lysis buffer)
NaOH
SDS
ddH20to lml
0.2M
1%
SOLUTION III (Neutralising buffer)
Glacial acetic acid
Potassium acetate
11.5%
3M
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4. HUMAN GENOMIC DNA EXTRACTION
CELL LYSIS BUFFER
Sucrose
Triton X-IOO
MgCh
Tris-HCI, ph 8.0
ddH20 to 1 litre
0.32M
1%
5mM
IOmM
3MNaAc
NaAc.3H20
ddH20
40.8Ig
50ml
Adjust pH to 5.2 with glacial acetic acid (Merck) and adjust volume toIOOml with ddH20.
Na-EDTA SOLUTION
NaCI
EDTA
Mix well.
18.75ml of4M stock solution
250ml of IOOmM stock solution
PHENOVCHLOROFORM
Mix phenol (saturated with IxTE), chloroform and 8-hydroxiquinoline in a ratio of25:24:1.
Store at 4°C.
CHLOROFORMIOCTANOL
Mix chloroform and octanol in a ratio of24:1. Store at 4°C.
METHODOLOGY
PHENOVCHLOROFORM AND CHLOROFORMIOCTANOL EXTRACTION
Add a volume of phenol/chloroform mixture equal to the volume of the sample, which is to be
extracted to the latter sample. Mix well, centrifuge at 13 000 rpm, in a benchtop eppendorf
centrifuge (Beckman model TJ-6) or Sorvall centrifuge (Du Pont Instruments, model RC-5B),
depending on the size of the sample centrifuge tubes, for 5 minutes, to separate the aqueous
phase from the organic phase. Remove top layer (aqueous phase) to a clean tube, and add to it
a similar volume of chloroformloctanol. Mix well, and centrifuge as before. Again, remove
the aqueous phase to a clean tube. This sample can now be ethanol precipitated to extend the
purification process.
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5. COLONY BLOT SOLUTIONS
DENATURING SOLUTION
NaCl
NaOH
ddH20 to llitre
1.5M
0.5M
NEUTRALISING SOLUTION
NaCl
Tris (pH 8)
ddH20 to llitre
1.5M
0.5M
PRE-WASH SOLUTION
SSC
SDS
EDTA
ddH20 to llitre
5X
0.5%
ImM
6. HYBRIDISATION STOCK SOLUTIONS
20XSSC
NaCl
Na citrate
0.15M
0.015M
lOOXDENHARDT'S SOLUTION
Fico1l400
Polyvinylpyrrolidine
BSA Fraction
Store at -20°C
0.025mM
0.027mM
2% (weight/volume)
20XSSPE
NaCl
Na2HP04
NaH2P04
SDS
PEGgooo
125mM
17mM
8mM
173mM
12,5Mm
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7. Solutions for Membrane Filters
PRE-HYBRIDISATION SOLUTION
20X SSPE
100X Denhardt's
10% SDS
Sonicated E. coli DNA
ddH20 to 80ml
20ml
4ml
1.6ml
5mglml
HYBRIDISATION SOLUTION
20X SSPE
lOOXDenhardt' s
10% SDS
Sonicated E. coli DNA
ddH20 to 80ml
y_32p[dATP] labelled (AAAT)lO oligo (Ipmol/ul)
20ml
4ml
1.6ml
5mglml
5-10 pmol
POST-HYBRIDISATION WASH SOLUTION
SSC
SDS
2X
0.1%
8. STOCK SOLUTIONS
30%ACRYLAMIDE STOCK SOLUTION FOR POLYACRYLAMIDE GELS
Acrylamide 30g
Bis-acrylamide 0.8g
Add H20 to 100ml, mix on magnetic stirrer for 2 hours, filter and store at 4°C.
lO%AMMONIUM PERSULPHATE
Ammonium persulphate
H20
Mix well and store at 4°C.
19
lOml
ETHIDIUM BROMIDE (lOmg/ml)
Ethidium bromide
H20
500mg
50ml
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Stir well on magnetic stirrer for 4 hours, store in a dark container at 4°C.
STEBUFFER
NaCI
Tris-HCI (pH 8.0)
EDTA
100mM
10mM
1mM
lOX TBE BUFFER STOCK SOLUTION
Tris-OH
Boric Acid
Na2EDTA
0.89M, pH 8.0
0.89M
20mM, pH 8.0
lOX TE BUFFER STOCK SOLUTION
Tris-HCI
EDTA
O.lM, pH 8.0
0.01M, pH 8.0
9. AGAROSE GEL SOLUTIONS
Concentration 0.7% 1% 1.5% 2%
Agarose (g) 0.35 0.5 0.75 1.0
lOx THE stock (ml) 5 5 5 5
H20 (ml) 45 45 45 45
Melt agarose (FMC) in a microwave oven on mOH power, swirling occasionally until it is
completely dissolved. Cool the solution for 10' to 50°C - 60°C and then add 5~1 ethidium
bromide (l Omg/rnl) prior to casting.
10. POLYACRYLAMIDE GEL SOLUTIONS FOR RE-DIGESTION ANALYSIS AND
SEQUENCING
12% NON-DENATURING POLYACRYLAMIDE GEL SOLUTION
30% acrylamide stock solution 8ml
lOx TBE stock solution 2ml
ddH20
10% ammonium persulphate
lOml
160~1
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TEMED
5% DENATURING POLYACRYLAMIDE GEL SOLUTION
30% acrylamide stock solution 10.8ml
lOxTBE stock solution 6ml
Urea 26.64g
12.75ml
Stir well with a magnetic stirrer until all urea is dissolved, then add
10% ammonium persulphate 500JlI
TEMED
METHODOLOGY
CASTING OF SEQUENCING GELS
Glass plates are prepared by carefully and meticulously washing both plates with detergent.
Any traces of detergent are subsequently removed by wiping the plates with 70% ethanol, and
drying them thoroughly. The notched plate is then silanised with Wynn's C-thru windshield
rain dispersant (Wynn Oil S.A. Pty Ltd, SA) to allow the gel to remain stuck to the large plate
upon dismantling after electrophoresis. Spacers of 0.35mm (SSLP analysis gels) or 0.5mm
(sequencing gels) thickness are placed lengthwise at the edges of the large glass plate, and the
notched plate placed silanised side-down on top of these spacers. This assembly is
subsequently sealed with the use of a rubber boot (S2 casting boot, Life ™ Technologies) and
the gel poured with the glass assembly slanted at a slight angle. The glass assembly is
subsequently layed down horizontally and the loading front formed with a top spacer of
identical thickness to the lengthwise spacers. The gel is allowed to set for 1-2 hours,
whereupon the top spacer is removed and replaced by a sharkstooth comb to separate wells
for loading of samples.
11. SSCP ANALYSIS GEL SOLUTIONS
O.35X MDE GEL SOLUTION
2xMDE™stock solution (FMC)
lOxTBE stock solution
H20
10%ammonium persulfate
TEMED
28ml
9.7ml
122ml
1.6ml
160JlI
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5% NON-DENATURING POLYACRYLAMIDE GEL SOLUTION WITH 10%
GLYCEROL
30% acrylamide stock solution
lOx TBE stock solution
Glycerol
H20
lO% ammonium persulphate
TEMED
27ml
8ml
16ml
l08ml
1.6ml
l60~1
10% NON-DENATURING POLYACRYLAMIDE GEL SOLUTION WITH 10%
GLYCEROL
30% acrylamide stock solution
lOx TBE stock solution
Glycerol
H20
10% ammonium persulphate
TEMED
54ml
8ml
l6ml
8Iml
l.6ml
I60~1
8%MILDLY-DENATURING POLYACRYLAMIDE GEL SOLUTION
30% acrylamide stock solution 32.4ml
lOx TBE stock solution 8ml
Urea
Glycerol
H20
10% ammonium persulphate
TEMED
24g
8ml
91.8ml
1.6ml
160~1
10%_MILDLY-DENATURING POLYACRYLAMIDE GEL SOLUTION
30% acrylamide stock solution 40.5ml
lOx TBE stock solution 8ml
Urea
Glycerol
H20
lO% ammonium persulphate
TEMED
24g
8ml
84ml
1.6ml
I60~1
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METHODOLOGY
CASTING OF SSCP GELS
Glass plates are prepared by carefully and meticulously washing both plates with detergent.
Any traces of detergent are subsequently removed by wiping the plates with 70% ethanol, and
drying them thoroughly. The notched plate is then silanised with Wynn's C-thru windshield
rain dispersant (Wynn Oil S.A. Pty Ltd, SA) to ease the separation ofthe gel from the notched
plate upon dismantling after electrophoresis. More 70% ethanol is now sprayed on the inner
surface of the large glass plate. A sheet of Gelbond™ (FMC Bioproducts, Rockland, Maine,
USA), cut to the same size as the large glass plate, is placed, hydrophobic side down, on this
plate, taking care not to remove the protective sheet of paper from the hydrophilic side of the
nylon membrane. Air bubbles trapped between the Gelbond™ and the glass are removed by
careful rubbing over the protective sheet of paper with a piece of paper towel. Subsequently,
this sheet of paper is removed from the nylon membrane and spacers of lrnm (SSLP analysis
gels) thickness placed lengthwise at the edges of the large glass plate. The notched plate is
placed silanised side-down on top of these spacers. This assembly is subsequently sealed with
the use ofa rubber boot (S2 rubber casting boot, Life™ Technologies) and the gel poured with
the glass assembly slanted at a slight angle. The glass assembly is subsequently layed down
horizontally and a square-tooth well-forming comb inserted. The gel is then allowed to set for
1-2 hours.
12. MOLECULAR SIZE MARKER
)J'st
Bacteriophage A genomic DNA
PstI (40U/JlI)
BufferH
ddH20
(SOJlg) 200JlI
3JlI
30JlI
67JlI
Incubate at 37°C for 2 hours, heat inactivate enzyme at 65°C for 5'. Use IJllofthis marker on
polyacrylamide gels, which will be silver stained, or 3JlI on ethidium bromide stained agarose
gels.
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Fragment sizes (bp):
11497, 5077,4749,4507,2838,2560,2459,2443,2140, 1986, 1700, 1159, 1093, 805, 514,
468,448,339,264,247,216,211,200,164,150,94,87,72.
13. LOADING DYES
BROMOPHENOL BLUE LOADING DYE FOR AGAROSE AND POLYACRYLAMIDE
GEL ELECTROPHORESIS
Bromophenol blue
Glycerol
Tris-CI, pH 8
0.1% (w/v)
60% (v/v)
10mM
Vortex to mix. This loading dye is deliberately not as intensely coloured as conventional
loading dyes in order to prevent masking of small PCR amplified DNA fragments on agarose
gels.
SSCP LOADING DYE
Bromophenol blue
Xylene cyanol
Formamide
NaOH
EDTA
0.1% (w/v)
0.1% (w/v)
95% (v/v)
10mM
20mM
Mix well. Aliquot and store at -20°C.
SEQUENCING STOP SOLUTION
Bromophenol blue
Xylene cyanol
Formamide
0.1% (w/v)
0.1% (w/v)
95% (v/v)
14. SILVER STAINING of NON-DENATURING POLYACRYLAMIDE GELS
AgN03 SOLUTION (0.1%)
AgN03
ddH20
19
1 litre
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DEVELOPING SOLUTION
NaOH
NaBH4
Formaldehyde
ddH20 to 1 litre
15g
O.lg
4ml
Mix well on magnetic stirrer until all NaOH pellets are dissolved.
METHODOLOGY
SILVER STAINING OF POLYACRYLAMIDE GELS
Dismantle gel casting plates and gently immerse polyacrylamide gel into a shallow receptacle
containing freshly prepared AgN03 solution, agitate for 10'. Pour off the AgN03 solution and
rinse both sides of the gel well with ddH20. Add freshly prepared developing solution and
agitate the gel in this solution until DNA fragments become visible as bands on the gel. Pour
the developing solution off, rinse the gel in ddH20 and air-dry (SSCP gels) and/or photograph
(12% polyacrylamide ASREA gels).
15. X-RAY FILM DEVELOPING
DEVELOPING SOLUTION
Polycon A variable contrast X-ray developer Polycon A
(Champion Photochemistry Pty Ltd, Midrand, SA) solution
Polycon A variable contrast X-ray developer solution 2
ddH20
litre
1.98 litre
18.1ml
9.9
STOP SOLUTION
Glacial acetic acid
Make up to 9 litres with ddH20
540ml
FIXING SOLUTION
Perfix (Champion Photochemistry Pty Ltd, Midrand, SA)
Hardener-S (Champion Photochemistry Pty Ltd, Midrand, SA)
Make up to 9 litre with H20.
1.8 litre
225ml
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METHODOLOGY
The X-ray film is clamped to a stainless steel frame under red light, and is immersed into the
developing solution for 4 min, then into the stop solution for 30 sec and fmally into the
developing solution for 2 min. Thereafter, the film is rinsed well with H20, after which it is
allowed to air-dry.
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a?2P-dCTP
Ampicilin
Agarose
Agar
Ammonium persulphate
Acetic acid
AgNo3
Acrylamide
Bis-acrylamide
BSA
Boric acid
5-Bromo-4-chloro-3-indoyl-I3-D
galactopyranoside
Bromophenol blue
(AAAT)1Ooligomer
CaCh
Chloroform
dATP
dCTP
dGTP
dTTP
E. coli host cell line, DH5a
E. coli, XL 1 Blue competent cells
Ethanol
Ethidium bromide
EDTA
Fico1l4000
fmo I'M sequencing kit
Formamide
Formaldehyde
GLAD®WRAP
Glycerol
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APPENDIX II
List of Suppliers
Amersham
Sigma
Seakem
Difco Laboratories
Merck
BDH Chemicals
Merck
BDH Chemicals
Merck
Seravae
Merck
Boehringer Mannheim
BDH Chemicals
DNA Synthesis Laboratory, UCT
Merck
BDH Chemicals
Boehringer Mannheim
Boehringer Mannheim
Boehringer Mannheim
Boehringer Mannheim
Stratagene, USA
Startagene, USA
Boehringer Mannheim
Sigma
Boehringer Mannheim
Merck
Promega
Merck
Merck
Multifoil Trading (Pty) Ltd.
BDH Chemicals
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Glucose BDH Chemicals
y32p_dATP Amersham
Hydrochloric acid BDH Chemicals
Iso-amyl alcohol Merck
Isopropyl-J3-D-thio-galactopyranoside Boehringer Mannheim
Hybond W membrane Amersham
Potassium acetate Sigma
Kanamycin Sigma
KpnI Promega
Lambda DNA Promega
Lysozyme Boehringer Mannheim
MgCh Sigma
Mineral oil BDH Chemicals
3 MM Whatman paper Merck
MOPS Sigma
NaCI BDH Chemicals
Na citrate BDH Chemicals
Na2HP04 BDH Chemicals
NaH2P04 BDH Chemicals
NaOH Merck
Na acetate Merck
Octanol Merck
One-Phor-All buffer Pharmacia
pBluescript SK vector Stratagene, USA
PEGsooo Pharmacia
Proteinase K Sigma
Phenol Merck
Polyvinylpyrolidine Sigma
PstI Promega
Qiagen ® plasmid purification kit Stratagene
RNase A Sigma
Sau3Al Promega
San Premega
SDS Sigma
Sephadex G25 gel Pharmacia
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GFX™ gel band purification kit
Taq Polymerase
T4 DNA ligase
T4 polynucleotide kinase
T3 and T7 vector primers
Temed
Tetracycline
Tris
Triton X-IOO
Tryptone
Trichloric acid
Urea
X-ray film
Xyl-enoeyano 1
Yeast estract
Amersham
Promega
Promega
Promega
Stratagene, USA
Promega
Sigma
Merck
BDH Chemicals
Biolab
Merck
BDH Chemicals
Protea
M&B Laboratory- Ch~cals
Oxoid
....
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August 1997:
October 1997:
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APPENDIX III
CONFERENCE PRESENTATIONS
Makubalo Z, Christoffels A, ArieffZ, De Jager T, Brink P,
Corfield V.
Closing in on the progressive familial heart block gene: candidate gene
screening and refming the search area.
4Ft Academic Year Day, Faculty of Medicine, University of
Stellenbosch.
Makubalo Z, Christoffels A, ArieffZ, De Jager T, Brink P, Corfield V
Attractive candidates and great looking maps: their role in the search
for the PFHB gene.
Experimental Biology Group 14rt General Meeting ..
Poster
May 1997: Makubalo Z, Christoffels A, Arieff Z, De Jager T, Brink P, Corfield V.
Mutation screening of GSYl and HRC: Progressive Familial Heart Block I
candidate genes and generation oftetranucleotide repeat genetic markers.
Seventh Biennial Southern African Society of Human Genetics. Pilanesberg.
(First prize for Best Poster)
Presented also at the Mutation detection workshop in Hinxton, Cambridge, UK
(September 1998).
March 1999: Makubalo Z, Moolman-Smook J, Brink P, Corfield V.
PFHBI gene update: DIY intronic sequencing and marker generation.
Eighth Biennial Southern African Society of Human Genetics. Gordon's Bay.
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